EP1341772A2 - Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests - Google Patents

Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests

Info

Publication number
EP1341772A2
EP1341772A2 EP01996125A EP01996125A EP1341772A2 EP 1341772 A2 EP1341772 A2 EP 1341772A2 EP 01996125 A EP01996125 A EP 01996125A EP 01996125 A EP01996125 A EP 01996125A EP 1341772 A2 EP1341772 A2 EP 1341772A2
Authority
EP
European Patent Office
Prior art keywords
chloro
halogen
alkyl
ring
ffl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01996125A
Other languages
German (de)
French (fr)
Inventor
Gary David Annis
Brian James Myers
Thomas Paul Selby
Thomas Martin Stevenson
William Thomas Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of EP1341772A2 publication Critical patent/EP1341772A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Definitions

  • This invention relates to certain quinazolinones and pyridinylpyrimidinones, their
  • N-oxides N-oxides, agriculturally suitable salts and compositions, and a method of use for controlling invertebrate pests in both agronomic and nonagronomic environments.
  • invertebrate pests The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer.
  • the control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action.
  • WO 99/14202 discloses pyrimidin-4-one and pyrimidin-4-thiones of Formula i as fungicides
  • X is O or S
  • A is fused phenyl or pyridyl
  • Rl and R2 are selected from H, halogen or trimethylsilyl
  • R3 is -Cg alkyl, Cj-Cg alkenyl or C j -Cg alkynyl, each optionally substituted;
  • R4 is optionally substituted phenyl.
  • This invention pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, its N-oxide or an agriculturally suitable salt of the compound (e.g., as a composition described herein)
  • B is O or S
  • J is a phenyl ring substituted with 1 to 4 R 5 , or a naphthyl ring system, a 5- or
  • K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R 4
  • R 3 is G; Ci-C6 alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C3-C 6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CN, NO 2 , hydroxy, Cj- alkoxy, Cj-C 4 haloalkoxy, C r C 4 alkylthio, C r C 4 alkylsulfinyl, C,-C 4 alkylsulfonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylcarbonyl, C3-C6 trialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from R 6 ; hydroxy; C r C 4 alkoxy; C j -C4 alkylamino; C 2 -C 8 dialkylamino; C 3 -C 6 cycloal
  • each R 4 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R 6 ;
  • each R 5 is independently H, alkyl, C 2 -C6 alkenyl, C 2 -CG alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C -Cg haloalkenyl, C 2 -C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 alkoxy, C C 4 haloalkoxy, C1-C4 alkylthio, Cj-C 4 alkylsulfinyl,
  • haloalkylsulfonyl C C 4 alkylamino, C -Cg dialkylamino, C3-C6 cycloalkylamino, C2-C5 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C -Cg alkylaminocarbonyl, C3 ⁇ C dialkylaminocarbonyl,
  • each R 5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R 6 ; or
  • each R 6 is independently C C 4 alkyl, C 2 -C 4 alkenyl, C -C 4 alkynyl, C3-C6 cycloalkyl, Cj-C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , -C4 alkoxy, Cj-C haloalkoxy, C r C alkylthio, C alkylsulfinyl, C C 4 alkylsulfonyl, -C4 alkylamino, C 2 -Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6
  • RU is H or - alkyl; each R 12 is independently Cj-C 2 alkyl, halogen, CN, NO 2 and C!-C 2 alkoxy; and n is 1 to 4.
  • This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
  • This invention also pertains to a compound of Formula la, its N-oxide or an agriculturally suitable salt of the compound
  • K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R 4
  • J substituted with 1 to 3 R 5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
  • R 3 is Cj-Cg alkyl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C r C 2 alkoxy, Cj-C 2 alkylthio, Cj-C 2 alkylsulfinyl and C1-C2 alkylsulfonyl; one R 4 group is attached to the K-ring at the 2-position or 5-position, and said R 4 is C r C 4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C 4 haloalkoxy, C ⁇ -C 4 alkylthio, C ⁇ -C 4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio,
  • V is N, CH, CF, CC1, CBr or CI; each R 6 is independently C1-C4 alkyl, C 2 -C alkenyl, C 2 -C 4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , C!-C alkoxy, C C4 haloalkoxy, C1-C4 alkylthio, C r C 4 alkylsulfinyl, C r C 4 alkylsulfonyl, C1-C4 alkylamino, C 2 -Cg dialkylamino, C 3 - C 6 cycloalkylamino, C_t,-C 6 (alkyl)cycloalkylamino, C2-C4 al
  • R 9 is H, C 2 -C 6 alkyl, C r C 6 haloalkyl, C 3 -C 6 alkenyl, C 3 -C 6 haloalkenyl, C 3 -C 6 alkynyl or C3-C6 haloalkynyl, provided that R 7 and R 9 are not both H;
  • R 1 0 is H or C !-C 4 alkyl or C ⁇ -C 4 haloalkyl;
  • R 11 is H or C 1 -C 4 alkyl; and n is 0, 1 or 2.
  • This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula la and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
  • This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula la and an effective amount of at least one additional biologically active compound or agent.
  • alkyl used either alone or in compound words such as “alkylthio” or “haloalkyl” includes straight-chain or branched alkyl, such as methyl, ethyl, 72-propyl, t-propyl, or the different butyl, pentyl or hexyl isomers.
  • alkenyl includes straight-chain or branched alkenes such as 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers.
  • Alkenyl can also include polyenes such as 1 ,2-propadienyl and 2,4-hexadienyl.
  • Alkynyl includes straight-chain or branched alkynes such as
  • Alkynyl can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl.
  • Alkoxy includes, for example, methoxy, ethoxy, 77-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers.
  • Alkoxyalkyl denotes alkoxy substitution on alkyl.
  • alkoxyalkyl examples include CH3OCH9, CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • Alkylthio includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers.
  • Cycloalkyl includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • heteroaromatic ring denotes fully aromatic rings in which at least one ring atom is not carbon and can contain 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each heteroaromatic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs (where aromatic indicates that the Hiickel rule is satisfied).
  • the heteroaromatic ring can be attached through any available carbon or nitrogen by replacement of hydrogen on said carbon or nitrogen.
  • halogen either alone or in compound words such as “haloalkyl” includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” include F 3 C, C1CH 2 , CF 3 CH 2 and CF 3 CC1 2 .
  • haloalkenyl “haloalkynyl”, “haloalkoxy”, and the like, are defined analogously to the tenn "haloalkyl".
  • haloalkynyl examples include HC ⁇ CCHCl, CF 3 C ⁇ C, CC1 3 C ⁇ C and FCH 2 C ⁇ CCH 2 .
  • haloalkoxy examples include CF 3 O, CCl 3 CH 2 O, HCF 2 CH 2 CH 2 O and CF 3 CH 2 O.
  • C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl
  • C 2 alkoxyalkyl designates CH 3 OCH 2
  • C3 alkoxyalkyl designates, for example, CH 3 CH(OCH 3 ), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2
  • C 4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • Stereoisomers of this invention can exist as one or more stereoisomers.
  • the various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers.
  • one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s).
  • the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
  • the present invention comprises compounds selected from Formula I, N-oxides and agriculturally suitable salts thereof, compositions thereof and methods of their use for invertebrate pest control.
  • nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides.
  • tertiary amines can form N-oxides.
  • N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and ??.-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane.
  • MCPBA peroxy acids
  • alkyl hydroperoxides such as t-butyl hydroperoxide
  • sodium perborate sodium perborate
  • dioxiranes such as dimethydioxirane
  • the salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • Preferred 2 Methods of Preferred 1 wherein J is a phenyl group substituted with 1 to
  • each R 5 is independently H, halogen, C r C 4 alkyl, C ⁇ -C 2 alkoxy, C C 4 haloalkyl, CN, NO 2 , C r C 4 haloalkoxy, C r C 4 alkylthio, C r C 4 alkylsulfinyl, C1-C4 alkylsulfonyl, -C4 haloalkylthio, C r C 4 haloalkylsulfinyl, C ⁇ -C 4 haloalkylsulfonyl or C 2 -C alkoxy
  • R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, CF 3 , OCF3, OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen;
  • a second R 4 is H, F, Cl, Br, I or CF 3 ;
  • each R 5 is independently H, halogen, methyl, CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 or S(O) p CF 2 CHF 2 ; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with C ] -C 4 alkyl, Cj-C 4 haloalkyl,
  • J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R 5
  • Q is O, S or NR 5 ;
  • W, X, Y and Z are independently N or CR 5 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N.
  • R 4 is C r C 4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C 4 haloalkoxy, C r C 4 alkylthio, C r C 4 alkylsulfinyl, C r C 4 alkylsulfonyl, 0 ⁇ 4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C1-C4 haloalkylsulfonyl; and each R 5 is independently H, C r C 4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 ,
  • J substituted with 1 to 3 R 5 is selected from the group consisting of J-6, J-7, J-S, J-9, J-10, J-l l, J-12 and J-13
  • V is N, CH, CF, CC1, CBr or CI; each R 7 is independently H, C Cg alkyl, C j -Cg haloalkyl, halogen, CN,
  • R 9 is H, C 2 -C 6 alkyl, C r C 6 haloalkyl, C 3 -C 6 alkenyl, C 3 -C 6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R 7 and R 9 are not both H; and n is 0, 1 or 2.
  • Preferred 10 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-6;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and
  • R 7 is halogen or CF 3 .
  • Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-7;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and
  • p is 0, lor 2.
  • R 6 is Cl or Br
  • R9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Preferred 14 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-S; R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • a second R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN R 6 is CH 3 , CF 3 or halogen;
  • R 7 is CH 3 , CF 3 or halogen; and p is 0, 1 or 2.
  • Preferred 15 Methods of Preferred 14 wherein R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and
  • R 7 is halogen or CF 3 .
  • Preferred 16 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-9;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 7 is CH 3 , CF 3 or halogen; and p is 0, 1 or 2.
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is Cl or Br; and R 7 is CF 3 .
  • Preferred 18 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-10; R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and
  • p is O, lor 2.
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is Cl or Br
  • R 9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Preferred 20 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-l 1;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, CF 3 , OCF3, OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is C r C 4 alkyl, C C 4 haloalkyl, halogen or CN; R 7 is CH 3 , CF 3 , OCHF 2 or halogen; and p is 0, 1 or 2.
  • Preferred 21 Methods of Preferred 20 wherein
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and
  • R 7 is halogen or CF3.
  • Preferred 22 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-l 2;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, Cj-C haloalkyl, halogen or CN;
  • R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and
  • p is 0, lor 2.
  • R 3 is C r C 4 alkyl
  • one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br
  • a second R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is Cl or Br
  • R 9 is CF 3 . CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Preferred 24 Methods of Preferred 9 wherein J substituted with 1 to 3 R 5 is J-l 3; R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and
  • p is 0, lor 2.
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and R 9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • the compound of Formula I is selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl-
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 7 is CH 3 , CF 3 , OCHF 2 or halogen; and
  • p is 0, 1 or 2.
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and R 7 is halogen or CF3.
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, CF 3 , OCF3, OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN; R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and p is 0, lor 2.
  • Preferred D Compounds of Preferred C wherein
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and
  • R 9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Preferred E. Compounds of Formula la wherein J substituted with 1 to 3 R 5 is J-8;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3,
  • a second R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN
  • R 6 is CH 3 , CF 3 or halogen
  • R 7 is CH 3 , CF 3 or halogen
  • p is 0, 1 or 2.
  • Preferred F Methods of Preferred E wherein R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and R 7 is halogen or CF3.
  • Preferred G Compounds of Formula la wherein J substituted with 1 to 3 R 5 is J-9;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, CF 3 , OCF3, OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN; R 7 is CH 3 , CF 3 or halogen; and p is 0, 1 or 2.
  • Preferred H Compounds of Preferred G wherein
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and
  • R 7 is CF 3 .
  • Preferred I Compounds of Formula la wherein J substituted with 1 to 3 R 5 is J-10;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and
  • p is 0, lor 2.
  • Preferred J Compounds of Preferred I wherein R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , Cl or Br; a second R is H, F, Cl, Br, I or CF 3 ;
  • R 6 is Cl or Br
  • R 9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Preferred K Compounds of Formula la wherein J substituted with 1 to 3 R 5 is J-l 1; R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C1-C4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 7 is CH 3 , CF 3 , OCHF 2 or halogen; and
  • p is 0, 1 or 2.
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and R 7 is halogen or CF3.
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 , CF 3 , OCF3, OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN; R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and p is O, lor 2.
  • Preferred N Methods of Preferred M wherein
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and
  • R 9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Compounds of Formula la wherein J substituted with 1 to 3 R 5 is J-l 3;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH 3 ,
  • R 4 is H, F, Cl, Br, I or CF 3 ;
  • R 6 is C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 9 is C 2 -C 6 alkyl or C r C 6 haloalkyl; and
  • p is 0, lor 2.
  • R 3 is C r C 4 alkyl; one R 4 group is attached to the K-ring at the 2-position and said R 4 is CH3, Cl or Br; a second R 4 is H, F, Cl, Br, I or CF 3 ; R 6 is Cl or Br; and R 9 is CF 3 , CHF 2 , CBrF 2 , CC1F 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula la and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
  • Preferred compositions are those comprising the above preferred compounds.
  • a method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of a compound of Formula 1 , its N-oxides or agriculturally suitable salts thereof
  • B is O or S;
  • J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 , or a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R 7 ;
  • n is 1 to 4;
  • R 3 is C Cg alkyl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl; C1-C4 alkoxy; C1-C4 alkylamino; C2-Cg dialkylamino; C3-C6 cycloalkylamino; C 2 -Cg alkoxycarbonyl or C 2 -Cg alkylcarbonyl; each R 4 is independently H, Cj-Cg alkyl, C 2 -Cg alkenyl, C 2 -C6 alkynyl, C3-C6 cycloalkyl, C j -
  • each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, C 2 -C4 alkenyl, C 2 -C 4 alkynyl, C3-C6 cycloalkyl, C 1 -C4 haloalkyl, C 2 -C4 haloalkenyl, C 2 -C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C 4 haloalkoxy, C r C 4 alkylthio, C r C 4 alkylsulfinyl,
  • each R 5 is independently Cj-Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C 2 -C haloalkenyl, C -Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 ,
  • each R 6 is independently H, halogen, C r Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl,
  • each R 6 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with - alkyl, C -C 4 alkenyl, C 2 -C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C -C4 haloalkenyl, C 2 -C 4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C 4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cj-C alkylamino,
  • each R 7 is independently a phenyl, benzyl, benzoyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C1-C4 alkyl, -C4 alkenyl, C -C4 alkynyl, C3-C6 cycloalkyl, C1-
  • J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 ; or J is selected from the group consisting of pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R 7 ;
  • R 3 is C 2 -C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ;
  • each R 4 is independently CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 or halogen;
  • each R5 is independently CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 ,
  • each R 6 is independently halogen or methyl; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN; each R 7 is independently H, halogen, CH 3 , CF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 , S(O) p CF 2 CHF 2 ; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C 1 -C4
  • J is a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 5 .
  • the term "optionally substituted" in connection with these J groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog.
  • R 5 An example of phenyl optionally substituted with 1 to 4 R 5 is the ring illustrated as U-l in Exhibit 1, wherein R v is R 5 and r is an integer from 1 to 4.
  • R v is R 5 and r is an integer from 1 to 4.
  • R v is R 5 and r is an integer from 1 to 4.
  • Examples of 5- or 6-membered heteroaromatic rings optionally substituted with 1 to 4 R 5 include the rings U-2 through U-53 illustrated in Exhibit 1 wherein R v is R 5 and r is an integer from 1 to 4.
  • J-l through J-5 below also denote 5- or 6-membered heteroaromatic rings.
  • U-2 through U-20 are examples of J-l
  • U-21 through LI-35 and U-40 are examples of J-2
  • U-36 through U-39 are examples of J-3
  • U-41 through U-48 are examples of J-4
  • LT-49 through U-53 are examples of J-5.
  • Examples of aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems optionally substituted with 1 to 4 R 5 include U-54 through LT-84 illustrated in Exhibit 1 wherein R v is R 5 and r is an integer from 1 to 4.
  • R v groups are shown in the structures U-l through U-85, it is noted that they do not need to be present since they are optional substituents. Note that when R v is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or R v . Note that some U groups can only be substituted with less than 4 R v groups (e.g.
  • G groups include those illustrated as G-l through G-41 in Exhibit 2 wherein m is an integer from 1 to 4.
  • the term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog.
  • (R 12 ) m are illustrated in the examples, they need not be present since they are optional substituents. Note that when the attachment point on these G groups is illustrated as floating, the G group can be attached to the remainder of Formula I through any available carbon or nitrogen of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon or nitrogen by replacing a hydrogen atom. Note that when G comprises a ring selected from G-24 through G-29 and G-32 through G-35, A is selected from O, S, NH or NR 12 .
  • R 3 can be (among others) Cj-Cg alkyl, C 2 -C6 alkenyl, C 2 -Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from (among others) a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R 6 .
  • the tem "optionally substituted" in connection with these groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog.
  • substituents include the rings illustrated as U-l through U-53 and U-8S illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R 6 rather than (R v ) r Note that R 6 substituents do not need to be present since they are optional substituents.
  • each R 4 is independently (among others) a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R 6 .
  • the term "optionally substituted" in connection with these R 4 groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such R 4 groups include the rings illustrated as U-l through U-53, U-86 and U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R 6 rather than (R v ) r . Note that R 6 substituents do not need to be present since they are optional substituents.
  • each R 5 is independently (among others) a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R 6 .
  • R 5 groups include the rings illustrated as U-l through U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R 6 rather than (R v ) r . Note that R 6 substituents do not need to be present since they are optional substituents.
  • K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring optionally substituted with 1 to 4 R 4 .
  • the tenn "optionally substituted" in connection with these K groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such K groups include the rings illustrated as K-l through K-5 in Exhibit 3. Note that K-2 through K-5 can be optionally substituted with one to three 3 R 4 groups.
  • the wavy line indicates that the K-ring is attached to the remainder of Formula I as illustrated below.
  • K-rings are K-l , K-2 and K-5. Most preferred is K-l .
  • the compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-13.
  • the definitions of B, J, K, R 3 , R 4 , R 5 and n in the compounds of Formulae I and 2-24 below are as defined above in the Summary of the Invention. Of note are compounds wherein K is K-l .
  • Compounds of Formula lb (Formula I wherein B is O) can be prepared by procedures outlined in Schemes 1-13. A typical procedure is detailed in Scheme 1 and involves dehydration of an o-amido amide of Formula 2 with sodium hydride and ethyl chloro fomiate in a suitable solvent (See e.g. Example 1).
  • Other methods for preparing compounds of Formula I include treating a compound of Formula 2 with acetic anhydride and sodium acetate, heating at greater than 70 °C neat or optionally in an appropriate solvent such as tetrahydrofuran, and treating 2 with a suitable acid scavenger and trimethylsilyl chloride in a suitable solvent. Further useful methods include heating o-amido amides of Formula 2 adsorbed on surface-active materials such as zeolites or clay, generally in the range of 50-150 °C. A specific example of this type is described in Example 2 and involves heating the anthranilic amide on Montmorillonite clay.
  • Compounds of Formula Ic can be prepared by conventional methods for conversion of amides to thioamides such as by treatment with phosphorus pentasulfide or Lawesson's reagent. (See (Bull. Soc. Chim. Belg.), 1978, 87, 229; and (Tetrahedron Lett.), 1983, 24, 3815 for general procedures).
  • Compounds of Formula 2 can be prepared by procedures outlined in Scheme 2.
  • a typical procedure involves coupling of an o-amino amide of Formula 3 with an acid chloride of Formula 4 in the presence of an acid scavenger to provide the compound of Formula 2.
  • Typical acid scavengers include amine bases such as triethylamine, diisopropylethylamine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate.
  • polymer-supported acid scavengers such as polymer-bound diisopropylethylamine and polymer-bound dimethylaminopyridine.
  • An alternate procedure for the preparation of compounds of Formula 2 involves coupling of an o-amino amide of Formula 3 with an acid of Formula 5 in the presence of a dehydrating agent such as dicyclohexylcarbodiimide (DCC).
  • a dehydrating agent such as dicyclohexylcarbodiimide (DCC).
  • DCC dicyclohexylcarbodiimide
  • Polymer supported reagents can be useful here, such as polymer-bound cyclohexylcarbodiimide.
  • acid chlorides of Formula 4 may be prepared from acids of Formula 5 by numerous well-known methods.
  • Formula 3 o- Amino amides are typically available from the corresponding o-nitro amides of Formula 6 via catalytic hydrogenation of the nitro group. Typical procedures involve reduction with hydrogen in the presence of a metal catalyst such as palladium on carbon or platinum oxide and in hydroxylic solvents such as ethanol and isopropanol. These procedures are well documented in the chemical literature.
  • the intermediate amides of Formula 6 are readily prepared from commercially available o-nitro acids of Formula 7. Typical methods for amide formation can be applied here. These include direct dehydrative coupling of acids of Fo ⁇ nula 7 with amines of Formula 8 using for example DCC, and conversion of the acids to an activated form such as the'acid chlorides or anhydrides and subsequent coupling with amines to form amides of Formula 6. Ethylchloro formate is an especially useful reagent for this type of reaction. Scheme 5
  • hitermediate o-amino amides of Formula 3 may also be prepared from anhydrides of Fomiula 9 (Scheme 6). Typical procedures involve combination of equimolar amounts of the amine 8 with the anhydride of Fomiula 9 in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100 °C.
  • polar aprotic solvents such as pyridine and dimethylformamide
  • An alternate procedure for the preparation of compounds of Formula 2 involves reaction of an amine 8 with a compound of Formula 10.
  • Typical procedures involve combination of the amine with the compound of Formula 10 in solvents such as tetrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent.
  • solvents such as tetrahydrofuran or pyridine
  • Benzoxazinones are well documented in the chemical literature and are available via known methods that involve the coupling of either an anthranilic acid or an isatoic anhydride with an acid chloride.
  • Compounds of Fo ⁇ nula I may also be prepared by modification of known procedures (J. Med. Chem. 1985, 28, 568). Usually this involves condensation of an aryl aldehyde of Formula 11 with a compound of Formula 3 in an alcoholic solvent and with a catalytic amount of base to produce intem ediate 12, which is then further oxidized to the Formula I compound by known methods. This reaction is shown in Scheme 8.
  • Preferred catalysts for the synthesis of compounds of Formula Id include but are not limited to Pd(PPh 3 ) , PdCl 2 (PPh 3 ) 2 , PdCl 2 (diphenyl ⁇ hosphinoferrocene), NiCl (PPh 3 )2, and Tetrakis(tri-2- furylphosphino)palladium.
  • Pd(PPh 3 ) PdCl 2 (PPh 3 ) 2
  • PdCl 2 (diphenyl ⁇ hosphinoferrocene) NiCl (PPh 3 )2, and Tetrakis(tri-2- furylphosphino)palladium.
  • the exact conditions for each reaction depend upon the catalyst used and the metal attached to the pyrazole.
  • the additional presence of an external base is necessary for reactions involving pyrazoles of Formula 14 where Met is B(OH) 2 . Similar procedures also can be used for other K-rings and J-groups.
  • Pyrazoles of Formula 14 can be made by lithiation of the pyrazole 17 followed by transmetallation with the appropriate metal as described in Scheme 10.
  • Pyridylpyrazoles 17 are prepared by the reaction of pyrazoles 15 with a 2,3-dihalopyridine of Formula 16 to afford the 1 -pyridylpyrazole 17 with good specificity for the desired regiochemistry.
  • Metallation of 17 with lithium diisopropylamide (LDA) followed by transmetallation with the appropriate metal affords the metal pyrazole of Formula 14.
  • LDA lithium diisopropylamide
  • For conditions and catalysts used in transmetallation and cross coupling reactions see Metal-catalyzed Cross-coupling Reactions. Diederich, Francois; Stang, Peter J.; Editors. 1998, p. 517, (Wiley-VCH, Weinheim, Germany) and references cited therein.
  • the starting pyrazoles 15 are known compounds. Pyrazole 15 wherein R 5 is CF3 is commercially available. Pyrazoles 15 wherein R 5 is Cl or Br can be prepared by literature procedures (Chem. Ber. 1966, 99(10), 3350-7). A useful alternative method for the preparation of 15 wherein R 5 is Cl or Br is depicted in Scheme 11. Metallation of the sulfamoyl pyrazole 19 with ⁇ -butyllithium followed by direct halogenation of the anion with either hexachloroethane (for R 5 being Cl) or 1,2-dibromotetrachloroethane (for R 5 being Br) affords the halogenated derivatives 20.
  • the benzoxazinones of Formula 21 are available by the method of Scheme 13. Coupling of a pyrazole acid of Fomiula 23 with an anthranilic acid of Formula 24 via sequential addition of methanesulfonyl chloride and triethylamine affords the benzoxazinone of Fomiula 21.
  • the intermediate acid of Formula 23 is available from the lithiated pyrazole 18 by quenching with carbon dioxide. Similar procedures also can be used for other K-rings and J-groups.
  • Step C Preparation of S,S-dimethyl-N-[4-(trifluoromethyl)phenyllsulfilimine
  • N-chlorosuccinimide (12.43 g, 93.1 mmol) in -170 mL of dichloromethane was added to a mixture of 4-(trifluoromethyl) aniline (15 g, 93.1 mmol) and dimethyl sulphide (6.35 g, 102 mmol) in 230 mL of dichloromethane at -5 to 0 °C.
  • N-chlorosuccinimide (0.02 g, 4.64 mmol) was added. After a further 30 minutes, the mixture was washed with 500 mL of IN sodium hydroxide.
  • Raney nickel 500 g wet paste, ⁇ 50 ⁇ was added portionwise to a solution of 2-[(methylthio)methyl]-4-(trifluoromethyl)benzenamine (55.3 g, 0.25 mole) in 1 L of ethanol over 30 minutes at 25-30 °C. The heterogeneous mixture was stirred vigorously for
  • This diazonium salt solution was then added portionwise via cannula to a stirred, 95 °C mixture of potassium cyanide (22 g, 0.34 mole), copper sulfate pentahydrate (20 g, 80 mmol) and 140 mL of water. After the addition the mixture was stirred for 30 minutes at 95 °C and then allowed to cool to room temperature. Ether was added and the heterogeneous mixture was filtered through celite. The solids were washed with ether, and the filtrate was partitioned. The aqueous phase was extracted with ether, and the combined organic extracts were dried over magnesium sulfate and concentrated under reduced pressure to afford 13.1 g of the title compound as a brown oil.
  • *H NMR (CDCI3) ⁇ 7.74 (d,lH), 7.60 (s,lH), 7.55 (d,lH), 2.64 (s,3H).
  • Step I Preparation of 2-methyl-N-[2-methyl-6-[ ( l-methylethyl)amino]- carbonyl1phenyl1-4-(trifluoromethyl)benzamide
  • the benzoyl chloride of Step H (0.29 g, 1.3 mmol) was added to a mixture of the aniline from Step B (0.36 g, 1.9 mmol) and diisopropylethylamine (0.26 g, 2.0 mmol) in 10 mL of chloro fo ⁇ n at room temperature. The reaction was allowed to stir overnight. The solid precipitate was filtered and dried to afford 0.38 g of the title compound, as a solid melting at 247-248 °C.
  • Step C Preparation of l-(3-chloro-2-pyridinyl ' )-3-(trifluoromethyl -lH-pyrazole-5- carboxylic acid
  • a solution of the pyrazole product from Step B (105.0 g, 425 mmol) in dry tetrahydrofuran (700 mL) at -75 °C was added via cannula a -30 °C solution of lithium diisopropylamide (425 mmol) in dry tetrahydrofuran (300 mL).
  • the deep red solution was stirred for 15 minutes, after which time carbon dioxide was bubbled through at -63 °C until the solution became pale yellow and the exothermicity ceased.
  • the reaction was stirred for an additional 20 minutes and then quenched with water (20 mL).
  • the solvent was removed under reduced pressure, and the reaction mixture partitioned between ether and 0.5 ⁇ aqueous sodium hydroxide solution.
  • the aqueous extracts were washed with ether (3x), filtered through Celite® diatomaceous filter aid to remove residual solids, and then acidified to a p ⁇ of approximately 4, at which point an orange oil formed.
  • the aqueous mixture was stirred vigorously and additional acid was added to lower the p ⁇ to 2.5-3.
  • Step D Preparation of 6-chloro-2-[T -(3-chloro-2-pyridinyl)-3-(trifluoiOmethyl)-lH- pyrazol-5-yl "
  • acetonitrile 75 mL
  • reaction temperature was then maintained at 0 °C throughout successive addition of reagents.
  • 2-amino-3-methyl-5-chlorobenzoic acid from Step A (5.1 g, 27.0 mmol) was added and stirring was continued for an additional 5 minutes.
  • a solution of triethylamine (7.5 mL, 54.0 mmol) in acetonitrile (15 mL) was then added dropwise, and the reaction mixture was stirred 45 minutes, followed by the addition of methanesulfonyl chloride (2.2 mL, 28.3 mmol).
  • the reaction mixture was then warmed to room temperature and stirred overnight.
  • Approximately 75 mL of water was then added to precipitate 5.8 g of a yellow solid.
  • An additional 1 g of product was isolated by extraction from the filtrate to provide a total of 6.8 g of the title compound as a yellow solid.
  • Step E Preparation of N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl " j-l-(3- chloro-2-pyridinyl)-3-(trifluoromethyl -lH-pyrazole-5-carboxamide
  • Step F Preparation of 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH- pyrazol-5-vH-3,8-dimethyl-4(3H)-quinazoline
  • Step A Preparation of 8-chloro-2-[ l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH- p yrazol-5-yll -4H-3 , 1 -benzoxazin-4-one
  • Step D Application of the procedure of Example 2, Step D with 2.91 g of the carboxylic acid of Example 2, Step C and 1.71 g of 2-amino-3-chlorobenzoic acid affords 2.5 g of the title benzoxazinone.
  • Step B Preparation of 8-chloro-2-[T -(3-chloro-2-pyridinyl)-3-(trifluoromethylV 1H- pyrazol-5-yll-3-methyl-4(3H -quinazolinone
  • methylamine 2.0 M solution in T ⁇ F, 10 mL
  • the solvent was removed under reduced pressure and the solid residue was washed with ether.
  • the ether soluble material was purified by chromatography on silica gel using hexanes/ethyl acetate (1 : 1) as eluant.
  • the title compound, a compound of the invention was isolated as a solid, m.p. 155-157 °C. ! ⁇ NMR (CDC1 3 ) ⁇ 3.8 (s,3 ⁇ ), 7.1 (s,lH), 7.4 (m,2H). 7.7 (d,lH), 7.9 (d,lH), 8.15 (d,lH), 8.35 (m,lH).
  • Me is methyl, Et is ethyl, Pr is propyl, z ' -Pr is isopropyl, t-Bu is tert butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CN is cyano, NO 2 is nitro, TMS is trimethylsilyl, S(O)Me is methylsulfinyl, and S(O) 2 Me is methylsulfonyl.
  • R 5b is Cl
  • R 5b is CF 3
  • R 5b is OCF3
  • R 5b is CF(CF 3 ⁇ -
  • R 5b is Cl
  • R 5b is CF 3
  • R 5b is OCF3
  • R 5b is CF(CF 3 ⁇
  • R 5b is CHF-> R 5b is CH 2 CF 3 R 5b is CFoCHFo

Abstract

This invention provides methods for controlling invertebrate pests comprising contacting the pests or their environment with an arthropodicidally effective amount of a compound of Formula (I), its N-oxides or agriculturally suitable salts wherein B, J, K, R?3 and R4¿ and n are as defined in the disclosure.This invention also pertains to certain compounds of Formula (I) and compositions for controlling invertebrate pests comprising a biologically effective amount of a compound of Formula I and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.

Description

TITLE
QUINAZOLI ONES AND PYRJDINYLPYRIMIDINONES FOR CONTROLLING
INVERTEBRATE PESTS
BACKGROUND OF THE INVENTION This invention relates to certain quinazolinones and pyridinylpyrimidinones, their
N-oxides, agriculturally suitable salts and compositions, and a method of use for controlling invertebrate pests in both agronomic and nonagronomic environments.
The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. The control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action.
WO 99/14202 discloses pyrimidin-4-one and pyrimidin-4-thiones of Formula i as fungicides
wherein, inter alia, X is O or S;
A is fused phenyl or pyridyl;
Rl and R2 are selected from H, halogen or trimethylsilyl;
R3 is -Cg alkyl, Cj-Cg alkenyl or Cj-Cg alkynyl, each optionally substituted; and
R4 is optionally substituted phenyl. SUMMARY OF THE INVENTION
This invention pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, its N-oxide or an agriculturally suitable salt of the compound (e.g., as a composition described herein)
wherein
B is O or S;
J is a phenyl ring substituted with 1 to 4 R5, or a naphthyl ring system, a 5- or
6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5; K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
R3 is G; Ci-C6 alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CN, NO2, hydroxy, Cj- alkoxy, Cj-C4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, C,-C4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylcarbonyl, C3-C6 trialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from R6; hydroxy; CrC4 alkoxy; Cj-C4 alkylamino; C2-C8 dialkylamino; C3-C6 cycloalkylamino; C2-C6 alkoxycarbonyl or C2-C6 alkylcarbonyl;
G is a phenyl ring or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12; each R4 is independently H, Cj-C6 alkyl, C2-C6 alkenyl, C2-Cβ alkynyl, C3-C6 cycloalkyl, C C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-Cg halocycloalkyl, halogen, CN, NO , hydroxy, Cι-C alkoxy, Cj-C4 haloalkoxy,
Cj-C4 alkylthio, Cj-C4 alkylsulfinyl, C]-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C C4 haloalkylsulfonyl, Cι-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, Cj-C4 alkoxyalkyl, Cj-C4 hydroxyalkyl, C(O)R10, CO2R10, C^NR^R1 !, NR10R! K N(R! ^COR10, N(R! ^CO^R^ or C3-C6 trialkylsilyl; or each R4 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H, alkyl, C2-C6 alkenyl, C2-CG alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C -Cg haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, C C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C C4 haloalkylthio, C]-C4 haloalkylsulfinyl, Cj- . haloalkylsulfonyl, C C4 alkylamino, C -Cg dialkylamino, C3-C6 cycloalkylamino, C2-C5 alkylcarbonyl, C2-Cg alkoxycarbonyl, C -Cg alkylaminocarbonyl, C3~C dialkylaminocarbonyl,
C3-C6 trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6; or
(R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O-, or -OCF2CF2O-; each R6 is independently C C4 alkyl, C2-C4 alkenyl, C -C4 alkynyl, C3-C6 cycloalkyl, Cj-C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, -C4 alkoxy, Cj-C haloalkoxy, CrC alkylthio, C alkylsulfinyl, C C4 alkylsulfonyl, -C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl; RlO is H or C C4 alkyl or -C4 haloalkyl;
RU is H or - alkyl; each R12 is independently Cj-C2 alkyl, halogen, CN, NO2 and C!-C2 alkoxy; and n is 1 to 4. This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
This invention also pertains to a compound of Formula la, its N-oxide or an agriculturally suitable salt of the compound
la
wherein
K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
R3 is Cj-Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, CrC2 alkoxy, Cj-C2 alkylthio, Cj-C2 alkylsulfinyl and C1-C2 alkylsulfonyl; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, Cι-C4 alkylthio, Cι-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C1-C4 haloalkylsulfonyl; and an optional second R4 is H, C\-C(_ alkyl, C2-C alkenyl, C2-C(_ alkynyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, Cj-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C]-C4 haloalkylsulfonyl, Cι-C4 alkylamino, C2-C8 dialkylamino, C -C6 cycloalkylamino, Cj- alkoxyalkyl, C1-C4 hydroxyalkyl,
C(O)R10, CO2R10, C(O)NR10Rn, NR10Rn, N(Rn)COR10, or C3-C6 trialkylsilyl;
R5 is
V is N, CH, CF, CC1, CBr or CI; each R6 is independently C1-C4 alkyl, C2-C alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl, C2-C haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C!-C alkoxy, C C4 haloalkoxy, C1-C4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3- C6 cycloalkylamino, C_t,-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C -C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3- C6 trialkylsilyl; each R7 is independently H, Cj- alkyl, Cj-Cg haloalkyl, halogen, CN, CrC4 alkoxy,
C1-C4 haloalkoxy or C1-C4 haloalkylthio; R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; R10 is H or C !-C4 alkyl or C ι-C4 haloalkyl;
R11 is H or C1-C4 alkyl; and n is 0, 1 or 2.
This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula la and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula la and an effective amount of at least one additional biologically active compound or agent.
DETAILS OF THE INVENTION In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" includes straight-chain or branched alkyl, such as methyl, ethyl, 72-propyl, t-propyl, or the different butyl, pentyl or hexyl isomers. "Alkenyl" includes straight-chain or branched alkenes such as 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers. "Alkenyl" can also include polyenes such as 1 ,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight-chain or branched alkynes such as
1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers. "Alkynyl" can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl. "Alkoxy" includes, for example, methoxy, ethoxy, 77-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers. "Alkoxyalkyl" denotes alkoxy substitution on alkyl. Examples of "alkoxyalkyl" include CH3OCH9, CH3OCH2CH2, CH3CH2OCH2, CH3CH2CH2CH2OCH2 and CH3CH2OCH2CH2. "Alkylthio" includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. "Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "heteroaromatic ring" denotes fully aromatic rings in which at least one ring atom is not carbon and can contain 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each heteroaromatic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs (where aromatic indicates that the Hiickel rule is satisfied). The heteroaromatic ring can be attached through any available carbon or nitrogen by replacement of hydrogen on said carbon or nitrogen.
The term "halogen", either alone or in compound words such as "haloalkyl", includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F3C, C1CH2, CF3CH2 and CF3CC12. The teπns "haloalkenyl", "haloalkynyl", "haloalkoxy", and the like, are defined analogously to the tenn "haloalkyl". Examples of "haloalkenyl" include (C1)2C=CHCH2 and CF3CH2CH=CHCH2. Examples of "haloalkynyl" include HC≡CCHCl, CF3C≡C, CC13C≡C and FCH2C≡CCH2. Examples of "haloalkoxy" include CF3O, CCl3CH2O, HCF2CH2CH2O and CF3CH2O.
The total number of carbon atoms in a substituent group is indicated by the "C;-C," prefix where i and j are numbers from 1 to 6. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkyl designates CH3OCH2; C3 alkoxyalkyl designates, for example, CH3CH(OCH3), CH3OCH2CH2 or CH3CH2OCH2; and C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH3CH2CH2OCH2 and CH3CH2OCH2CH2. In the above recitations, when a compound of Formula 1 contains a heteroaromatic ring, all substituents are attached to this ring through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen. When a group contains a substituent which can be hydrogen, for example R3, then, when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.
Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
The present invention comprises compounds selected from Formula I, N-oxides and agriculturally suitable salts thereof, compositions thereof and methods of their use for invertebrate pest control. One skilled in the art will appreciate that not all nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides. One skilled in the art will also recognize that tertiary amines can form N-oxides. Synthetic methods for the preparation of N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and ??.-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane. These methods for the preparation of N-oxides have been extensively described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Orgamc Synthesis, vol. 7, pp 748-750, S. V. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistiγ, vol. 3, pp 18-19, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advances in Heterocyclic Chemistiγ, vol. 43, pp 139-151, A. R. Katritzky, Ed., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. Katritzky and A. J. Boulton, Eds., Academic Press. The salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
Preferred methods for reasons of better activity, cost and/or ease of synthesis are: Preferred 1. Methods wherein for the compounds of Formula I B is O and R3 is
C Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C C2 alkoxy, C C? alkylthio, Cι-C2 alkylsulfinyl and C C2 alkylsulfonyl. Preferred 2. Methods of Preferred 1 wherein J is a phenyl group substituted with 1 to
4 R5. Preferred 3. Methods of Preferred 2 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is C 1 -C4 alkyl, C ! -C4 haloalkyl, halogen, CN, NO2, C _ -C4 alkoxy,
C]-C4 haloalkoxy, Cp alkylthio, C C4 alkylsulfinyl, CrC4 alkylsulfonyl, C]-C4 haloalkylthio, Cj-C4 haloalkylsulfinyl or Cj- haloalkylsulfonyl; and each R5 is independently H, halogen, CrC4 alkyl, Cι-C2 alkoxy, C C4 haloalkyl, CN, NO2, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, C1-C4 alkylsulfonyl, -C4 haloalkylthio, CrC4 haloalkylsulfinyl, Cι-C4 haloalkylsulfonyl or C2-C alkoxycarbonyl; or each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6; or (R5)2 when attached to adjacent carbon atoms can be taken together as
-OCF2O-, -CF2CF2O- or -OCF2CF2O-. Preferred 4. Methods of Preferred 3 wherein R3 is C1-C4 alkyl optionally substituted with halogen, CN, OCH3 or
S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with C]-C4 alkyl, Cj-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2. Preferred 5. Methods of Preferred 4 wherein R3 is t-propyl or t-butyl. Preferred 6. Methods of Preferred 1 wherein J is a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R5. Preferred 7. Methods of Preferred 6 wherein
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R5
J-l -2 J-3 j_4 J-5
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N. Preferred 8. Methods of Preferred 7 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said
R4 is CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, 0^4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C1-C4 haloalkylsulfonyl; and each R5 is independently H, CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2,
CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, CrC4 haloalkylthio, C C haloalkylsulfinyl, C]-C haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6. Preferred 9. Methods of Preferred 8 wherein
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-S, J-9, J-10, J-l l, J-12 and J-13
R5 IS
V is N, CH, CF, CC1, CBr or CI; each R7 is independently H, C Cg alkyl, Cj-Cg haloalkyl, halogen, CN,
C1-C4 alkoxy, C1-C4 haloalkoxy or C1-C4 haloalkylthio; R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; and n is 0, 1 or 2. Preferred 10. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-6;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C1-C4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred 11. Methods of Preferred 10 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is halogen or CF3. Preferred 12. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-7;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred 13. Methods of Preferred 12 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred 14. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-S; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3) OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen;
R7 is CH3, CF3 or halogen; and p is 0, 1 or 2. Preferred 15. Methods of Preferred 14 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is halogen or CF3. Preferred 16. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-9;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
Preferred 17. Methods of Preferred 18 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R7 is CF3. Preferred 18. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-10; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is O, lor 2. Preferred 19. Methods of Preferred IS wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred 20. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-l 1;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, C C4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred 21. Methods of Preferred 20 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is halogen or CF3. Preferred 22. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-l 2;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, Cj-C haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred 23. Methods of Preferred 22 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3. CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred 24. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-l 3; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2. Preferred 25. Methods of Preferred 24 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
Most preferred is the method wherein the compound of Formula I is selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-S-methyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-8-methyl-3- (l-methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3- (1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3,8-dimethyl- 4(3H)-quinazoline, 6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-S-methyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3- ( 1 -methylethyl)-4(3H)-quinazoline,
6-chloro-2-[3 -chloro- 1 -(3 -chloro-2-pyridinyl)- 1 H-pyrazol-5 -yl] -3 - (l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3,S- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl- 8-methyl-4(3H)-quinazoline, 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3 -( 1 -methylethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-(l-methylethyl)- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline, 2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (1 ,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- ethyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-methyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3- (1 -methylethyl)-4(3H)-quinazoline,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyι-idinyl)-lH-pyrazol-5-yl]-3-methyl- 4(3H)-quinazoline,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-ρyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-ρyrazol-5-yl]-3-
( 1 -methylethyl)-4(3H)-quinazoline. Preferred compounds for reasons of better activity, cost and/or ease of synthesis are: Preferred A. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-6; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCΗ3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred B. Compounds of Preferred A wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
Preferred C. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-7;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2. Preferred D. Compounds of Preferred C wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred E. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-8;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2. Preferred F. Methods of Preferred E wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3. Preferred G. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-9;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2. Preferred H. Compounds of Preferred G wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is CF3. Preferred I. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-10;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred J. Compounds of Preferred I wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred K. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-l 1; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C1-C4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred L. Compounds of Preferred K wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
Preferred M. Compounds of Foπnula la wherein J substituted with 1 to 3 R5 is J-l 2;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is O, lor 2. Preferred N. Methods of Preferred M wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred O. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-l 3;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred P. Methods of Preferred O wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
Most preferred is the compound of Formula I selected from the group consisting of:
8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-8-methyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-
(1,1 -dimethyl ethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3,8-dimethyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-8-methyl- 4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline, 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazoI-5-yl]-3,8- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl-
8-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3 -( 1 -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-p)τidinyl)-lH-pyrazol-5-yl]-S-methyl-3-(l-methylethyl)-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline, 2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline, 6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- ethyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyι-azol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-methyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,S-dichloro-3- ( 1 -methyl ethyl)-4(3H)-quinazoline, 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-methyl-
4(3H)-quinazoIine,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3- (1 -methylethyl)-4(3H)-quinazoline.
This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula la and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. Preferred compositions are those comprising the above preferred compounds.
Of note is a method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of a compound of Formula 1 , its N-oxides or agriculturally suitable salts thereof
wherein
B is O or S; J is a phenyl group substituted with 1 to 2 R5 and optionally substituted with 1 to 3 R6, or a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R7; n is 1 to 4;
R3 is C Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO2, hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl; C1-C4 alkoxy; C1-C4 alkylamino; C2-Cg dialkylamino; C3-C6 cycloalkylamino; C2-Cg alkoxycarbonyl or C2-Cg alkylcarbonyl; each R4 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, Cj-Cg haloalkyl, C2-C6 haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl,
C3-C6 trialkylsilyl; or each R4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl,
C C4 alkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C -C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R5 is independently Cj-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C2-C haloalkenyl, C -Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, Cj-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cj-C4 haloalkylthio, C C4 haloalkylsulfinyl, C!-C4 haloalkylsulfonyl, C]-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl,
C2-Cg alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3~Cg dialkylaminocarbonyl, C3-C6 trialkylsilyl; or (R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O-, or -OCF2CF2O-; each R6 is independently H, halogen, CrCg alkyl, C2-C6 alkenyl, C2-C6 alkynyl,
C3-C6 cycloalkyl, CpC alkoxy or C2-C4 alkoxy carbonyl; or each R6 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with - alkyl, C -C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C -C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cj-C alkylamino, C?-Cg dialkylamino, C3- cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R7 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C -Cg haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, C]-C4 haloalkoxy, Cι-C alkylthio, C2-C4 alkylsulfinyl, C]-C4 alkylsulfonyl,
C!-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C C alkoxycarbonyl, C1-C4 alkylamino, C -Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl, C3-C6 trialkylsilyl; or each R7 is independently a phenyl, benzyl, benzoyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C1-C4 alkyl, -C4 alkenyl, C -C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, -C4 haloalkenyl, C -C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1 -C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6
(alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl. Of note are compounds of Formula 1 wherein
B is O;
J is a phenyl group substituted with 1 to 2 R5 and optionally substituted with 1 to 3 R6; or J is selected from the group consisting of pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R7; R3 is C2-C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; each R4 is independently CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2 or halogen; each R5 is independently CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3,
OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; each R6 is independently halogen or methyl; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN; each R7 is independently H, halogen, CH3, CF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3, S(O)pCF2CHF2; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C C4 haloalkoxy, halogen, NO2 or CN; and p is 0, 1 or 2.
As noted above, J is a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5. The term "optionally substituted" in connection with these J groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. An example of phenyl optionally substituted with 1 to 4 R5 is the ring illustrated as U-l in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4. An example of a naphthyl group optionally substituted with 1 to 3 R5 is illustrated as U-85 in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4.
Examples of 5- or 6-membered heteroaromatic rings optionally substituted with 1 to 4 R5 include the rings U-2 through U-53 illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4. Note that J-l through J-5 below also denote 5- or 6-membered heteroaromatic rings. Note that U-2 through U-20 are examples of J-l, U-21 through LI-35 and U-40 are examples of J-2, U-36 through U-39 are examples of J-3, U-41 through U-48 are examples of J-4 and LT-49 through U-53 are examples of J-5. Examples of aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems optionally substituted with 1 to 4 R5 include U-54 through LT-84 illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4. Although Rv groups are shown in the structures U-l through U-85, it is noted that they do not need to be present since they are optional substituents. Note that when Rv is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or Rv. Note that some U groups can only be substituted with less than 4 Rv groups (e.g. U-14, LT-15, U-18 through U-21 and U-32 through U-34 can only be substituted with one Rv). Note that when the attachment point between (Rv)r and the U group is illustrated as floating, (Rv)r can be attached to any available carbon atom of the U group. Note that when the attachment point on the U group is illustrated as floating, the U group can be attached to the remainder of
Formula I through any available carbon of the U group by replacement of a hydrogen atom.
Exhibit 1
U-5 U-6 U-7
U-8
U-l l 3
U-9 U-10 U-12 U-1
U-16 U-17
U-27 U-28 U-29 U-30
U-40 U-41 U-42 U-43
-44 U-45 U-46 U-47 U-48
U-54 U-55 U-56 U-57
U-58 U-59 U-60 U-61
U-66 U-67 U-68 U-69
U-70 U-71 U-72 U-73
U-74 U-75 U-76 U-77
U-78 U-79 U-80 U-81
U-83 U-84
U-82 U-85
As noted above G can be a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12. Examples of such G groups include those illustrated as G-l through G-41 in Exhibit 2 wherein m is an integer from 1 to 4. The term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Although (R12)m are illustrated in the examples, they need not be present since they are optional substituents. Note that when the attachment point on these G groups is illustrated as floating, the G group can be attached to the remainder of Formula I through any available carbon or nitrogen of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon or nitrogen by replacing a hydrogen atom. Note that when G comprises a ring selected from G-24 through G-29 and G-32 through G-35, A is selected from O, S, NH or NR12. Note that when G is G-3, G-5, G-7, G-9, G-16 through G-l 8, G-23, and G-24 through G-29, and G-32 through G-35 (when A is NR12), the nitrogen atoms that require substitution to fill their valence are substituted with H or R12. Exhibit 2
G-l G-3 G-4 G-5
G-6 G-7 G-8 G-9 G-10
(R12)nι G-16 G-17
π(R.il2)m,
G-21 G-23 G-24 G-25
G-30 G.31
G-26 G-27 G"28 G-29
G-37 G-38 G-39 G-40 G-41
As noted above, R3 can be (among others) Cj-Cg alkyl, C2-C6 alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from (among others) a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. The tem "optionally substituted" in connection with these groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such substituents include the rings illustrated as U-l through U-53 and U-8S illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r Note that R6 substituents do not need to be present since they are optional substituents.
As noted above, each R4 is independently (among others) a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. The term "optionally substituted" in connection with these R4 groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such R4 groups include the rings illustrated as U-l through U-53, U-86 and U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r. Note that R6 substituents do not need to be present since they are optional substituents.
As noted above, each R5 is independently (among others) a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such R5 groups include the rings illustrated as U-l through U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r. Note that R6 substituents do not need to be present since they are optional substituents. Note that in J-6 through J-l 3, R7 and R9 are subsets of R5. As noted above K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring optionally substituted with 1 to 4 R4. The tenn "optionally substituted" in connection with these K groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such K groups include the rings illustrated as K-l through K-5 in Exhibit 3. Note that K-2 through K-5 can be optionally substituted with one to three 3 R4 groups. In the exemplified K groups, the upper right bond is attached through the available linking carbon atom to the nitrogen atom of the N=C-J portion of Formula I and the lower right bond is attached through the available linking carbon atom to the carbon atom of the C(=B)NR3 portion of Foπnula I. The wavy line indicates that the K-ring is attached to the remainder of Formula I as illustrated below.
Exhibit 3
Preferred K-rings are K-l , K-2 and K-5. Most preferred is K-l .
The compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-13. The definitions of B, J, K, R3, R4, R5 and n in the compounds of Formulae I and 2-24 below are as defined above in the Summary of the Invention. Of note are compounds wherein K is K-l . Compounds of Formula lb (Formula I wherein B is O) can be prepared by procedures outlined in Schemes 1-13. A typical procedure is detailed in Scheme 1 and involves dehydration of an o-amido amide of Formula 2 with sodium hydride and ethyl chloro fomiate in a suitable solvent (See e.g. Example 1). Other methods for preparing compounds of Formula I include treating a compound of Formula 2 with acetic anhydride and sodium acetate, heating at greater than 70 °C neat or optionally in an appropriate solvent such as tetrahydrofuran, and treating 2 with a suitable acid scavenger and trimethylsilyl chloride in a suitable solvent. Further useful methods include heating o-amido amides of Formula 2 adsorbed on surface-active materials such as zeolites or clay, generally in the range of 50-150 °C. A specific example of this type is described in Example 2 and involves heating the anthranilic amide on Montmorillonite clay. Compounds of Formula Ic (Formula I wherein B is S) can be prepared by conventional methods for conversion of amides to thioamides such as by treatment with phosphorus pentasulfide or Lawesson's reagent. (See (Bull. Soc. Chim. Belg.), 1978, 87, 229; and (Tetrahedron Lett.), 1983, 24, 3815 for general procedures).
Scheme 1
Compounds of Formula 2 can be prepared by procedures outlined in Scheme 2. A typical procedure involves coupling of an o-amino amide of Formula 3 with an acid chloride of Formula 4 in the presence of an acid scavenger to provide the compound of Formula 2. Typical acid scavengers include amine bases such as triethylamine, diisopropylethylamine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate. In certain instances it is useful to use polymer-supported acid scavengers such as polymer-bound diisopropylethylamine and polymer-bound dimethylaminopyridine.
Scheme 2
An alternate procedure for the preparation of compounds of Formula 2 involves coupling of an o-amino amide of Formula 3 with an acid of Formula 5 in the presence of a dehydrating agent such as dicyclohexylcarbodiimide (DCC). Polymer supported reagents can be useful here, such as polymer-bound cyclohexylcarbodiimide. Synthetic procedures of Schemes 2 and 3 are only representative examples of useful methods for the preparation of Formula 2 compounds as the synthetic literature is extensive for this type of reaction.
Scheme 3
One skilled in the art will also realize that acid chlorides of Formula 4 may be prepared from acids of Formula 5 by numerous well-known methods.
Formula 3 o- Amino amides are typically available from the corresponding o-nitro amides of Formula 6 via catalytic hydrogenation of the nitro group. Typical procedures involve reduction with hydrogen in the presence of a metal catalyst such as palladium on carbon or platinum oxide and in hydroxylic solvents such as ethanol and isopropanol. These procedures are well documented in the chemical literature.
Scheme 4
The intermediate amides of Formula 6 are readily prepared from commercially available o-nitro acids of Formula 7. Typical methods for amide formation can be applied here. These include direct dehydrative coupling of acids of Foπnula 7 with amines of Formula 8 using for example DCC, and conversion of the acids to an activated form such as the'acid chlorides or anhydrides and subsequent coupling with amines to form amides of Formula 6. Ethylchloro formate is an especially useful reagent for this type of reaction. Scheme 5
hitermediate o-amino amides of Formula 3 may also be prepared from anhydrides of Fomiula 9 (Scheme 6). Typical procedures involve combination of equimolar amounts of the amine 8 with the anhydride of Fomiula 9 in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100 °C.
Scheme 6
An alternate procedure for the preparation of compounds of Formula 2 involves reaction of an amine 8 with a compound of Formula 10. Typical procedures involve combination of the amine with the compound of Formula 10 in solvents such as tetrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent. Benzoxazinones (compounds of Formula 10 wherein K is K-l) are well documented in the chemical literature and are available via known methods that involve the coupling of either an anthranilic acid or an isatoic anhydride with an acid chloride. Scheme 7
10
Compounds of Foπnula I may also be prepared by modification of known procedures (J. Med. Chem. 1985, 28, 568). Usually this involves condensation of an aryl aldehyde of Formula 11 with a compound of Formula 3 in an alcoholic solvent and with a catalytic amount of base to produce intem ediate 12, which is then further oxidized to the Formula I compound by known methods. This reaction is shown in Scheme 8.
Scheme 8
oxidation
12
An alternate procedure for the preparation of specific quinazolinones of Fomiula I
(Formula Id) is depicted in Scheme 9. This procedure may be specifically suitable for pyrazole-substituted quinazolinones which may prove difficult to prepare by alternate procedures. The cross coupling reaction of quinazolines of Formula 13 (wherein X is a leaving group such as halogen, triflate or fluorosulfonate) with pyrazoles of Formula 14 (where Met is Sn, Zn, B(OH)2, Mg, Li or Cu and additional counterions as necessary) in the presence of a palladium or nickel catalyst produces compounds of Formula Id. Quinazolines of Fomiula 13 wherein X is halogen are known in the art (PCT patent application publication WO98/26664 and references cited therein). Preferred catalysts for the synthesis of compounds of Formula Id include but are not limited to Pd(PPh3) , PdCl2(PPh3)2, PdCl2(diphenylρhosphinoferrocene), NiCl (PPh3)2, and Tetrakis(tri-2- furylphosphino)palladium. The exact conditions for each reaction depend upon the catalyst used and the metal attached to the pyrazole. The additional presence of an external base (such as an alkali carbonate, tertiary amine or alkali fluoride) is necessary for reactions involving pyrazoles of Formula 14 where Met is B(OH)2. Similar procedures also can be used for other K-rings and J-groups.
Scheme 9
Pyrazoles of Formula 14 can be made by lithiation of the pyrazole 17 followed by transmetallation with the appropriate metal as described in Scheme 10. Pyridylpyrazoles 17 are prepared by the reaction of pyrazoles 15 with a 2,3-dihalopyridine of Formula 16 to afford the 1 -pyridylpyrazole 17 with good specificity for the desired regiochemistry. Metallation of 17 with lithium diisopropylamide (LDA) followed by transmetallation with the appropriate metal affords the metal pyrazole of Formula 14. For conditions and catalysts used in transmetallation and cross coupling reactions see Metal-catalyzed Cross-coupling Reactions. Diederich, Francois; Stang, Peter J.; Editors. 1998, p. 517, (Wiley-VCH, Weinheim, Germany) and references cited therein.
Scheme 10
15 16 17 IS
14
The starting pyrazoles 15 are known compounds. Pyrazole 15 wherein R5 is CF3 is commercially available. Pyrazoles 15 wherein R5 is Cl or Br can be prepared by literature procedures (Chem. Ber. 1966, 99(10), 3350-7). A useful alternative method for the preparation of 15 wherein R5 is Cl or Br is depicted in Scheme 11. Metallation of the sulfamoyl pyrazole 19 with π-butyllithium followed by direct halogenation of the anion with either hexachloroethane (for R5 being Cl) or 1,2-dibromotetrachloroethane (for R5 being Br) affords the halogenated derivatives 20. Removal of the sulfamoyl group with tri fluoro acetic acid (TFA) at room temperature proceeds cleanly and in good yield to afford the pyrazoles 15 wherein R5 is Cl or Br respectively. One skilled in the art will recognize that Formula 15c is a tautomer of Fomiula 15b.
Scheme 11
An alternate procedure for the preparation of quinazolinones of Formula Id involves prolonged heating of a benzoxazinone of Formula 21 with an amine of Formula 22 as shown in Scheme 12. Reactions times as long as 1-7 days may be required. An example of this type is detailed in Example 3. Similar procedures also can be used for other K-rings and
J-groups.
Scheme 12
The benzoxazinones of Formula 21 are available by the method of Scheme 13. Coupling of a pyrazole acid of Fomiula 23 with an anthranilic acid of Formula 24 via sequential addition of methanesulfonyl chloride and triethylamine affords the benzoxazinone of Fomiula 21. The intermediate acid of Formula 23 is available from the lithiated pyrazole 18 by quenching with carbon dioxide. Similar procedures also can be used for other K-rings and J-groups.
Scheme 13
It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula I may not be compatible with certain functionalities present in the intermediates. In these instances, the incoiporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted in any individual scheme, it may be necessary to perform additional routine synthetic steps not described in detail to complete the synthesis of compounds of Fomiula I. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Fomiula I.
One skilled in the art will also recognize that compounds of Formula I and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except for cliromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise indicated. !H NMR spectra are reported in ppm downfield from tetramethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiple., dd is doublet of doublets, dt is doublet of triplets, br s is broad singlet.
EXAMPLE 1
Preparation of 8-methyl-3-(l -methylethyl)-2-[2-methyl-4-(trifluoromethyl)phenyl]-4(3H)- quinazolinone
Step A: Preparation of 3-methyl-N-( 1 -methylethyl)-2-nitrobenzamide
A solution of 3-methyl-2-nitrobenzoic acid (2.00 g, 11.0 mmol) and triethylamine (1.22 g, 12.1 mmol) in 25 mL of methylene chloride was cooled to 10°C. Ethyl chloroformate was carefully added and a solid precipitate formed. After stirring for 30 minutes isopropylamine (0.94 g, 16.0 mmol) was added and a homogeneous solution resulted. The reaction was stirred for an additional hour, poured into water and extracted with ethyl acetate. The organic extracts were washed with water, dried over magnesium sulfate and evaporated under reduced pressure to afford 1.96 g of the desired intermediate as a white solid melting at 126-128 °C. !H ΝMR (CDC13) δ 1.24 (d,6H), 2.38 (s,3H), 4.22 (m,lH), 5.80 (br s,lH), 7.4 (m,3H). Step B: Preparation of 2-amino-3-methyl-N-( 1 -methylethyDbenzamide
The 2-nitrobenzamide of Step A (1.70 g, 7.6 mmol) was hydrogenated over 5% Pd/C in 40 mL of ethanol at 3.45 X 105 Pa. When the uptake of hydrogen ceased the reaction was filtered through celite and the celite was washed with ether. The filtrate was evaporated under reduced pressure to afford 1.41 g of the title compound as a solid melting at
149-151 °C.
*H ΝMR (CDC13) δ 1.24 (dd,6H), 2.16 (s,3H), 4.25 (m,lH), 5.54 (br s,2H), 5.85 (br s,lH),
6.59 (t,lH), 7.13 (d,lH), 7.17 (d,lH).
Step C: Preparation of S,S-dimethyl-N-[4-(trifluoromethyl)phenyllsulfilimine A solution of N-chlorosuccinimide (12.43 g, 93.1 mmol) in -170 mL of dichloromethane was added to a mixture of 4-(trifluoromethyl) aniline (15 g, 93.1 mmol) and dimethyl sulphide (6.35 g, 102 mmol) in 230 mL of dichloromethane at -5 to 0 °C.
After the addition was complete, the mixture was stirred at 0-5 °C for 1 hour, and
N-chlorosuccinimide (0.02 g, 4.64 mmol) was added. After a further 30 minutes, the mixture was washed with 500 mL of IN sodium hydroxide.
The organic phase was dried and evaporated to give the product as a solid 19.72 g melting at 101-103 °C (after crystallization from ethyl acetate/hexanes).
IR (Νujol®) 1603, 1562, 1532, 1502, 1428, 1402, 1335, 1300, 1270, 1185, 1150,
1103, 1067, 1000, 972, 940, 906, 837, 817 cm \ !H NMR (CDCI3) δ 7.35 (d,2H), 6.84 (d,2H), 2.67 (s,3H).
Step D: 2-[(methylthio)methyl]-4-(trifluoromethyl)benzenamine
Sodium methoxide in methanol (1.95 g, 9.02 mmol, 25%) was added to
S,S-dimethyl-N-[4-(trifluoromethyl)phenyl]sulfilimine from Step C (2 g, 9.04 mmol) in
15 mL of toluene. The mixture was warmed to ~80°C for ~1 h. The mixture was allowed to cool to 25 °C and was poured into 100 mL of water. The mixture was extracted with
2x100 mL of ethyl acetate and the combined extracts were dried and evaporated to give the product 1.8 g as a solid melting at 65.5-67.5 °C (after crystallization from hexanes).
IR (Νujol®) 3419, 3333, 1629, 1584, 1512, 1440, 1334, 1302, 1235, 1193, 1139,
1098, 1078, 979, 904, 832 cm"'. JH NMR (CDCI3) δ 7.35 (dd,lH), 7.26 (s,lH), 6.72 (d,lH) 4.39 (br s,2H), 3.69 (s,2H), 1.99
(s,3H).
Step E: Preparation of 2-methyl-4-(trifluoromethyl)benzenamine
Activated Raney nickel (500 g wet paste, ~50μ) was added portionwise to a solution of 2-[(methylthio)methyl]-4-(trifluoromethyl)benzenamine (55.3 g, 0.25 mole) in 1 L of ethanol over 30 minutes at 25-30 °C. The heterogeneous mixture was stirred vigorously for
30 minutes after the addition. The stirring was stopped, and the solids were allowed to settle over one hour. The liquid was decanted from the solids and poured through filter paper.
The filtrate was evaporated under reduced pressure, and the residue was taken up in dichloromethane. The organic phase was separated from a small volume of water, dried over magnesium sulfate and evaporated under reduced pressure to afford 37.6 g of the title compound as an amber oil.
IH NMR (CDC13) δ 7.28 (m,2H), 6.68 (d,lH), 3.87 (br s,2H), 2.19 (s,3H). Step F: Preparation of 2-methyl-4-(trifluoromethyl)benzonitrile
Concentrated hydrochloric acid (16 mL) was added dropwise at a moderate rate to a heterogeneous mixture of 2-methyl-4-(trifluoromethyl)benzenamine (14 g, SO mmol) and 120 mL of water while stirring vigorously. A thick suspension resulted which was stirred for 20 minutes, diluted with 280 mL of water and cooled to 5 °C. A solution of sodium nitrite (5.5 g, SO mmol) in 25 mL of water was added slowly to the reaction suspension. After stirring for 30 minutes at 5 °C a solution resulted which was stirred cold for 30 more minutes and then neutralized with potassium carbonate. This diazonium salt solution was then added portionwise via cannula to a stirred, 95 °C mixture of potassium cyanide (22 g, 0.34 mole), copper sulfate pentahydrate (20 g, 80 mmol) and 140 mL of water. After the addition the mixture was stirred for 30 minutes at 95 °C and then allowed to cool to room temperature. Ether was added and the heterogeneous mixture was filtered through celite. The solids were washed with ether, and the filtrate was partitioned. The aqueous phase was extracted with ether, and the combined organic extracts were dried over magnesium sulfate and concentrated under reduced pressure to afford 13.1 g of the title compound as a brown oil. *H NMR (CDCI3) δ 7.74 (d,lH), 7.60 (s,lH), 7.55 (d,lH), 2.64 (s,3H).
Step G: Preparation of 2-methyl-4-trifluoromethyl benzoic acid
Potassium hydroxide (15.7 g, 0.28 mole) and 15 mL of water were added as a solution to a stirred, heterogeneous mixture of 2-methyl-4-(trifluoromethyl)benzonitrile (13 g, 70 mmol) and 135 mL of ethylene glycol. The reaction mixture was heated at 120-130 °C for 20 hours and allowed to cool to room temperature. The dark solution was poured into 800 mL of water and filtered through celite. The filtrate was washed with ether and then the aqueous was acidified with concentrated hydrochloric acid. This aqueous phase was extracted three times with ethyl acetate, the organic extracts were combined, dried over magnesium sulfate and evaporated under reduced pressure to afford the title compound as a tan solid.
IH NMR (CDCI3) δ 7.98 (d,lH), 7.70 (s,lH), 7.65 (d,lH), 2.60 (s,3H). Step H: Preparation of 2-methyl-4-(trifluoromethoxy)benzoyl chloride
Thionyl chloride (0.42 g, 3.5 mmol) was added to a solution of the benzoic acid from Step G (0.50 g, 2.4 mmol) in 10 mL of toluene at room temperature. The reaction was reflux ed for three hours then cooled to room temperature. The solvent was evaporated under reduced pressure and excess thionyl chloride was removed by azeotroping with toluene. The benzoyl chloride obtained was used directly in Step I. Step I: Preparation of 2-methyl-N-[2-methyl-6-[ ( l-methylethyl)amino]- carbonyl1phenyl1-4-(trifluoromethyl)benzamide The benzoyl chloride of Step H (0.29 g, 1.3 mmol) was added to a mixture of the aniline from Step B (0.36 g, 1.9 mmol) and diisopropylethylamine (0.26 g, 2.0 mmol) in 10 mL of chloro foπn at room temperature. The reaction was allowed to stir overnight. The solid precipitate was filtered and dried to afford 0.38 g of the title compound, as a solid melting at 247-248 °C.
»H ΝMR (CDC13) δ 1.24 (d,6H), 2.41 (s,3H), 2.58 (s,3H), 4.20 (m.lH), 5.94 (br d,lH), 7.2-7.3 (m,2H), 7.40 (d,lH), 7.52 (s,lH), 7.53 (d,lH), 7.70 (d,lH), 9.36 (br s,lH). Step J: Preparation of 8-methyl-3-( l-methylethyl -2-r2-methyl-4-
(trifluoromethyl)phenyl~|-4(3H)-quinazolinone A slurry of the benzamide of Step I (0.25 g, 0.6 mmol) in N N-dimethylformamide (4 mL) was added cautiously to a slurry of ΝaH (0.03 g, 0.7 mmol, 60%) in NN-dimethylformamide (2 mL). Gas evolution was seen and the mixture became a light yellow solution. After stirring for approximately 5 min, methylchloro formate (0.11 g,
1.2 mmol) was added and a solid precipitate formed. The reaction was stirred for 30 min, then poured into water (50 mL) and extracted with ethyl acetate (2x50 mL). The combined extracts were washed with water (2x50 mL) then dried and evaporated to give 0.16 g of the title compound, a compound of the invention, as a solid melting at 100-103 °C. ]H ΝMR (CDCI3) δ 1.25 (d,6H), 2.52 (s,3H), 2.81 (s,3H), 4.28 (m,lH), 7.26 (t,lH), 7.43 (d,lH), 7.57-7.61 (br s,2H), 7.98 (d,lH), 8.07 (d,lH).
EXAMPLE 2
Preparation of 6-chloro-2- [" 1 -(3 -chloro-2-p yridinyl)-3 -(trifluoromethyl)- 1 H-pyrazol-5-yl] -
3,S-dimethyl-4(3H)-quinazoline Step A: Preparation of 2-amino-3-methyl-5-chlorobenzoic acid
To a solution of 2-amino-3-methylbenzoic acid (Aldrich, 15.0 g, 99.2 mmol) in NN-dimethylformamide (50 mL) was added N-chlorosuccinimide (13.3 g, 99.2 mmol) and the reaction mixture was heated to 100 °C for 30 minutes. The heat was removed, the reaction was cooled to room temperature and let stand overnight. The reaction mixture was then slowly poured into ice-water (250 mL) to precipitate a white solid. The solid was filtered and washed four times with water and then taken up in ethyl acetate (900 mL). The ethyl acetate solution was dried over magnesium sulfate, evaporated under reduced pressure and the residual solid was washed with ether to afford the desired intermediate as a white solid (13.9 g). *Η ΝMR (DMSOA5) δ 2.11 (s, 3Η), 7.22 (s, IH), 7.55 (s, IH). Step B: Preparation of 3-chloro-2-|"3-(trifluoromethyl)-lH-pyrazol-l-yl1pyridine
To a mixture of 2,3-dichloropyridine (99.0 g, 0.67 mol) and 3-trifluoromethyl pyrazole (83 g, 0.61 mol) in dry N,N-dimethylformamide (300 mL) was added potassium carbonate (166.0 g, 1.2 mol) and the reaction was then heated to 110-125 °C over 48 hours. The reaction was cooled to 100 °C and filtered through Celite® diatomaceous filter aid to remove solids. NN-Dimethylformamide and excess dichloropyridine were removed by distillation at atmospheric pressure. Distillation of the product at reduced pressure (b.p. 139-141 °C, 7 mm) afforded the desired intermediate as a clear yellow oil (113.4 g). Η ΝMR (CDC13) δ 6.78 (s, 1Η), 7.36 (t, 1Η), 7.93 (d, 1Η), 8.15 (s, 1Η), 8.45 (d, 1Η). Step C: Preparation of l-(3-chloro-2-pyridinyl')-3-(trifluoromethyl -lH-pyrazole-5- carboxylic acid To a solution of the pyrazole product from Step B (105.0 g, 425 mmol) in dry tetrahydrofuran (700 mL) at -75 °C was added via cannula a -30 °C solution of lithium diisopropylamide (425 mmol) in dry tetrahydrofuran (300 mL). The deep red solution was stirred for 15 minutes, after which time carbon dioxide was bubbled through at -63 °C until the solution became pale yellow and the exothermicity ceased. The reaction was stirred for an additional 20 minutes and then quenched with water (20 mL). The solvent was removed under reduced pressure, and the reaction mixture partitioned between ether and 0.5 Ν aqueous sodium hydroxide solution. The aqueous extracts were washed with ether (3x), filtered through Celite® diatomaceous filter aid to remove residual solids, and then acidified to a pΗ of approximately 4, at which point an orange oil formed. The aqueous mixture was stirred vigorously and additional acid was added to lower the pΗ to 2.5-3. The orange oil congealed into a granular solid, which was filtered, washed successively with water and IN hydrochloric acid, and dried under vacuum at 50 °C to afford the title product as an off-white solid (130 g). (Product from another run following similar procedure melted at 175-176 °C.) !Η ΝMR (DMSOA;) δ 7.61 (s, IH), 7.76 (dd, IH), 8.31 (d, IH), 8.60 (d, IH). Step D: Preparation of 6-chloro-2-[T -(3-chloro-2-pyridinyl)-3-(trifluoiOmethyl)-lH- pyrazol-5-yl"|-8-methyl-4H-3,l-benzoxazin-4-one To a solution of methanesulfonyl chloride (2.2 mL, 28.3 mmol) in acetonitrile (75 mL) was added dropwise a mixture of the carboxylic acid product from Step C (7.5 g, 27.0 mmol) and triethylamine (3.75 mL, 27.0 mmol) in acetonitrile (75 mL) at 0-5 °C. The reaction temperature was then maintained at 0 °C throughout successive addition of reagents. After stirring for 20 minutes, 2-amino-3-methyl-5-chlorobenzoic acid from Step A (5.1 g, 27.0 mmol) was added and stirring was continued for an additional 5 minutes. A solution of triethylamine (7.5 mL, 54.0 mmol) in acetonitrile (15 mL) was then added dropwise, and the reaction mixture was stirred 45 minutes, followed by the addition of methanesulfonyl chloride (2.2 mL, 28.3 mmol). The reaction mixture was then warmed to room temperature and stirred overnight. Approximately 75 mL of water was then added to precipitate 5.8 g of a yellow solid. An additional 1 g of product was isolated by extraction from the filtrate to provide a total of 6.8 g of the title compound as a yellow solid.
*H NMR (CDC13) δ 1.83 (s, 3H), 7.50 (s, IH), 7.53 (m, 2H), 7.99 (m, 2H), 8.58 (d, IH).
Step E: Preparation of N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl"j-l-(3- chloro-2-pyridinyl)-3-(trifluoromethyl -lH-pyrazole-5-carboxamide
To a solution of the benzoxazinone product of Step D (6.6 g, 15 mmol) in tetrahydrofuran (50 mL) was added methylamine (2.0 M solution in TΗF, 38 mL,
77.38 mmol), and the reaction mixture was heated to 60 °C, stirred for 1 hour and then cooled to room temperature. The tetrahydrofuran solvent was evaporated under reduced pressure, and the residual solid was purified by chromatography on silica gel to afford the title compound, as a white solid' melting at 225-226 °C.
!Η ΝMR (CDCI3) δ 2.17 (s,3Η), 2.95 (m,3H), 6.2 (m,lH), 7.2 (m,2H), 7.4 (m,2H), 7.85
(md,lH), 8.45 (md,lH), 10.2 (br s, IH).
Step F: Preparation of 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH- pyrazol-5-vH-3,8-dimethyl-4(3H)-quinazoline
A solution of the title compound from Step E (50 mg, 0.11 mmol) in dichloromethane
(20 mL) was mixed with 2 g of montmorillonite K10 clay (Aldrich, preactivated by heating under vacuum) and evaporated to dryness in vacuo. The dry residue was heated using a steam bath (ca. 90-95 °C) for a total of 24 hours. The solids were then extracted twice by mixing with dichloromethane and ethyl acetate (1 :1) and filtering. The combined filtrates were evaporated to leave a film. This material was chromatographed on silica gel using 5% ethyl acetate in dichloromethane as the eluant. Pure fractions were combined, evaporated and the residue crystallized from dichloromethane/hexanes to afford 15 mg of the title compound, a compound of the invention, as a white solid. IR (KBr) 1674, 1598, 1462, 1241, 1194, 1169, 1140 cm"1.
!Η ΝMR (CDCI3) δ 2.10 (s,3Η), 3.78 (s,3H), 7.06 (s, IH), 7.37 (dd,lH), 7.42 (d,lH), 7.87
(dd,lH).
EXAMPLE 3
Preparation of 8-chloro-2-π-(3-chloro-2-p\;ridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yll-3- methyl-4(3H)-quinazolinone
Step A: Preparation of 8-chloro-2-[ l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH- p yrazol-5-yll -4H-3 , 1 -benzoxazin-4-one Application of the procedure of Example 2, Step D with 2.91 g of the carboxylic acid of Example 2, Step C and 1.71 g of 2-amino-3-chlorobenzoic acid affords 2.5 g of the title benzoxazinone.
1Η ΝMR (CDCI3) δ 7.46 (t,lΗ), 7.50 (m,lH), 7.52 (s,lH), 7.76 (d,lH), 8.00 (d,lH), 8.11 (d,lH), 8.58 (d, IH). Step B: Preparation of 8-chloro-2-[T -(3-chloro-2-pyridinyl)-3-(trifluoromethylV 1H- pyrazol-5-yll-3-methyl-4(3H -quinazolinone A solution of the title compound of Step A (300 mg) in 2 mL of tetrahydrofuran was treated with methylamine (2.0 M solution in TΗF, 10 mL), sealed in a capped bottle and stirred for four days at room temperature. The solvent was removed under reduced pressure and the solid residue was washed with ether. The ether soluble material was purified by chromatography on silica gel using hexanes/ethyl acetate (1 : 1) as eluant. The title compound, a compound of the invention, was isolated as a solid, m.p. 155-157 °C. !Η NMR (CDC13) δ 3.8 (s,3Η), 7.1 (s,lH), 7.4 (m,2H). 7.7 (d,lH), 7.9 (d,lH), 8.15 (d,lH), 8.35 (m,lH).
By the procedures described herein together with methods known in the art, the following compounds of Tables 1 to 33 can be prepared. The following abbreviations are used in the Tables: t is tertiary, s is secondary, n is normal, / is iso, c is cyclo. Me is methyl, Et is ethyl, Pr is propyl, z'-Pr is isopropyl, t-Bu is tert butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CN is cyano, NO2 is nitro, TMS is trimethylsilyl, S(O)Me is methylsulfinyl, and S(O)2Me is methylsulfonyl.
Table 1
R5b is Cl R5b is CF3 R5b is OCF3 R5b is CF(CF3ϊ-
R3 R4a R4b R3 R4a R4b R3 R4a R4b R3 R4a R4b
.-Pr Me H /-Pr Me H /-Pr Me H /-Pr Me H -Pr Cl H /-Pr Cl H /-Pr Cl H /-Pr Cl H
/-Pr Me Cl /-Pr Me Cl /-Pr Me Cl /-Pr Me Cl
/-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl -Pr Me Br /-Pr Me Br /-Pr Me Br -Pr Me Br
/-Pr Cl Br /-Pr Cl Br /-Pr Cl Br /-Pr Cl Br t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Me Cl t-Bu Me Cl t-Bu Me Cl /-Bu Me Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Me Br t-Bu Me Br t-Bu Me Br t-Bu Me Br
Table 2
R5b is Cl R5b is CF3 R5b is OCF3 R5b is CF(CF3 τ
R3 R4a R4b R3 R4a R4b R3 R4a R4b R3 R4a R4b
/-Pr Me H /-Pr Me H /-Pr Me H /-Pr Me H
/-Pr Cl H /-Pr Cl H /-Pr Cl H /-Pr Cl H
/-Pr Me Cl /-Pr Me Cl /-Pr Me Cl /-Pr Me Cl
/-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl
/-Pr Me Br /-Pr Me Br /-Pr Me Br /-Pr Me Br
/-Pr Cl Br /-Pr Cl Br /-Pr Cl Br /-Pr Cl Br t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Me Cl t-Bu Me Cl t-Bu Me Cl /-Bu Me Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Me Br t-Bu Me Br t-Bu Me Br t-Bu Me Br t-Bu Cl Br t-Bu Cl Br t-Bu Cl Br t-Bu Cl Br
Table 3
Table 4
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6
Me CH3 H Br Cl Me Cl H CF3 Br Me Cl CF3 Br
Et CH3 H Br Cl Et Cl H CF3 Br Et Cl CF3 Br
/-Pr CH3 H Br Cl /-Pr Cl H CF3 Br /-Pr Cl CF3 Br t-Bu CH3 H Br Cl t-Bu Cl H CF3 Br t-Bu Cl CF3 Br
Me CH3 H Br Br Me Cl H Cl Cl Me Cl Cl Cl
Et CH3 H Br Br Et Cl H Cl Cl Et Cl Cl Cl
/-Pr CH3 H Br Br /-Pr Cl H Cl Cl /-Pr Cl Cl Cl t-Bu CH3 H Br Br /-Pr Cl H Cl Cl t-Bu Cl Cl Cl
Me CH3 F CF3 Cl Me CH3 Cl CF3 Cl Me Cl Cl Br
Et CH3 F CF3 Cl Et CH3 Cl CF3 Cl Et Cl CI Br
/-Pr CH3 F CF3 Cl /-Pr CH3 Cl CF3 Cl /-Pr Cl Cl Br t-Bu CH3 F CF3 Cl t-Bu CH3 Cl CF3 Cl t-Bu Cl Cl Br
Me CH3 F CF3 Br Me CH3 Cl CF3 Br Me Cl Br Cl
Et CH3 F CF3 Br Et CH3 Cl CF3 Br Et Cl Br Cl
/-Pr CH3 F CF3 Br /-Pr CH3 Cl CF3 Br /-Pr Cl Br Cl t-Bu CH3 F CF3 Br t-Bu CH3 Cl CF3 Br t-Bu Cl Br Cl
Me CH3 F Cl Cl Me CH3 Cl Cl Cl Me Cl Br Br
Et CH3 F Cl Cl Et CH3 Cl Cl Cl Et Cl Br Br
/-Pr CH3 F Cl Cl /-Pr CH3 Cl Cl Cl /-Pr Cl Br Br t-Bu CH3 F Cl Cl t-Bu CH3 Cl Cl Cl t-Bu Cl Br Br
Me CH3 F Cl Br Me CH3 Cl Cl Br Me Cl CF3 CF3 Cl
Et CH3 F Cl Br Et CH3 Cl Cl Br Et Cl CF3 CF3 Cl
/-Pr CH3 F Cl Br /-Pr CH3 Cl Cl Br .-Pr Cl CF3 CF3 Cl t-Bu CH3 F Cl Br t-Bu CH3 Cl l Br t-Bu Cl CF3 CF3 Cl
Me CH3 F Br Cl Me CH3 Cl Br Cl Me Cl CF3 CF3 Br
Et CH3 F Br Cl Et CH3 Cl Br Cl Et Cl CF3 CF3 Br
/-Pr CH3 F Br Cl /-Pr CH3 Cl Br Cl /-Pr Cl CF3 CF3 Br t-Bu CH3 F Br Cl t-Bu CH3 Cl Br Cl t-Bu Cl CF3 CF3 Br
Me CH3 F Br Br Me CH3 Cl Br Br Me Cl CF3 Cl Cl
Et CH3 F Br Br Et CH3 Cl Br Br Et Cl CF3 Cl Cl
/-Pr CH3 F Br Br /-Pr CH3 Cl Br Br /-Pr Cl CF3 Cl Cl t-Bu CH3 F Br Br t-Bu CH3 Cl Br Br t-Bu Cl CF3 Cl Cl
Me CH3 Br CF3 Cl Me Cl F CF3 Cl Me Cl CF3 Cl Br
Et CH3 Br CF3 Cl Et Cl F CF3 Cl Et Cl CF3 Cl Br
/-Pr CH3 Br CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl CF3 Cl Br t-Bu CH3 Br CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl CF3 Cl Br
Me CH3 Br CF3 Br Me Cl F CF3 Br Me Cl CF3 Br Cl d CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CQ CQ CQ CQ CQ CQ CQ CQ CQ Q CQ oa DQ CQ eQ OQ CQ e CQ CQ m eQ oa CQ CQ ι- 3 c I 3 3 3 3 oil « ϊ 3 s W ^ ffl CQ CQ CQ w ^ in ffl ffl CQ ς UI CQ 5 W Pi CQ 3
il CQ CQ CQ u o υ u CQ CQ CQ CQ O U J u m CQ CQ CQ U CJ U CJ CQ CQ CQ eQ CJ U O CJ CQ CQ CQ CQ CJ ro co co co ro ro co ro ro ro ro ro il Ui Ui Ui J CJ J CJ CJ CJ u cq m ff CQ CQ CQ CQ CQ U PL U U U U U PL U,
CJ J J J l υ cj cj cj u u υ cj cj cj cj υ cj cj υ υ U o m •° I ro d U U PL U U PL U U PL U U PL PL PL U PL PL U PL J CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ O CJ U υ id o ϋ o u υ υ u υ u u υ u o u o o υ u υ υ υ u υ cj cj cj c c o υ cj cj cj cj cj CQ
oil CQ CQ CQ CJ u υ cj CQ CQ CQ o cj o U CQ CQ CQ CQ U U U U CQ CQ CQ eQ U O U U eQ CQ Cq CQ U co co ro co co co co co co co co , , -_- __ . , , , ,
Oil PL PL PL r ) U PL U PL U PL PL PL r , r _ r . r ) r _ r _ r _ υ o CJ CJ ^ u υ υ cj o CJ u CQ CQ CQ CQ CQ CQ CQ CQ J CJ O C CJ CJ U U ^ ^ ^ ^ ^ CQ
-0 I id CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ αo a I co co co ro ro o co co c eo co co co co co co co co co co co co co co
X X X X K 33 33 X X X X 33 HI ffi 33 33 33 33 33 S Ε -, 33 MH H pH 3H Ε H -l ?H M-l -l -,
CJ cj υ u u u u J u u υ J U J CJ J CJ CJ U O CJ CJ CJ U CJ U CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ o O n 3 3 n 3 it co I il s ξ ω «? ά? CQ 2 « £ 2 ω w CQ ___ i ^ ∞ ___ m ^ & '___ m p? '___ m CQ S
H ωH Hω, ω H „o _o o--- o_. roHH ro H, -ω, ω HroH ro HH ω ►, ro HH o „ o„ o,--. o^ o„ o„ o„ o„ Q. Q. JQ. JQ. (jQl JQ. Ql JQ. w^ d HH HωH ro HH ro H, ω HH l?α
o o o o o o o ω ro ro ω o o o o tjo ω ω w o o o o ω w w ro o o o o w ro ω w o o 3 M 3ϊ tro >^ !-? |ϊ ro ^ £ |ϊ rø 'fl £ 2 ro >fl M 2 V9. ro ro ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro co ro
I s» o o o o o o o o o o o o o o o o o o o o o o o o o o o o o Q Q Q Q Q Q Q Q ro ro ro ro ro ω ro ro o o o o o o o o Q Q Q Q Q Q I ~Λ ro ω ro o o o o ω ω ω ω o o o o ro ro ro ω o o o o ω ro w cd o o o o w ω ω ω o o I CΛ
■HH w S ώ ^ ^ S t ^H w ^ ro ^ w S ώ iHH w S ώ ^ M S ro I j ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro w ro ro w ro ro w ro ro ro ro w 1^ ω ro ω ro ω ω w ω ω w ω ro ro ω w o o o o o o o o o o o o o o o o o o o o o o I cr π o " o o o^ o^ o i-Q '-Q oQj i-Q oQ- i-Q i-Q Q. ro *• ω "• ro ^ rø ro ^ ro ^ ω ,_1 ro ^ o ~ o ~ o o ~ o ~ o ~ o ~ o ~ ιQj i-Q Q Q t-ζj Q I ro ω ω o o o o ω ω ro ω o o o o ro ω ro ω o o o o ω ω ro ω o o o o c w ro ω o o I o
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl l Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Table 6
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl H Cl Br Me Cl Br Cl Br
Et CH3 H CF3 Cl Et Cl H Cl Br Et Cl Br Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl H Cl Br /-Pr Cl Br Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl H Cl Br t-Bu Cl Br Cl Br
Me CH3 H CF3 Br Me Cl H Br Cl Me Cl Br Br Cl
Et CH3 H CF3 Br Et Cl H Br Cl Et Cl Br Br Cl -Pr CH3 H CF3 Br /-Pr Cl H Br Cl /-Pr Cl Br Br Cl t-Bu CH3 H CF3 Br t-Bu Cl H Br Cl t-Bu Cl Br Br Cl
Me CH3 H Cl Cl Me Cl H Br Br Me Cl Br Br Br
Et CH3 H Cl Cl Et Cl H Br Br Et Cl Br Br Br
/-Pr CH3 H Cl Cl /-Pr Cl H Br Br /-Pr Cl Br Br Br t-Bu CH3 H Cl Cl t-Bu Cl H Br Br t-Bu Cl Br Br Br
Me CH3 H Cl Br Me Cl H CF3 Cl Me Cl I CF3 Cl
Et CH3 H Cl Br Et Cl H CF3 Cl Et Cl I CF3 Cl
/-Pr CH3 H Cl Br /-Pr Cl H CF3 Cl /-Pr Cl I CF3 Cl t-Bu CH3 H Cl Br t-Bu Cl H CF3 Cl t-Bu Cl I CF3 Cl o o o o o o o o o o o o o
HH 3-! 33 33 3. 33 33 33 33 33 ro ro ro ro ro Ti n J Tj Tj Tj Tj Tj TJ TI p It c
O O O O
TJ TJ TJ TJ TJ ro ro ro ro ro ro ro ro O O O O O O O O
Q TI Tj TJ TJ O TJ O TJ TJ TJ ^ roJ. w ro co or w w ro i-o to ω ι-o i-o l-O ) l-O i- to i-o ω i-o ^ I fi ro o o o o ro w ro ro o o o o ro ro ro ro o o o o ro ro ω ro o o o o ω ω w ro o o o o I Λ w 5 m £
O O O O o o o o o o o o o o o o o o o o o o o O O O O O -
3J 33 33 3! 33 Q O O O O O O '1 j T TJ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33 33 33 33 33 33 33 33 f It cr i- ω o o o o w ro ro w o o o o ro ω ro ω o o o o ro ro ro ω o o o o o o o o ro ro ro ro I O
o o o o o o o o o o o o o o O o o o o o o o o o o o o o o o o o o o o o o I -εfe>-
0 Tj 0 Tj 0 , 0 Tj 0 T 0 "ri 01τj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj o W i ^ UJ i UJ U-> t^ ) UJ OJ > lJ l > -i > tno p I cr ro ^ o o o o o o o o toQ toQ toQ tQo toQ toQ toQ n W rø ro w ro ω ro ro o o o o o o o o ζ. Q Q Q I sj, o w ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o w ro ro ro
tn n. ω 5 tn W TJ t mn ro TJ tn tn z ___•> 5? or J tn ω TJ t mn r TJ t ra tnn
3 3 3 K H? S ro o r TJ t tni
3 3 ct o
3 I to
O O O O O o o o o o o o o o o o o o o o o o o o o o o o o o
HH X HH WH ffi uC HH HH HH HH HH HH HH H HH HH HH HH H HH HH HH oHH i-H oHH oHH o3-J 33 33 33 to o P ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ω p 1 <r ω ro o o o o o .-. .-. - O O O O O O O
Q O O iTj Tj Tj Tj Tj Tj Tj Q ro ro r Lis °TJ °TJ OTJ |5«.
' ' ' ' to to to to to to to ω ω ro ro ω ω o o o o o o o to o to o o w ω ω ro o o o o ro ro ro ro o o o o ω ro ro w o o o o ro ro ro ro o o o o w ω ro I ON
« ? w ϊ S ώ w S ro w S ro ζ m S ro ζ m S ro ζ w S ro I t w ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o pi
Q Q n o ro ro w ro ro ro ro o o o o o o o o Q Q Q o o w ro ro ro o o o o rø w ro ω o o o o ro ω ω ω o o o o ro ω ro ro o o o o ro ro ω I Os
£ j|' ώ ζ w S ώ ζ w 2 ώ τj W ^ ώ w 2 ώ j w S p to rt ct 3 ι- rt t c ι-1 ^ ι-1 " '- ^ C ^ n C ^ n e •? S '- <1> S ,-' ' w w w ro ro ro ro w ro ro w ro ro ro w ro ro w ro ro ro w ro ro ro ro o o o o o o o o o o o
O O TJ TJ TJ Tj TJ n n n n n n n n n n n n n n n n n n n θ O O O ^ »τj τj τj Tj τj τj to to to o i-o t o I cr
Ω Q ro ro ro ro ω H H Q o ι-o -1 ~* -1 *' -1 -?H l-?l HHHI3 Q H- QH- QH- Q_ QH- QH- 0H- °H- LQ(J υnJ Q) ) n) Q) n) Q) π H- oH- oH- oH- roH, ro I"! ro -1 ro »H ro -1 ro >1 ro "H I I -*
o o w ro ro ro o n o o w ω w w o o o n ro ω ro ijϋ o o n o o n o n t' ro ω t' o o o I I O*N
τj W i- ro ro ώ τj ro τj W
^. ^-. - - ^ - ^-. O O O O O O O O O O O O O O O O O O O O O O O O o π o o π π π iτj > τj n n n n j j n n n n τj τj τj τ] τj τj τj τj τj τj τj |-H ι-H |ι ι1 >— ■ i-1
— — — — — — ' ' to to ι-o t-o t-o t-o t-o ι-o to to to to ι-o to ι-o ι-o t-o ι-o (.- t-o t-o ι-o ι-o to I - cfe- ro ro ro o o o o ro w ro ro ro ro ro ro o o o o o o o o Q Q Q Q Q Q Q Q ro ro ro ro ro ro I m o o o o o o o ro ro ω ω o o o o ro ro ro ro o o o o ro ω ω ro o o o o w ro ro ω o o τj W , crj ζ w ; t30 j W S ro τj W S « ζ w ^ tB j W ^ I I t3o ro w w ro ro w ro ro ro ro ro ro ro w ro ro ro ro ro ro ro w ro w ro ro ro ro ro ro ro ro w ro ro ro w PI o o o o o o o o o o o o o o o o o o o o o o p Ii cr o o o o o o o Q Q Q Q Q Q Q Q ro ro w w ω ro ro ro o o o o o o o o Q Q Q Q Q Q I J, ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o w ro ro ro o o o o ω ro ro ω o o
^ S ^ ro Tj w S ro j w S to ^ w S ro iHj ro S t ^ ro S ro P rt n S Hr ^ ft C Hy '-* m C HH " f C H ^ ft C Hy rt Q C Hr r* C 3 HH '+ ft C h^ Cl C '^ I ti l-1 o w ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro w ro ro ro ro w ro ω ro ro ro ro ω ω ω ω ω ω ro ro ro o o o o o o o o o o o o o o o o o o o o o o I - cfer-
w or ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o 150 I a
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl Cl Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Table 7
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl H Cl Br Me Cl Br Cl Br
Et CH3 H CF3 Cl Et Cl H Cl Br Et Cl Br Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl H Cl Br /-Pr Cl Br Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl H Cl Br t-Bu Cl Br Cl Br
Me CH3 H CF3 Br Me Cl H Br Cl Me Cl Br Br Cl
Et CH3 H CF3 Br Et Cl H Br Cl Et Cl Br Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl H Br Cl /-Pr Cl Br Br Cl t-Bu CH3 H CF3 Br t-Bu Cl H Br Cl t-Bu Cl Br Br Cl
Me CH3 H Cl Cl Me Cl H Br Br Me Cl Br Br Br
Et CH3 H Cl Cl Et Cl H Br Br Et Cl Br Br Br
/-Pr CH3 H Cl Cl /-Pr Cl H Br Br /-Pr Cl Br Br Br t-Bu CH3 H Cl Cl t-Bu Cl H Br Br t-Bu Cl Br Br Br
Me CH3 H Cl Br Me Cl H CF3 Cl Me Cl I CF3 Cl
Et CH3 H Cl Br Et Cl H CF3 Cl Et Cl I CF3 Cl
/-Pr CH H Cl Br -Pr Cl H CF3 Cl /-Pr Cl I CF3 Cl t-Bu CH3 H Cl Br t-Bu Cl H CF3 Cl t-Bu Cl I CF3 Cl o o o o O o o o O o o o o o o o o o o o o o O o O o o o o o o o o o o O O
33 33 33 33 33 33 33 33 33 33 33 33 3! 33 33 33 3! 33 33 33 33 33 33 3! 33 33 33 X 33 33 33 33 3! 33 33 33 33 pi
o o O o o ro or ro ro ro ro ro ro O O O O O O O O O o o O O O O O ro ro ω ω ω ro ω ro
ro o O or ro ro ro O O O O ro ro ω W O O O O ro ro ro ro O O O o ro ro >-- ω ro o o o o
*.
2 ro tn ro ω m ro tn 2 ro tn ro tn 2 ro m 2 tn ro w |?3
3 3 3 c 3 3 3 o o o o O o O O
O o o o o o o o o O O o O o o o O o O
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 3! 3! 33 33 33 33 o o o o o o o o
o O O O O O O O O O O O O O O O o O O O O O O 33 33 33 33 33 33 3! 33 •fe- o O ω w W W ro ro ro ω o O O o O O O O O o O O O O O O O O O O O O Pi
W O O O O ro ro ro o o o o ro ro w w o o o O ro ro ro ro O O O O O O O O ro W W ro Pi
ro tn 2 ro 2 ro or 2 or ro m 2 ro tfl ro ro ω w ro ro
3 3 3 3 3 3 3 3 o o o o o o O o o o O o o o o O o o o o o o O o o o O o o o o o O o O o o Pi -fe- o o o o o o o o o o O o o o o o o
1 σ*
o ω ro ro ω o o o o ro w ro ω O O O O ro ro ω w o o o o ro ro ω ω o o o O ω ω ro w Pi
m TJ £? ω tn m z ro TJ £? o TJ m t tnn ro TJ g ini ω TJ ro ro ro TJ ra tn ro TJ 2?
3 -I ω TJ 2? r
3 -i 3 -i c 3 I to o o o o o o o o o o o o o
33 33 o H-H H-π o3l oK oE oK o3. oK o3H offi oK offi oW oK o3l oK oK oHL oH oW oH-H oH oH-H oH-H o 3 H-H t 3o3 to3 t 3o3 to to i-o to to i-o i-o i-o i-o i-o to to i-o i-o i-o to to i-J to i-o to to to to i-o to to 33 3! 33 33 33 3 33 Pi fe- w ro ro ro ro ro w ro ro ro ro ro ro w ro ro ro w ro ω ro o o o O O c Oj c Oj c Oj Tj o TJ o Tj o TJ o τι T oJ o Tj w ro ro ro w w ro o o o o o o o r Q. o TJ o TJ o TJ Pi to to to to to ro to to l-O I tn o o ro ro ro ro o o o o ro ro ro ro o o o o ro ω ω ro o o o o ro ro ro ro o o o o w ro ro I σs
w w o o o o o o o o o o o o o o o o o o o o o o o o o o O O O O PI
O O
TJ Tj -J o to o o o o o o o tQo tQo tQo tQo tQo toQ tQo tQo ro ^ ro ^ ω ^ ω ω ^ ro ro ^ ω ^ o " o'-^ o~ o" o" o'-^ o~ ol-^ tQo tQ ι-Q I tn o o ro ro w ro o o o o ω ω ro w o o o o ro ro ro ro o o o o ro w ro ro o o o o ro ω ro I C\ m ct ro
3 § w S rø ζ w ώ ς w ; ώ ζ w 2 ώ ς ro ώ J ro _ά_, ro - roό τj 3J τj Wra ? B i. fj I
3 3 3 i-i e ° C i-l I L5O ro ro ω ro ro ω ω w w ro ro ro w ro ro ω ro ro ro ω ro ro ro ro ro ro o o o o o o o o o o o fl
Q o TJ τj n n n n n n n n n n n ro n n n τj n n n τj n n θ O O θ Q ζ >τi >τ| τj n ι f Il cr
o o ro ro ω ro o o o o ro ω ω ro o o o o ω ro ro ro o o o o o o o o ω ω ro ro o o o l°
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O Q O O O i_i —1 H^ H^ H-3 S H H 3l H-H H^ H-H HH 3-, Ε S S S H H-H M H-H H-H H-H H-H h-H S H H-H t-O LO O LO tO l-O l-O l-O LO t-O t-O L LO l-O L t-O t- LO l-O tO l-O LO l-O l-O l-O L^ f Il co
^ -, ^-, ^, ^^ - -. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Pi --- Q Q ϋ -2 --. ϋ n n τj n n j n n n n n n τj ι-tj j n τj n n τι n τj n n ^ w M " w ι-1 -fe- ro HH roHH roHH oH- oH- oH- o— ωH, ro-, Hro, Hω, HroH Hro, Hro, roH, o- o- -o o- o- o- o- Ho- ^QJΩI JQI ^Q GI JQ JQJQI Hro ro-1 -ω, roH, ωH, ωHH Ifo
I tn o o o o o o o ro w ro ro o o o o or ro ro ro o o o o ro ro ro w o o o o ro ro ro ro o o |?3
ζ ? l* rø τj , l' ro τj W ^ ώ τ 2) ϊ ro τj ? l" rø H M
-ι ^ f 3 ιrt ft c ,-< n S '-' 0 3 '-^ 0 3 '- 0 ,0 3 ,-< Λ C >^ <1> 3 ,- I '-o w w ro w ro w ro ro ro w ro ro ro w ro ro w ro ro w ro ro ro w w ro w o o o o o o o o o o o o o o o o o o o o o o f Il cr L o o o o o o o Q Q Q Q Q Q Q Q ω ro ro ω ro ω ro ro o o o o o o o o Q Q Q Q Q Q Pi
I LΛ ro ro ro o o o o ro ro ω ω o o o o ro ro ro ro o o o o ro ω ω ω o o o o w ro ω ω o o I Os
>- S c. ^ S S ro fl W S ώ ^ !J td ifl W w >. w 2 td ^ w ^
H " » C ^ n S ,ι <, C '' ', C 'i (, i: >ι ,, C ,ι ', C H '> C H - C Hi I i-o
ω ω w rø rø w ω ω ro w ω ro w tG ω o o o o o o o o o o o o o o o o o o o o o o f Il cr
ro ω ro o o o o ω ro w ro o o o o ro ω ro ro o o o o ω ro ω ro o o o o ro ro w ω o o I p*
R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl Cl Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Table 8
R3 R4a R4b R5 ≠ R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ
Me CH3 H CF3 Cl Me Cl H Cl Br Me Cl Br Cl Br
Et CH3 H CF3 Cl Et Cl H Cl Br Et Cl Br Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl H Cl Br /-Pr Cl Br Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl H Cl Br t-Bu Cl Br Cl Br
Me CH3 H CF3 Br Me Cl H Br Cl Me Cl Br Br Cl
Et CH3 H CF3 Br Et Cl H Br Cl Et Cl Br Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl H Br Cl /-Pr Cl Br Br Cl t-Bu CH3 H CF3 Br t-Bu Cl H Br Cl t-Bu Cl Br Br Cl
Me CH3 H Cl Cl Me Cl H Br Br Me Cl Br Br Br
Et CH3 H Cl Cl Et Cl H Br Br Et Cl Br Br Br
/-Pr CH3 H Cl Cl /-Pr Cl H Br Br /-Pr Cl Br Br Br t-Bu CH3 H Cl Cl t-Bu l H Br Br t-Bu Cl Br Br Br
Me CH3 H Cl Br Me Cl H CF3 Cl Me Cl I CF3 Cl
Et CH3 H Cl Br Et Cl H CF3 Cl Et Cl I CF3 Cl
/-Pr CH3 H Cl Br /-Pr Cl H CF3 Cl /-Pr Cl I CF3 Cl t-Bu CH3 H Cl Br t-Bu Cl H CF3 Cl t-Bu Cl I CF3 Cl
O o o o O o O o o o o o o o o o o o o o o o o o o o o O o O O O O O O O
33 33 33 33 33 33 33 3! 33 33 33 33 33 33 to PI
W ro ω ro ro TJ TJ Tj TJ Tj TJ TJ Tj Tj TJ 33 ft
O o O
TJ o TJ o ω ro ω ro ro ro ro ro o o o o o o _-- o o i- o TJ o o o o o O O TJ TJ ro ro w w ro ro w ro I LΛ ro o o o o ro ro ro ro o o o o ro ro ω ro o o o o ω ro ro ro o o o o ω ro ro ω o o o o I O
2 ro J in m t ro T ,J tn S ro Tj W ^ T- Tj W ^ ro TJ ? TJ in
3 r W
3 2? ω TJ w ro T 2 3 r? S I to
O o o O O o o o O O O O O O O O O o o o o O O O O O
33 33 33 O O O O O O to t to 33 33 33 33 t So Q f Il co
T] TJ τj O O O O O O O O O O Q O O O O O O O O O O θ 33 33 3 3, 33 3; 3; jιj 3 I cr Ov o τι O
TI o τι o Tj O ro w ro ro ro ro ro ro o o o o o Q Q o n o Tj oTJ T oJ T o] T oJ oTJ TJ π J t to to LO LO to to to Q Q Q TJ TJ J t to to to I tn ω o o o ro ro ro w o o o o ro ro ro ro o o o o ro ω ro ro o o o O O o o o ro ro w ω Pi l OS
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Ilco oj o Tj oj oj o Tj oj oj oj o T oj o Tj o Tj oj o Tj oj o Tj o Tj fl ω Q Q Q Q Q Q Q Q n o n o y o n o n o n o y o M ro ro ro ro ro w ro ro o o o ω ro ro ω o o o o ro ro w ω o o o o ro ro ω ro o o o o w w ro ro o o o o ω ω ω ro |! O
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
33 33 33 33 33 33 ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro
I cr ro ω o o o o O O O o O O O O
TJ o Tj Tj TJ j TJ Tj ro ro ro ro ω ro ro ro o o o o o o o r. o TJ o TJ o τι Pi
I tn o o ro ro ro ro o o o o ro w ro ro o o o o ro ro ro ro o o o o ro ro w ro o o o o ro ω ω I PS Ch. tn m ro -_-rJ 21 ro tn ro J 21 ro TJ tn ro J u in ro TJ ra tn 2 ω ro 21 ro tn ro l" 3 3 y 21 V I t3o ω w o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o P
P n O O O O O O O O O O O O O O O O n ro ro n Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj fl Os tO
Q Q o o O O O O Tj Tj T Tj Tj Tj Tj Tj o t o w w w co c- w td do o o o ri o o n o Tj Tj j OJ ) I 1^ tn o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o w ro ro ro o o o o w ro ω V I C3Λ
21 ro ro 21 S ro τj W : ro 21 : ro 2ϊ : ro τj 21 : ro τj W : ro ro ro τ ro j W ^ ro j 21 l!:S- ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro w ro o o o o o o o o o o o f Il co
O O Tj TJ Tj n n n n ro n τj n ro ro n n ro τι n n n ro τj τj τj O O O θ Q Q Q y y y Q
I cr
o o ro ro ro ro o o o o ro w ro ro o o o o ro ro w ro o o o o o o o o ro ro ro w o o o PI
HH rt t e c ^ ^ c; ι-t '* ft C HH ^ Ct c; ι-t ™ fD c; '-' <" '-' 0) β ,-l rD S ,-1 <" S ,-< 1 LO
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O fl
- -. - ω HH roH, ωH, o o o o Mro ωHH ωHt roH, roH, roH, roH, roH, o .-. o^ o^ o — o→ o^. o^ o^ JQj ^Q ^Q Jj JQj ^Q ^Ω JQj ro*. ωH, ωH, ωH, Hω, wH, Pi
1 i-n o o o o o o o ro w ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ω ω o o s 21 §» ro τH 21 l rø ro 21 l ώ ro 2? l* ro τ3 2? l* ro ro 2? l* ro ro |?3
^ ^ > c X n G X a' G X n G X a' G X r'' G X n G X c[' G X a' G X 1 i-
,~ --1 l— ' l~ l— ' o o o o o o o Q Q Q Q Q Q Q Q ω ro w ro ω w ro ro o o o o o o o o Q Q Q Q Q Q
ω ω ro o o o o ro ro ro ω o o o o ro ro ω ro o o o o ro ro ro ro o o o o w ro w ro o o P)
I Ch ro 2? ^ ro ^ 2, ^ ro ^ 2? - ro τH 2? ^ ro ro 2? ^ ro >n 2, ^ ro 'n 21 i> ro Ϊ 2ϊ ^ ro ^ w ^ ro τ I t ro ro w ro w ro w w w w ro ro w ro ro ro ro ro ro ro ro ro ro ro w ro ro w ro ro ro ro ro ro ro w w ro ω ro ω ω ω ro ro ω ω ro ro w ω ro o o o o o o o o o o o o o o o o o o o o o o f Il cr
ω ω ω o o o o ω ro ro ω o o o o ro w ro ω o o o o ro w rø ω o o o o ro ro ω ω o o I Ch
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6 t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl Cl Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
R-i R4a R4b R! E-ϊ R-1 R4a R4b R-1 Rδ R-- P R4b R! R-ϊ
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl
/-Pr CH3 H Cl Br -Pr Cl F Cl Br /-Pr Cl H CF3 Cl o o o o O O O O O O O o o o π o o o o o o o o o o o o o o o o o o o o o o
33 33 33 33 H^ H^ HH HH HH HM H HH HH f Ilco
Q Q Q Q hn hn τj τj TJ Tj TJ TJ TJ TJ TJ Tj Tj Tj τj τj τj τj 3 jr; a a 3 3; 33 3; 33 I cr o o ω ro ro ro ro ro ro ro o o O O O O
TJ oTJ Tj oTj o TJ o n T TJ TJ Tj Tj Tj ro ro ro ro ro ro ro w o Pi to to LO to o o o o o o oJ to to LO to to t to to I tn o o o o ω ro ω ro o o o o ω ro ro ω o o o o ro ω ω ro o o o o ω ro ro ω o o o o ro rø TJ m? S ro ω J m s ro TJ . or _3 n m z ro 2? W TJ 2 m? £ ω ro 2 ω TJ t 2n1 ro TJ tt 2n1 ro TJ 2 tn1 fe fe r roo I t O O O o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Ilco
H^ H^ Hf H Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q ro Tj Tj Tj Tj Tj Tj Tj Tj fl ro) OnJ τJj Q-ϊ ro ro ro ω ω ro ω ω o o o o o o o o Q Q Q Q Q Q Q Q ro w ω ω ro ro ω ro o I tn o o o o ω w ro ro o o o o w ro ro w o o o o ro ro ω ro o o o o ro ω ro ro o o o o ω P I C3h
I o
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O ro ro w ω ω ro ro ω ω ω ro ro 3i H T| τι τi 33 33 3; 33
Ω Ω Ω Ω Ω Ω Ω Ω n Q Q Q n Q Q Q ro ro ro ro ro ro ro ro o o o o o o o o Q Q Q Q Q ω ω ω ω o o o o ro ω w ω o o o o ro ro ro ω o o o o ro ro ro ro o o o o ro ω ω ro o I Ch
c ro TJ tn ro TJ ro ro TJ w 2 ro TJ
3 3 3 3 W fe' ro j 2] £ ro τj 2? ro τj 2? S ώ τ ffl 2 ro τj S &' I P Li c O o o o o o o o o o o o O o o O o o o o o o o o o o o o o o o o o o o o o o
33 33 33 33 33 33 33 33 33 33 X 33 33 33 HH HL H ffi E K E HH H» H-H HH HH HH HH HH HH 3< HU HH HH HH HH O LO t to to to to to to to LO to to to LO 31 l- tO l-O I-O l-O tO l-O L l-O LO tO tO I-O l-O l-O LO tO I-O t tO t LO I cfeo- ro ro ω ro ro ro W ω ω ω ro ro ro ro ro ro ro o o o o o o o o o o o o o o o o o o o o Pi I • cfer- ro o o O O o o o o o Tj o Tj O Tj Oj O
Tj o TJ LO LO to to to LO L Ω tQo ro ^ ro "• ro ^ ^ro ro *< ro -1 ro "• ro ^ o — o H- oH- o H- oH- o - o H. -o jQ Q1 j11 I*. o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro I Ch
ro ro ro ro ro ro ro w ro w ro ω ro ro ro ω ro ro ro ro w Od co C ro ro ro ro w o o o o o o o o fl ro ro ro ro ro w ro ro ro ro w w w ro ro ro f Il cr 0 w ro ω ω ro o o o o o o o o oy oy oy oy oy oy oy oy ω ω ro w rø ro ω ro o o o o Q Q Q Q P I tin ro o o o o ω ro ω ω o o o o ω w ro ro o o o o ro ω ω ω o o o o o o o o ω ro ω ω I Ch
β Hr " ft 3 Hr " ft C H-r " ft C Hr " ft I ii-o ro o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Il t
^ ^ -. ^ - O O O O O O O O O O O O O O O O O O O O O O O O ^ ϋ ϋ ϋ ϋ ro ro n n n ro n n ro ro ro ro n ro ro n Tj Tj Tj Tj Tj Tj Tj Tj fl n Ω Ω Ω Ω H? H? H? H? H? H? H? H? Ω Ω Ω Ω Ω Ω Ω Ω n ro Q Q Q Q Q Q ro ro ω w ro ro ω ω P I <i-n o o o o o ω ω ω ro o o o o ro ro ω ro o o o o ro ω ro w o o o o ro ro w ro o o o o I Ch
tn ro TJ ra tn ro TJ 2> ro TJ 2 m1 it r ro t m ooo TJ 1 m-V w
3 3 3 « o n ro m ro 2 2 e 3 ~1 ft ^ ώ r
O O O O O O O O O O O O O O o o O O O O O O O O O O O o o O O O O O O 1*
33 33 33 33 33 33
o TI ToJ TJ TJ Tj TJ ro ro ro ro ro ro ro ro o O O O O O O T oJ o TJ T oj o T o O J Tj TJ O TJ o TJ ro ro ro ro ro ro w 1*3 O LO LO to to LO to to to to to I tn w ω o o o Ω H? ro ω w o o o o w ro w ro o o o o ro ro ro ro o o o o w ro ro ro o o o 1*3 I Ch w rø TJ 2 m1 ro TJ tn ro ro w ro ro w ω ro ro ω w ro ro w ro ro ro ro ro ro ro w ro ro ro ro w ro ro w ro w ro w ro w ro P w ro ro ro ro ro w ro ro ro o TJ o o 0 0 0 0 0 0 O O
TJ TJ o O 0 0 0 1*3 j o Tj j TJ J 0 Tj 0 Tj 0 Tj O TJ TJ TJ Tj Tj Tj Tj O TJ o TJ o TJ T Tj Tj to to 1-0 t to to to LO LO to t to to to to to to LO > to I • cfer- CJ
, ---,- ,Q-, 0j 0Tj 0Tj 0j 0Tj 0Tj 0j TJ υ ro- ω ro ω ro ro w ro O O O O O O r tO LO to Q. X> 0 TI O TJ 0J O TJ TJ 0J 0 TI O TJ ro ro ro 1*3 tO LO LO LO to ~> to to to to l-O to o. o I tn o o w ro ro ro o o o o ro ω ro ω o 0 0 0 ro w ro ro o o o o ω w ro ro o o o o w ro ω 1*3
I Ch w ω TJ ro ro ro TJ 21 TJ 21 ro J ϋ roJ o ra m m 2 ro TJ 21 a ro 3
3 3 ω r ΪΓ ro ro 2?
3 3 -> ft s ft- ro G ro HI w " § ct* G 1- V 1* I to ro ro ro ro ro ro ro ro w ro ro ro ro ω ro 0d Cd Cd oo C oo Dd dd CO CO Od oo oo cd oo 00 Cd 00 co Cd oo dd P
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ro" τj τj τj τj ro n n n n ro n n n n n n n n n n τι τι 1*3
I T Ω Ω Ω Ω Ω Ω ro ro Q Q Q Q Q Q ω ro ω ro ro ro ro ro o o o o o o o o Q Q Q Q Q Q Q Pi
I tn ro ro o o o o ro ro ro ro o o o o w ro ro ro o o o o ro ro ω ro o o o o ro ro ro ro o o o 1*3 I Ch
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6
/-Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl /-Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br CI
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br «-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br H-Bu CH3 Cl Cl Cl i-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br 5-Bu CH3 Cl Cl Cl
Table 10
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl
/-Pr CH3 H Cl Br /-Pr Cl F Cl Br /-Pr Cl H CF3 Cl ro TJ ? ω TJ S m-J TJ ϋ WJ ro r 21 ro TJ i roi-1 ω w r TJ ϋ tn r ro 1*3
3 3 ω 3 o 3 3 i? ω TJ o
3 21 J o J
3 3 21 3 I LO o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o Tj j Tj Tj j ►rj Tj Tj j Tj Tj Tj j Tj 1*3
-fe- I cr n Q Q Q rø ro ro ω ro w ro ro o o o o o o o o Q Q Q Q Q Q Q Q ro ro ω ro ro ro ro ro o 1*3
I tn o o o o ro ro w ro o o o o w ro ro ro o o o o ω ro ω ω o o o o rø ω ro w o o o o ω 1*3 I Ch ro ^ ro & rø ro 2? & ω ro ro ^ rø ro ro & ro ro ro & ω τj 2i ^ W ro 2? !' W ro 2ϊ ^ W ω TJ -? fe' ώ τ- W fe' ώ HH m fe' ώ HH t 2 ώ - ro 2 ώ τ- W fe'
3 -i
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 1*3
I co
1*3
H^ H^ H^ HH^ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ^ ^ ro Tj Tj Tj Tj Ti Ti I cr
wy tyo yT Ly w^ ro^ ω-• ro-< ro^ ω-• ro-< ro"• oH- oH- oH- oH- oH- oH- o- o1- wy' wy y, y? u? Jy tuo LyO ro'1 ro ro-• ro^ ro-• ω ω 1*3 -■ ro^ o— I tn o o o o ro ro ω ro o o o o ro ro ω ro o o o o ro ro w ro o o o o ω ro ro ω o o o o ω
W ro ? |? ro ro 1 i' W ro W l^ W ro 21 2 w ro ? S ro 1*3 I t o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o 1*3
I co ω ro ro ro ro ω ω ro ro ω ro ro i 3; ; 3i 33 3; H 33 33 f Il cr
Ω Ω Ω Ω Ω Ω Ω Ω ro y Q Q Q y Q y ro ro ro ro ro ro ω ro o o o o o o o o Q Q Q Q Q 1*3 I tn ro ω ω ro o o o o ω ω ro ro o o o o ro ω ro ro o o o o ro ω ω ro o o o o ro ω ro ro o 1*3 I Ch
ro TJ ro ω TJ w 2 ro TJ t tn ω TJ t ron ro TJ t Sn ω ω TJ m w TJ t ra tnn W ro ro 2? P t r TJ rt tio
3 3 3 f o
3 3 3 -< C '"i 3 c
O o o o o o o o O o o O o o o o o O O O O O O O O O o o o o o o o o o o o
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 to to to to to 33 33 33 33
I co ro ω ro ro ro ω ro ro ro ro ro ro ro ro ro w ro o o o o o o o o o o o o o o o o o o o o f Il cr w O o o O o o o O o O O
Tj T oj Tj o O
TJ Tj Tj o Tj o TJ ro ro ro ro ro ω o TJ o TJ o TJ TJ 1*3 LO to to to LO to ro rø o o o o o o o o to to to to I SJ, o W ro ro ro o o o O ro ro ω w O O o o ro ω ro ro o o o o ro ro ro ro o o o o ro ro ro ro Pi
ω m 1*3 ro ω W w ro ω W ro ω ω ro ro ro ω ro ro ro ro ro ro ro w w ro w ro ro ro ro o o o o o o o o p I co ro ro w ro ro ro w ro ro ro ro ro ro w ro ro f Il cr ro rø ro rø ro o o o o o o o o Oy Oy Oy ω o o o o ω w ro ω o o o o ω ro ro ω o o o o ro ro ro w o o o o o o o o ro w ω ω I
H-. v- <? a a fe ω ϋ ro ro >rj ro τj mro fe =_, ro τj ro m 2 ro TJ w S ω TJ 2 w § ό ro TJ ro ro S ro TJ ro m 2 ro TJ w S ά
3 3 3 - C ^ CD C - ro ro w 2 1*3
3 I ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f It P
^ - - - - O O O O O O O O O O O O O O O O O O O O O O O O ro y 2 _J ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro τj τj τj τj τj τj Tj τj τj
I cr ro Q Q O o ro ro ro ro ro ro ω ro o o o o o o o o Q Q Q Q Q Q Q Q ro ro ro ro ro ro w ro o o o o o ro ro ω ro o o o o ro ro ro ro o o o o ro ro ω ω o o o o ro ω ro ro o o o o 1*3
I ON
m S ω ro t Sin1 ro m o ϋ tnJ ct o TJ ro ro TJ tn ø TJ ffl 2 ro o 21 ro TJ TJ ra tn 1*3
3 3 t r c TJ r
3 ft r
3 3 3 r 3 - 21 ro 1 3 1 to o o o o o o o o O O O O O O O O o O o o o O o o O o 1*3
33 33 33 HH HH HH 33 33 33 33 33 33 33 33 3! 33 o o o o o o o o o o o
HH 3H HH HH HH HH HH HH HH HH 3H
LO LO LO LO LO LO LO t Xo to to t to to to to to LO to to to to to to to to LO LO
ro ω o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro w w o o o o ro ro ro ro o o o 1*3 I Ch m ω tn ro TJ 21 ro TJ i ro-V ro ^ tnJ tn ω
3 ro 2 ro TJ r TJ 2? Pi
3 -i 3 3 3 ro 2? ro w
3 o G -> I to ro w ro ro ro rø ro ro w ω w w ro rø rø rø ro w ro ω rø rø rø rø rø ω ro ro w ro ro rø rø w rø ro ro
I co ro ro ro ro ro ro rø ro ro ω o o O O O O O O O O
Tj Tj o Tj o Tj o Tj o Tj o TJ o n o Tj o TJ o Tj o TJ o TJ o TJ o TJ oj Tj Tj Tj Tj j Tj Tj Tj tO tO tO LO LO LO tO LO LO LO LO LO I-O tO LO tO LO L LO LO LO LO LO LO I σ- ~~
Ω Ω o ro ro o O O r w ω ω o O O O O O O O O HH HH H-,
T J Tj J Tj ro w ro rø ø O O O O O O
L r J o T o O LO LO LO LO to LO LO n τj τj τj τj τι τj τj _? ;? EP
LO LO LO LO LO LO LO LO o o w ro rø W O O O rø rø rø ro o o o o ro rø rø ω o o o o rø rø rø ro o o o o w ro ω 1*3 I Ch w ω ro 2? ro m r TJ 2 tn ro m 1*3
3 3 o ? ro ro 2 ro1 S ό ft ro TJ
3 rt C -ι I1 C 1 c 1 " I t rø rø w ro w ro ro ro ω ro ro w ro ro ro ro ro ro w ro ω ro w ro ro w ro ro ro ro ro ro ro ro ro ro ro
I co o o o o o o o o o o o o o o ro Tj Tj Tj Tj Tj j j j Tj Tj Tj Tj 1*3 I σ -fe* ro rø o o o o rø rø ro ω o o o o ω ro ro ro o o o o rø rø ω ω o o o o ω w ro rø o o o
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 Rθ
/-Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl -Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br Cl
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br «-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br H-Bu CH3 Cl Cl Cl /-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br 5-Bu CH3 Cl Cl Cl
Table 11
Ri PA R4b R Ei R. R4a R4b R5 Ei R! R4a R4b Ri -i
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl -Pr CH3 H Cl Br /-Pr Cl F Cl Br /-Pr Cl H CF3 Cl
*3
O O o O TJ Tj ro TJ TJ Tj Tj Tj TJ j Tj TJ TJ Tj TJ TJ TJ Tj TJ Tj Tj TJ Tj 33 3! 33 33 33 33 33 33 33 4-. cr o o O
TJ J ω ro or ro ro ω ro ω O O
O O O O O
Tj TJ o TJ o O
Tj j ro ro ω ro ro rø ro ro *3 to to to to t to tn o O o O rø or ω t o o O o rø ro ro ro O O O o ro rø w rø o O O O rø rø ro w O o o O rø *3 Ch
ro J w rø J m o TJ W £ rø ro m £ w TJ ro rø J tn m n to
3 3 t r
3 3 r £ rø J ro £ rø TJ
3 3 3 G t rø ro i *3
3 ct ω
o o o o o o o o o o O o O O o o O o o o O o o o o O O o O o o o o o o 1 ω rø rø ω o O o o o o o o o o o o o o o o o O o O o o O TJ TJ TJ TJ Tj J Tj j j
Ci o o ω ro ω ro ω r ro ω o o o o o o O O O
TJ oJ o o o o TJ TJ o TJ J o Tj o Tj o Tj TJ ro rø ω ro rø rø ω rø O *3 to to to to to to tn
O o o o rø ω Cd O o O o rø ro w rø o o o o rø ro ro ro o O O O ro rø ro w o o o o ω *3 Ch
o o o o o O o o o o o o O o o o O o o o O O o o o O o o O o o o o o o 1 rø w rø ω w rø rø rø w ro rø rø *3
33 X 33 X 33 EC 33 33 X -fe. cr o o o o o o O o TJ o Tj o o TJ o TJ o TJ J o rø Cd rø rø ro Cd ro o O o o o o O o o Tj o Tj oj T oJ o Tj *3 to to to to to tn rø ør ω rø o o o o ro ω ω W o O O o Cd W Cd W o o o O rø w rø rø o o o o rø rø rø rø o *3 Ch
ώ TJ ro £ ro ro m £ ro r 2 -1 £ ω τ 1*3
3 3 3 o j 21 £ ω τ- 2l ω ro in r in
3 ro 2? ø
3 rø i £
3 - ro n I 2? ώ TJ rø 1 to
O o o o O o o o O o o o o o o o o o o o o o o o o o o o o o o o o o o o o 1*3
33 33 33 33 33 33 33 33 33 31 HH HH HH Έ K K Έ Έ Έ Έ Έ Έ K Έ S S HH HH H HH HH HH HH HH HH HH HH
-o 1 co ro rø rø ro ro ro rø rø ro ro ro cd cd ro t-d cd cd o o π n π o n o n π o π o o o o o o o o 1*3
1 cfer- rø o o o o o o o o T oJ Q Q Q Q Q Q Q rø rø rø rø ro rø ro ro o o o o o o o o Q ro Q τj 1*3
1 <-n o ω ro rø td o o o o rø ω rø rø o o o o ω rø rø ffl Ω Ω Ω Ω H? H? S? H? Ω Ω Ω o ffl rø ro ro 1*3
1 Ch
£ rø ? w £ 1*3 t rø r m £ rø
3 f 3 o 3 ro - tniJ rø ro 2 m in1 rø ro 2 m w1 rø ro w rø ro 2 t tnn? rø w
C -• ro 2? rø
3 1 to
rø rø rø rø rø rø ro ro ro ro ro ro ro rø rø rø 1*3
1 cr ^4 4-- ω rø rø ro ro o o o o o o o r Q. oι-r| oTj oTj oTJ O O Oj mH? rø rø rø o Tj o J Oro T Tj o TJ T T 1*3. to to to LO rø w ro ro
LO LO LO LO ^ Ω Ω Ω Ω Tj o j LO LO LO LO ro o o o o ro ω w ω o o o o ro ro ro ro o o o o ro rø rø rø o o o o o o o o dd Cd Cd Cd 1*3 I Ch
^ rø rø ro τj rø ro w S ro ^ w 2 ro ^ ro £ ro τj rø 2 rø ro rø ^ rø ro tϊ rø TJ ra w £ ω TJ tn £ 1*3 3 -1 3 ". I '-o
W O O O O O O O O O O O O O O O O O O O O O O O O O o o o o o o o o o o o
^ - - - -. O O O O O O O O O O O O O O O O O O O O O ro Q Q Q ro ro or ro τj τj τj τj τj τj τj τj τj ro τj τj τj τι τj τ] τj o o o
F I+ cr ro Q Q O o w w ω ro ro rø rø rø o o o o o o o o Q Q Q Q o o o o o rø ω w rø o o o o rø rø rø w o o o o rø ω rø w o o o o rø ro ro ro o o o o 1*3 I Ch
o o o o o o o o o o O O o o o o o o o o o o o o o o o o o o o o o o o 1*3
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 to to to to to to to to to I - cfeo-
O O O O O O
Tj Tj Tj Tj Tj Tj cd cd td Cd Cd Cd d O LO LO LO LO LO rt> oJ o Tj oJ o TJ o O TJ J ro ro w ro ro ro ro ro o o o o o o o o o o o Tj o Tj o TJ o o £. S roJ. ro w w rø rø w 1*3 to LO LO to to ~> I tn
rø rø o o o rø ro ω rø o o o o w w w ω o o o o ω rø ω rø o o o o ω ω w ω o o o 1*3
ro rø ro ϋ mJ ro TJ ro £ ro ro ffl rø ffl rø m £ rø
3 -ι 3 3 3 3 3 ro ϋ mJ ro
3 ro 2 ø
3 ? r
3 ro 2> 1*3 I to ro rø rø rø rø rø w ro ro ω ro ro ro ro rø rø rø rø rø w rø rø ro ro rø rø rø rø rø rø rø rø rø ro w rø rø f Il co rø W rø rø rø rø rø rø W rø o o O O o O O O O O O O O O O O O O O O O O O Tj Tj Tj o TJ TJ Tj TJ Tj TJ Tj TJ ro TJ Tj Tj Tj Tj O O O Hrj i-rj i-tj TJ Tj j o ro o TJ ω ω ω ω ω ω ω rø o o o o o o Tj o TJ to i-o to l-O o o Q o Tj o Tj o Q Q Q » ro ω 1*3
I tΛ o o ro rø ro rø o o o o ω rø ω rø o o o o rø rø rø rø o o o o rø ro ro rø o o o o w ro w w ω ro ro 2? „ ω ro ffl m £ ω TJ ro f- 3 i-t rø ro rø ro m rø tn rø ffl rø ro ϋ wJ
3 -I 3 -I 3 3 ct ω
3 ro 2? 1*3
I t ro ro rø w rø rø rø rø ω ω ω ω rø w rø w W TO W W rø rø ω rø rø rø rø rø W W W W rø rø rø rø W 1*3 I o
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ro' j Tj Tj Tj Tj ffl Tj ffl ffl ffl 'n Tj Tj Tj ffl ffl Tj ffl ffl ffl 'TO Tj o o o o o o Q Q Q Q Q Q Q Q rø ω ω rø rø ro ro rø o o o o o o o o LOQ LOQ LOQ LOQ LQO LOQ LOQ rø rø o o o o rø ro rø rø o o o o rø rø ω ω o o o o rø ω rø rø o o o o rø rø rø ω o o o
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6
/-Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl /-Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br Cl
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br ?z-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br n-Bu CH3 Cl Cl Cl /-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br --Bu CH3 Cl Cl Cl
Table 12
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl ro w ω ro 2> rø ro w ω ro E? rø ro w ro rø ro « ro in rø T) - ffliJ ω ro 21 rø r 1*3
3 -I 3 -I 3 M o
3 3 I to
o TJ o TJ o TJ ro ro ro ro ω ω ω ro o o o o o o o o o TJ o Tj oo o TJ o o o o r
-o LO LOr LO toro J Tj TJ rø rø ø ro rø rø rø o o LO H? Ω Ω 1*3 I t-h
O O O rø rø rø rø o o o o ro ro rø rø o o o o rø rø ω ω o o o o ro ro ro rø o o o o w » 1*3 I Ch
ro - ffliJ ro J 2 ffl? ro TJ ϋ- r w
3 3 5?1 ro ro 2? ro tn rø ro 2? ø rø 3 T -iJ 2? i? ro £ S ϊt _ rø? ro 1*3 I LO
3 "i o o o o o o o o o o o o o π o o o o o o o o o o o o o o o o o o o o o o o I co
-? W H? Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ffl ro ro τ] τj τj τj τj τj τj 1*3 I cr
Q Tj Q TJ Q Tj rø - w ω ω ro ω ω ω o o o o o o o o Q Q Q Ω Ω Q Q Q ro rø w ω ω rø rø ro o o 1*3
I tn o o o rø w w w o o o o ω w rø ω o o o o rø w w rø o o o o w w ω ro o o o o rø rø 1*3 I Ch
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Il co rø rø ω ω rø ω ω ω ro rø rø rø 3 3 33 33 33 3| 3J H 33 3i o o o o o o o Q Q Q Q Q Q Q Q rø rø rø rø rø rø w ro o o o o o o o o Q 1*3
LOQ LQO LOQ LQO tQo tO I tn ω rø w o o o o rø rø rø rø o o o o rø ω rø rø o o o o rø rø rø rø o o o o rø w rø rø o o 1*3 I Ch
ro ro ro rø r rø rø TJ ra W
3 ro w ø ro w rø TJ ffl ra rø
3 "• 3 ro -i w rt rø — T —J ro ω ro s £ A rø- 1*3 ft c I to
3 o o o O o o o o o o
33 33 33 33 33 o o o o o o o o o o n x o o o o o o o o o O O
33 33 33 X 33 33 3! o to 33 33 33 33 33 33 P ro ro ro ro ro ro rø ro ro rø w rø ro rø w rø o o o o o o o o o o o o o o o o o o o o o
rø rø rø rø o o o o rø ro rø ro o o o o ro rø rø rø o o o o rø rø w ro o o o o rø w w w o 1*3 I Ch
W ro ffl rø ffl rø ffl ω w £ r ro s ffl -£ r 3ø " ro S tn? u W ro ww £ rø ro ϋ ffl rø 1*3
3 -I 3 ø W £ rø ro S
3 3 " I to ro ω ro rø ro ro ro ro rø rø ro ω rø rø w rø rø rø rø ro rø ω rø rø rø rø ω w o o o o o o o o o f Il co rø rø rø rø ro rø w rø rø rø rø w rø rø rø rø rø f Il cr o
H? ω H? ω Ω Ω Ω Ω Ω Ω Ω Ω ro ro ro ro Q Q Q Q rø ω rø w rø rø rø rø Q Q θ o Q Q Q Q Q 1*3
I Ln o o o o ω ω rø rø o o o o ro w rø ω o o o o ω ω ω ω o o o o o o o o rø w rø w o 1*3 I Ch
-.. -. ώ ώ ro τj ro τj 21 ^ rø τj W 2 rø j ) S rø ro rø S ώ τj rø ^ rø ro 2) ^ rø ro W 1*3
I to
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
o o o o w rø ro w ω ro ro ω o o o o o o o o Q Q Q Q Q Q Q Q rø rø ω rø rø rø o o o o ro w ω rø o o o o ω rø w ro o o o o ω rø rø rø o o o o ω rø rø rø o o o o ω 1*3 I Ch
cd TJ S1 w ro 21 W ro ro £ o ffl £ TJ tn ff £ ω ro ra ffl ro ro ϋ fflJ l*λ
3 -1 2? j? ro 5 « ct r
3 ro ct rø
3 £ ct rø ro l
3 c 3 3
O O O O O O O O O O O O O o o o O o O O O o o O o O O O O O O O O
33 33 33 33 33 33 33 33 33 33 33 33 33 33 to to to fl
o o o o o ___ O
TJ TJ j TJ TJ St; o LO to LO LO ω ^ ro rø rø w w rø w o o o o o o r, ,-, O O O Q Q ffl Tj TJ Oj o Tj oTj o Tj O toj LO to to LO LO LO w rø w w w rø rø w I tn rø o o o o rø rø ω w o o o o rø rø ro ro o o o o ω ω ro rø o o o o rø ro ro rø o o o o
ro rø w rø rø rø rø W rø rø W W rø rø rø rø rø rø rø w ro rø w rø rø rø rø rø w rø rø w rø rø rø rø rø f Il ro rø rø w rø rø rø HH HH O O O O O O O ro rø ro τ] ro τj τj Tj τj O O o H-j or ro oj Tj oj oro o O ro Tj O Tj Oj OTj OTJ LO LO LO LO LO LO LO to LO to to LO LO f 1lcr o rø rø w w o o o o w rø ω rø o o o o rø ro rø rø o o o o rø rø ω rø o o o o rø rø ro w 1*3 I Ch
rø ro 2? rø roro W rø ro w S w Tj W S rø ro W ^ rø ro W ^ ό ro ro w ώ ΪJ w S ώ ζ -H ^ 1*3
3 -I I to rø rø ro w rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø W W rø rø rø rø w ro w rø w rø rø rø w rø w rø fl
Q Q Q Q Q Q Q Q Ω Ω Ω Ω rø rø ro' ro ro ro n ro ro n ro n ro ro ro ro ro ro ro ro n n rø ro l? cr Ω Ω Ω Ω Ω ro ro Q Q Q Q Q Q rø ffl ffl rø rø rø rø w o o o o o o o o Q Q Q Q Q Q Q Q 1*3 tn rø o o o o rø ω rø rø o o o o rø rø rø w o o o o w rø w rø o o o w rø rø rø o o o o 1*3 I Ch
R3 R4a R4b R5 R6 R R4a R4b R5 R6 R3 R4a R4b R5 R6
Et CH3 CF3 CF3 Br Et Br Br Cl Cl Et Br Cl Cl Br -Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl /-Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br Cl
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br M-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br H-BU CH3 Cl Cl Cl /-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br s-Bu CH3 Cl Cl Cl
R5b is CHF-> R5b is CH2CF3 R5b is CFoCHFo
R-- R4a R4b R5a R3 R4a R4b~ R5a R R4a " R4b " R5a
/-Pr Me H Me /-Pr Me H Me /-Pr Me H Me
ffl w ro rø rø rø rø rø |*3 to £ £ £ £ £ £ ffl w w ffl ffl ffl |*3
3 3 3 3 3
£ CD £D £CD £CD £CD £CD £CD £CD £CD £CD £CD £CD £ *3 CD £CD I| ja £ CD C£D £CD £CD £CD £CD £CD £C £D £CD £CD £ 1 D C CD
ro - tnJ. ω ro ro ffl ω rø ro π ffliJ ro 3 ro t "- 2n1 |*3 I to £ £ £ £ £ ffl lff ffl ffl I*3,
°
o o o o o o o o o o o o o o o
Hfl Hj-| τj Tj Tj ro τj 33 33 33 33 33 33 33 S3 ro rø rø o o o o rø rø rø rø o o o o 1*3
£ £ £ £ £ £ £ £ £ £ I
— - — - rø J ώ ro ffl £ ct rø TJ ffl £ l £ TJ ffl £ rø TJ ro £ TJ ro 1*3
3 ør
3 3 ct rø ■ rø or m £ rø
3 rt ro ff
3 3 3 r ώ
3 3 ro ffl £ ct rø £
3 1 to
3 o o o o o o o o o o o o o o O o o o o o o o o o o o O o o o O o o O O o |*3
33 33 33 33 33 33 33 33 S3 33 S3 X 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 tn O to LO LO to to LO LO to to LO LO LO LO LO to to LO LO to LO to to LO to to LO LO LO to LO to -fe *3
-a'
O p 1i5 Ito *
o o o rø rø M rø O O O O rø rø rø rø O O O o w •"H w ω rø O o o o rø rø rø rø O O O O rø
O o o o o O o o o o o o o o o o o O o o o O O o o o O O O O o o o O o *3
|*3 tn
33 33 33 S3 3! 33 33 S3 33 33 33 S3 33 33 33 33 33 33 S3 33 33 33 33 33 33 33 S3 33 33 33 33 33
LO LO LO LO to to to LO LO LO LO ι-o to to LO LO t 3o3 to to to to to to to LO LO to LO to to to LO •fe-
33 00 o O O O O O O O w r TJ Tj TJ Tj rø rø rø O O O O O O O O to to LO to to ffl t ro TJ n rø ω ω W rø to LO ro f Q
£ rø TJ £ rø ro ffl £ TJ m rø TJ ffl £ TJ ffl £t rø TJ ffl TJ ffl r |*3
3 3 ct rø £
3 3 rt ώ 3 r £ w £
3 t fl
3 3 ώ ro f Ct ø
3 1 to
ro 2- rø r 2- rø ro S £t rø ro roi' rø ro 2 ffl rø
3 o 3 3 3 ? £ rø r ro rø |*3
3 ro 2? rt rø 3 3 ro 2- W
3 o 3 I LO
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
rø ro ω ro ro rø rø rø 3 | H 3ϊ 3; 33 θ O O O Tj
o o o rø rø rø rø o o o o w rø rø rø o o o o w rø rø rø o o o o ω rø rø rø o o o o o |*3
ro ro £ „ ro ro 21 ^ ro ro w ^ W ro 1 ^ W ro 2? ^ W ro ? ^ « ^ 21 S w ro 2? ^ W ro m S w |^
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o I*? ro
P
33 o o o Ito 4
Tj o T TJ l J ) W rø rø ω 33 33 S3 S3 33 S3 33 S3 Ω Ω Ω Ω Ω Ω Ω Ω flf ffl ffl rø ffl 1 f*A3 |Q
o o o ω w ω ω o o o o ω rø ω ω o o o o ω ω rø ω o o o o ω ω rø ω o o o o ω |*3
ro -? rø"- -c^t ro ro -? ~^ -^ rø ro ffl ^ ro ro ^ H c fw^ -5-?0 W --- o^.--. « ^.Λ- Hζ,u u «™--- ^c. — CD g' -o - ct ^ -? «■ rt fl ■ gro w- H -ϊ-u - _--..- 2c *—t - gw-'- - -ϊy u S^ _-- ■^r —t ■ 5 • .^ -, ■5. u" _"W--- ■^r — - ώ w g' |l ι^ ,
ro ω ro w ω ra rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
n n ro ro ro n n Q ro Q ro τj i-ri ro τj T] τj τj τι τj τj j Tj 33 33 33 3 33 ω rø ω o o o o o o o o rø w rø rø o o o o rø ω rø rø o o o o ω rø rø ω o o o o ω |*3
ro ffl ra £ rø ro tn £ rt ør ro w rø ro ^ fflJ m
3 3 ω 3 ro ϋJ ro
3 ro 3 w
3 ro w rø ø
3 ro 21 r ro 2- rø 1*3
ts ro rø rø w rø rø rø rø rø rø rø rø rø rø rø w ro rø rø rø rø rø ro rø rø rø o o o o o o o o o *3
I co i-n on o
33
HH HH HH rø ω ω rø rø rø rø rø o o o o o o o τι τι τ O O ro ro oflf o ffl o O ffl ffl Tj ffl TJ ffl Fl ffl
Ito
o o o w rø rø ω o o o o ω ω w rø o o o o ro rø rø w o o o o o o o o w w rø ω o |*3
? s π s ^ i ^ H ? s H ? ™ H ? - ^ ? - ? H H s » i ^
*3 rø ro rø w rø ro rø w rø w rø rø rø w rø rø rø rø rø rø rø rø rø rø rø rø rø o o o o o o o o o I*. tn
O
.33 0 Ito
» ro ^ ro^ ro ω ro ω ro Ω Ω Ω Ω Ω Ω H- ΩH- Ω ro τι τj ro τj τι τι τj θ o — o — o -* Q tQ tQ toQ tQ |il σ* ,'| iro
Ito o o o ω rø ω rø o o o o rø rø rø ω o o o o rø rø ω ω o o o o o o o o rø ω ω ω o |*3
ro w | rø ro w £ ώ ro w ! ώ ro « ! ώ 5 „ ! ώ $ 21 ^ ro ro w ! ro ro
w rø ro ro ro ro rø o o o o rø rø rø w o o o o ω ω rø rø o o o o rø rø rø w o o o o ro iro Oh
rø ro ør r ϋroJ rø tn | TJ tn |*3
3 -I £ *3 ct 3 or tn rø
3 ro 2- rø o
3 3 ro I to ώ £ rø
3 3 1 LO
rø o o o o rø ω w ω o o o o rø rø w rø o o o o |*3 o o o o ro I 1* C3h
^ H ™ I 7 ™ M » H s » H 5 « H ™ « H - ^ I 7 ™ i «
_ ,-, -, - ,_ 0 0 0 0
Q Q Q Q Q -3 -3 -3 -3
ro ffl ro ro ro Q _. θ — H- oH-
ω o o o o o o o o rø ω ro rø o o o o rø w ω rø o o o o rø ω rø rø o o o o ω rø ω |*3
S ώ ro -? 2 rø ro 21 l' rø ro 2? 5 ώ ro ffl rø ro 21 £ rø ro rø 2
rø o o o o rø ω rø ω ω rø rø rø o o o o w rø rø ω o o o o rø rø rø rø o o o o ω rø ω |*3
| rt* ro p. »ro. "2i l o* ro 3 ro -y 2, - c^t rø c πro-r ^1 'c^t W c ro -y m " ^ <t rø ro rø 2 ro c ro M £ g" -y c H-r ^ D £ -y Η" I t
- ^, ^ ^, - ^, -, - ^, 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 iro
Q Q Q Q Q Q Q Q Q -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 K K lι: K K K K K a i-l -3 -3 -3 -
HH 3 33 33 33 33 S3 33 33 flf Q Q Q Q Q Q Q HH HH HH H- HH HH --, HH rø rø rø W ω rø rø rø O O θ |; rø o o o o rø ω rø rø ω ω rø ω o o o o rø rø rø rø o o o o w rø rø w o o o o ω rø ω |*3
rø ro ffl rø ro w ra rø ro iwϊ rø
o w w w w o o o o rø w rø ω o o o o w rø ω rø o o o o w w rø rø o o o o w rø rø PS.
ro ω or ? £ ct ør o <? - H? -L. ffl £ r ro Ww £ rø ro ffl 21 £ rø
3 3 ro 2? £ rø r £ f £
3 ct ω fl
3 t rø r
3 ro 2 £ ø
3 ro 2? £ ø fl
3 3 -i ffl o 2f? I
3 r
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
*• -. o τι o TJ o TJ o TJ oJ o o o TJ ro -? -? ro --3 --3 33 S3 3J S3 S3 S! Q Q Ω Ω Ω Ω Ω o rø ro rø ω o o o o rø rø rø ω o o o o rø rø w rø o o o o ω ω rø rø o o o o ω rø rø |*3
§- ro 3 - <-->3 £ §' ro --3 S £ ro ro 2, !| ro 3 ro-ι 3 -> 3 -I
rø o o o o w rø rø w o o o o o o o o rø rø ω rø o o o o rø w rø ω o o o o rø w ω |*3
ω ro 2? £t ω ro rø w w tn w ro 21 ω ro 5 rø
3 ro 2- rø ro m c £t 3 ω ro r fflV 3.
3 -i 3 ι
w rø rø rø rø rø rø ro rø rø rø rø w rø rø rø rø rø rø rø rø rø rø ro rø w rø rø w rø rø rø o o o -t
rø rø rø rø rø rø w ω o o o o o o o o ffl ro ro TJ
ro w rø rø o o o o rø rø w rø o o o o ω rø ω rø o o o o w w rø rø o o o o o o o |*3 I Ch
~. t. s rø r i røV £ ro ro ffl £ røώ oroA-? £ ώ ro 21 ^ rø ro 2- ^ rø ro 21 l» rø J ffl £ ra ro
3 o r
3 -! 3 -1 rø ro -? ct « » rø rto
ro ro ro ro ro ro w ro ro ro ro ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro
ω rø rø rø W rø rø rø O O O O O O O O τj τj τj τj ro τj τj τj O O O rø ro ω ro o o o o ω rø rø rø o o o o rø ω rø rø o o o o w ω w ω o o o o o o o |*3
ώ 3 roH? 2rt1 §tt* rø^ τ-rj rø^ |r' Wc ro-, rø'^ SCD røc ro-? 2rt, ^c røc ro-^ ^1 ct' We ro- " c c -^ -* tf 3 H -ri rt- ft - -^ ','
o o o o o o o o w w rø ro rø ω rø rø w rø rø w rø w rø rø w rø rø
O O O O O O O θ H-j ι-rj Tj τj τj τj n τj
LO LO l-O LO LO LO LO LO ω rø ω o o o o ω rø w w rø ω rø ω o o o o ω rø ω rø o o o o rø rø rø ω o o o o ω w ω i*3
rø ro rø ro tn
3 -I 2? f^ ff ro 2 in1 ro 3 ro -> 2? rø
3 ro 2- ra o 21 rø ro ϋ wJ £ I?,
3 r 3 o o o o o o o o o o o o o o o o o o o o o o o o o o o o iro
HH r^* ^ HH HH HH HH HH HH HH HH HH HH ffi HH 1-H HH r^ HH 1-H HH H-4 HH H HH HH HH HH * * *3 tn
ω rø ω ω o o o o o o o θ τj ro ro τj Tj ffl 33 33 33 33 33 3J S3 33 I c i"
O O O O rø W rø rø o o o o rø rø rø rø o o o o ω ω rø ω o o o o |*3
ω ro 2? £ ro ro 1 w4J ro or ro sij ω ts rø ro i roi? £ ts £ IS
3 3 rø ro £ to
3 3 3 3 21 fl
3 rø f
3 rø ro ffl
rø rø rø rø o o o o w rø w rø o o o o w rø rø ω o o o o ω rø ro rø o o o o w rø w rø |*3
I o Os
|ctAi?ϊt-
- - - - - - ^ - - - - ^ - - - - O O O O O O O O O O O O O O O O O O O O 'ro *3
O O O O O O O O O O O O O O O O ^ ji3 3j 33 K 33 33 33 33 S3 33 33 33 33 33 33 33 33 S3 33 t:- tn
P
Ω Ω Ω Ω Ω Ω Ω Ω S3 33 33 33 33 33 33 33 ffl ro Q Q Q Q Q Q o o o o 'iro
o o o o rø ω ω ω o o o o ω w ω ω rø rø ω rø o o o o rø ω ω rø o o o o rø ω rø rø |*3
rø ro S W £ rø ro M 2? £ !-? ffl rø i rofl W -, rø- row B ro -, ώ * 5 § ffl iτi S ? ffl ifl W S ffl w W l B rø w ro W ro S R,
3 -1 3 -• 3 -ι
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 S3 S3 S! 33 S3 33 33 33 33 3; S3 S3 S3 33 S3 33 3; 3; 3! pl
Ω Ω Ω Ω Ω Ω Ω Ω ro ro τj τj τj τj τ] ro 33 3; 33 33 33 33 33 3; O θ 2. o o o o w rø rø ω o o o o w rø rø rø rø rø rø rø o o o o rø ω rø rø o o o o rø rø w w |*3
ro rø ω rø o o o o o o o o o o o o
ω -i ro >-, rø H, rø -t ro ro ro ffl - o-- o-- o-- ro ffl ffl ro
o o o o o o o o o o o o rø rø M rø O o o o ro rø rø rø o o o o rø rø w rø O i — O — O — O , — 1 I*C3Λ
w ffl rø ω ω ro rø ffl ft Zr ro tn rø ro w £* ro ro S ffl ro ro 2? rø m £ ώ ζ rø § |*3.
3 "I C 3 3 -i C 3 -I
rø ω ør ro o o o o
— ro —ro f —fl —ro Q ,-, ,-, o,-, ,-, o o o o o o o o rø rø rø rø o o o o rø w rø rø o o o o ω ω ω rø o o o o rø rø rø w |*3
W ro W : rø ro 21 |; rø ro l ^ rø ro w S rø ro - w? ^ £ ro ro 2? i' rø ^ 2? ^ rø ro S ^ rø ro w' s £ i P?L.
ω ω rø ra ω
Q O O O ro o o o o rø ω rø rø o o o o o o o o rø rø ω w o o o o w rø w w o o o o rø rø ro ω |*3
rø ro m rø ro 2 m1 rø ro 21 ro ro 21 rø ro 2? rø ro w rø ro 2 m? 1*3
3 -i I tt-o
w ts w w ts rø w rø rø ro rø w rø ro rø rø rø rø rø rø w rø rø rø rø w rø w
O O O O O O O O ro TJ ro TJ ro rø rø rø rø
Il cr ito
W rø rø W O O O rø rø rø rø o o o o ro rø w rø o o o o rø rø w rø HI
rø ro ro ffl m ro z_τ ro 2- £ ft? rø r rø o t 2n - r rø ro ro 5 m? r ro 2 m- rø ro m rø ro 21 |*3
3 ø I t
w rø rø w rø rø rø rø rø ro rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø _ *3 Ln
IS rø ts ro rø w rø rø rø O — O — O — O — O — O — O — O — τj τj ffl ffl P Il σ*" itiτoj
rø rø ω ω o o o o w rø w rø o o o o rø rø rø rø o o o o rø rø ro w |*3
S ro 1 ; rø ro 21 w ro 21 S rø 3 ro -I ) ? ω 3 ro "i , ^ ω 3 ro -I 1 <? w 3 ro -Ϊ 21 | |?S
rø rø ro rø rø w rø rø rø rø rø w
Q Q Q Q rø ts ro rø o o o o rø rø rø rø o o o o rø rø rø rø o o o o rø rø rø rø |*3
33 H -H -H H -H -H -H p-! o Q Q ϋ U υ U ffl ffl ffl m
ro ro ro ro ro r r ro r co ro ro co co co co ro ro ro ro ro H-l HH Hr -]H -lH HH HH --H HH -H -ζ -M --H HH -H -C --H -"H pH --H -lH αo u u u u u o u u u o υ u υ υ u u u o u υ u o CQ g -q ro ffl
o o o o o o o o o o - - - Ω Ω Ω
o rø rø ω rø o o o o rø ω ω rø o o o o ro w rø rø o o o o rø rø rø W o o o o rø rø rø 1*3
I Ch
rø ro « rø ro rø £ ω r £ 2> rø ro tn rø r tn r w rø ro 2? |*3
3 -I m o
3 -i rø ro m LO
C -I 3 ro -i 21 ø ω o
3 ->
Q Q Q Q π o Q n Q o n n o n o o g S S a S 3 S S S S a S S S S S S S S P. ro tn
ffl Ω Ω Ω Ω Ω Ω Ω Ω S3 S3 S3 S3 33 33 53 33 ro ro ro ro ro ro ro ro '- '- '- " -H -H -H -- θ O θ - l-i r- itfflo
rø o o o o rø rø rø rø o o o o rø rø rø rø rø rø rø rø o o o o rø w rø rø o o o o rø w rø |*3
3 -I 3 -I 3 -I
o o o o o o o o i π π π
Ω — Ω —
H rø| -o— -o— —o o— HrøH røHt HrøI HwH o— o— oH-. oH- røHH Hrøf HrøH ωHt røHH Hωf ωH| røHt o— o— o— o-Hi Hrø| rø-H wH| røH| o— oH-l o-_i o-Hi ωH| rø-H ω-| ||*{3J,
ts ro t t 2nn? rø ro t ron ro rø ro ro m ø rø ro rø ø ffl £ r
3 3 W ro 2? r
3 ro 21 3 -ι t r rø
3 ro -5 3 ro w ø
3 ro 2 w? 1^
ω ω ro rø ts o o o o o o o o o o o
ω ω ts rø w ro ro ro o o o o ro
w o o o o o o o o o o o o ro w ω rø o o o o ω ω rø ω o o o o rø rø rø w o o o |-L
Sϊ ώ rø ^J Wrø ^ ^ όrø w ro jj rø ro « : rø ro 21 ^ rø 3 ro "-i 2? ; W ro 21 : rø 3 ro -i 2? : rø δ ^ ? ro 3 - "- 5 l;;S
rø o o o o o o o o rø w rø rø o o o o w rø ω ω o o o o ω rø rø rø o o o o rø rø rø |*3
- 3? rø -i ^ rø ro 21 ;? rø 3 ro -i 2? ϊ? ώ ro 21 : rø 3 ro -i 3 ΉJ
rø o o o o rø rø rø rø o o o o o o o o ω rø ω rø o o o o rø rø rø rø o o o o w ω rø |*3
w ro -3 rø ro ro tn rø tn ffl m rn rø z_ ro ___• 2 ro? rø ro 2 tn? rø ro 2 ffl- 1*3 ft -H LO
3 -i rø rø rø w rø rø rø rø rø w w rø rø rø rø w w rø rø w rø w w rø rø rø rø
O O O O O O O O n ro ro ro ro ro ro ro W W rø cfer
ts ts w ts o o o o rø ro rø rø o o o o » rø rø rø o o o o rø w w 1 I* O3s
ts £ ro ro -iJ rø W ro tn ffl ro 2? rø ro t ϋn.
3 t ts
3 3 s -ι 3 3 » -? w PS,
rø rø rø rø rø rø w w rø w rø w rø w rø rø rø rø rø rø rø ro rø rø rø rø rø
rø rø rø rø Ht rø Ht ω HH ω rø HH -H - - - --, -H -H θ o o o o o o o τj ffl ffl
rø rø rø rø o o o o rø rø w rø o o o o rø rø rø rø o o o o w rø rø |*3
rø ro S
G -I rø £ ffl ώ roro ffl21 £^ rø ro 2, ^ rø ro r ffl |*3
3 H^ ^ t c -ϊ" co c ø ω c ro -? S -*- ^ rt rø c ro H-H 2-^? >c^t rø ro ^ 2 -l ' t
ro rø rø rø rø rø rø rø rø rø rø rø
tO LQ LQO LQO rø ω ω ω o o o o rø rø rø w o o o o rø rø w rø o o o o rø rø w |*3
cj CJ ffl eQ
J CJ
S 'S
^ --3 33 θ CJ CQ m 53 X cj CJ CQ eQ 53 53 cj CJ m ffl S3 3l Q CJ cQ eQ
U 2 CJ S U 2 CJ 2 CJ 2 Q S U S C-J S CJ
^ ^ ^ ^ ^ ω w w w w w S S S S
rø ro rø w TI £ ør J flf £ rø TJ m £ rø TJ ffl £ ,
T) lf ffl β -i 3 3 3 r rt rø f £ rt rø TJ £
3 3 3 c
O O O O o O O o O O o o O o o o o o o o O o o o o o
33 33 33 33 53 33 33 33 S3 33 33 33 33 33 S3 33 33 33 33 33 33 33 S3 33
-o to to t to t to to to to to to to to p 1i co
T j j j 33 S! 33 S3 33 S3 S3 S3 33 33 S3 33 S3 33 33 33 S3 33 S3 S3 33 S3 S3 S3
1 PI cr o o n o o rø rø rø rø rø rø rø rø O O o O o O o ffl fl O |*3
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o [ 1 co rø rø rø rø rø ts rø ω rø rø ω rø o rø rø rø w o o o o w rø rø rø O O O o ω ω rø ω o o O o ω rø rø ω |*3 1 Os
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Et CH3 F CF3 Br Et CH3 Cl CF3 Br Et Cl Br Cl
/-Pr CH3 F CF3 Br /-Pr CF_3 Cl CF3 Br /-Pr Cl Br Cl t-Bu CH3 F CF3 Br t-Bu CH3 Cl CF3 Br t-Bu Cl Br Cl
Me CH3 F Cl Cl Me CH3 Cl Cl Cl Me Cl Br Br
Et CH3 F Cl Cl Et CH3 Cl Cl Cl Et Cl Br Br
/-Pr CH3 F Cl Cl /-Pr CH3 Cl Cl Cl /-Pr Cl Br Br t-Bu CH3 F Cl Cl t-Bu CH3 Cl Cl Cl t-Bu Cl Br Br
Me CH3 F Cl Br Me CH3 Cl Cl Br Me Cl CF3 CF3 Cl
Et CH3 F Cl Br Et CH3 Cl Cl Br Et Cl CF3 CF3 Cl
/'-Pr CH3 F Cl Br -Pr CH3 Cl Cl Br /-Pr Cl CF3 CF3 Cl r-Bu CH3 F Cl Br t-Bu CH3 Cl Cl Br t-Bu Cl CF3 CF3 Cl
Me CH3 F Br Cl Me CH3 Cl Br Cl Me Cl CF3 CF3 Br
Et CH3 F Br Cl Et CH3 Cl Br Cl Et Cl CF3 CF3 Br
/-Pr CH3 F Br Cl /-Pr CH3 Cl Br Cl /-Pr Cl CF3 CF3 Br t-Bu CH3 F Br Cl t-Bu CH3 Cl Br Cl t-Bu Cl CF3 CF3 Br
Me CH3 F Br Br Me CH3 Cl Br Br Me Cl CF3 Cl Cl
Et CH3 F Br Br Et CH3 Cl Br Br Et Cl CF3 Cl Cl
/-Pr CH3 F Br Br /-Pr CH3 Cl Br Br /-Pr Cl CF3 Cl Cl r-Bu CH3 F Br Br t-Bu CH3 Cl Br Br t-Bu Cl CF3 Cl Cl
Me CH3 Br CF3 Cl Me Cl F CF3 Cl Me Cl CF3 Cl Br
Et CH3 Br CF3 Cl Et Cl F CF3 Cl Et Cl CF3 Cl Br -Pr CH3 Br CF3 Cl /-Pr Cl F CF3 Cl -Pr Cl CF3 Cl Br
/-Bu CH3 Br CF3 Cl t-Bu Cl F CF3 Cl /-Bu Cl CF3 Cl Br
Me CH3 Br CF3 Br Me Cl F CF3 Br Me Cl CF3 Br Cl
Et CH3 Br CF3 Br Et Cl F CF3 Br Et Cl CF3 Br Cl
/-Pr CH3 Br CF3 Br /-Pr Cl F CF3 Br /-Pr Cl CF3 Br Cl t-Bu CH3 Br CF3 Br t-Bu Cl F CF3 Br /-Bu Cl CF3 Br Cl
Me CH3 Br Cl Cl Me Cl F Cl Cl Me Cl CF3 Br Br
Et CH3 Br Cl Cl Et Cl F Cl Cl Et Cl CF3 Br Br
/-Pr CH3 Br Cl Cl /-Pr Cl F Cl Cl /-Pr Cl CF3 Br Br t-Bu CH3 Br Cl Cl t-Bu Cl F Cl Cl .-Bu Cl CF3 Br Br
Me CH3 Br Cl Br Me Cl F Cl Br n-Pτ Cl Cl Cl Cl
Et CH3 Br Cl Br Et Cl F Cl Br ti-Bu Cl Cl Cl Cl
/-Pr CH3 Br Cl Br -Pr Cl F Cl Br s-Bu Cl Cl Cl Cl
/-Bu CH3 Br Cl Br t-Bu Cl F Cl Br /-Bu Cl Cl Cl Cl
Me CH3 Br Br Cl Me Cl F Br Cl Me Br F CF3 Cl
Et CH3 Br Br Cl Et Cl F Br Cl Et Br F CF3 Cl --i ffl £ ro ro ? S ώ ro -3
O O O O O O O O O O
►--C ffi K ffi ffi ffi ffi ffi ffi ffi
LO LO ' J LO LO LO LO LO LO LO
Q Q Q o o o o ; : _ M, , » rø rø w rø w fl
Q Q Q Q Q Q Q ω rø w rø rø rø rø rø Q o o o o o o o Q Q ffl ffl ffl ffl ffl Q ro ω w rø ω rø iro
LO LO LO LO LO LO LO ^ ^ ^ ^ ^ ** ^ ^ ~ ~ ~ -^ ~ ~ ~ ~ LO LO t tO LO LO ^ ^ ^ ^ -I I LΛ rø ω w o o o o rø w rø rø o o o o ω ω rø w o o o o rø rø ω rø o o o o ω rø rø ω o o |*3
ro 2J ^ ct ώ __ ro 2? !'c ro -y ^rø c' grø' H.jr' Ηrø- £ct ώ c -roϊ' rø-'- 2fD rø ro rø S ro ro -r " ft -? "" CO ___ c H- i O rø rø ω w rø ω w rø ω rø rø ω ω rø ω o o o o o o o o o o o o o o o o o o o o o o l
Ω Ω Ω Ω Ω Ω Ω ro Q Q Q Q Q Q Q θ o o o o o o Q Q Q Q Q Q Q Q ω rø ω ω rø w |*3
rø rø rø o o o o rø rø ω w o o o o ω ω rø ω o o o o ω rø rø rø o o o o rø rø rø rø o o |*3
ro HH -^S ^ft rø Ϊ -H rt1 ic- rø c ro πT ^? ^t rø c ro -y 2 <-*J• ^ o> ώ j- ro H-r rø^ St rø g' ro-^ 2'-^1 -rtl' ώ c Ϊ H- 2Η-? rt> rø g* ro -y 2ϊ o' rø c H-r ^ ft g' -y i '-o rø rø rø rø ro rø w rø rø rø rø rø ro rø rø rø rø rø rø rø rø rø rø rø rø rø rø w rø rø w rø rø rø w rø rø Pi
Ω ^ Ω Ω Ω Ω Ω ro ro ro ro ro ro ro Q rø rø w rø w rø rø rø o o o o o o o o Q Q Q Q Q Q iro
rø ts ω o o o o w rø rø rø o o o o rø rø rø rø o o o o rø rø rø rø o o o o ω rø ω rø o o |*3
ro HH O
Q Q Q Q Q Q Q rø rø ω ω rø rø rø rø o o o rø rø rø ro ω rø rø ω o o o o o o o o Q 1*3
I LΛ ro rø ts o o o o rø rø rø rø o o o o o o o o rø ω ω rø o o o o ω ω ω ω o o o o ω |*3 I s
- H? ffl ~ £ ro ^ ro H? w ~ S rt ro ^ ro-? S^ Sf ro ^ ro -? ~| S 1* rt ro -? m ~ - fl^) ro £- roH? 2~| 2Ct ro ft ro g' ro-? S^ 20) ro ^ roTJ SHH ^O, W W ro ^ S -, S „ ro W t3o o o o rø rø ør rø rø rø rø rø rø rø w rø rø rø rø rø rø rø w rø rø w rø rø rø rø w rø rø w w rø w |*3 I -o
— HH — o o o o o o o o
-T Hr H? M -^ -^ --ι - - M -| -, --' --l w " --| " M M M " --l " --' " " ro ro ro ro ro ffl ffl ro ro
"- "- "- tO to tO LO LO LO LO LO LO P IIr o o o o rø ω rø rø rø ω rø ω o o o o o o o o Q Q Q Q Q Q Q Q ω w rø rø rø rø ω rø o |*3 I tr, o o o rø rø rø rø o o o o rø rø ω w o o o o rø rø rø rø o o o o ω rø rø rø o o o o w 1*3 I 5h ώ ώ ώ ro 21 ^ rø ro 21 ' rø ro 2- ^ rø ro , ^ rø ro 1 > rø ro 2? ^ rø ro 2- ' ro ro 1 ^ ro 1*3 I to o o rø rø rø rø rø w rø w rø rø rø rø rø rø rø rø rø rø rø rø w rø rø rø rø rø rø rø rø rø rø rø ts II rø rø rø ro ts w rø w rø rø w rø rø rø w ts rø rø rø rø rø rø rø rø rø rø o o o o o o o o o
I rt cr o Q rø rø w rø rø w rø rø o o o o o o o o Q Q Q Q Q Q Q Q w ro ro ro ro rø rø ro o |*3
I fl o rø rø rø rø rø o o o o rø w rø rø o o o o rø rø rø rø o o o o rø rø w rø o o o o rø |*3
I o,
o o o o o o o o o o o o O O O O o o o o o o O O o o o O o ffi UZ K K K ffi 33 S3 33 33 33 33 53 33 53 S3 53 S3 53 53 o to PI τj ffl ffl τ] τj --3 --3 --3 33 33 33 33 33 33 33 33 33 33 33 53 33 33 33 S3 33 S3 33 S3 S3 P II cr
o o o o o o o o o o o o o O o O o o O O O o o o o O O O O rø rø ts ts rø |*3
X 33 33 53 53 33 33 33 33 53 33 X 53 S3 33 33 33 33 33 S3 S3 33 33 33
1 cr
o rø rø rø rø o O O ro rø ffl ω o o o o rø rø rø rø o o o o ω ω rø rø |*3
ffl rø ro 2? rø tn rø ro rømrø
3 -i 3 ro-i 2? rø ro wffl £ rø tn o ϋfflJ o > |*3 I
3 -i ir rø r w 3 ro-i 2? W r LO o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o Tj ffl TJ ro ro ffl ffl ffl TJ
o o rø rø w w o o o o rø rø rø rø o o o O rø W w rø o o o o rø rø rø rø o o o o rø rø rø 1*3 I Os ffl rø ffl £t rø ro W £
3 r t rø
3 r 21 ' W ro 21 ^ ro ro t-? S w ro ) ^ W ro w S ro ^ 2, ' W ro w 1 I* t3o rø rø rø rø rø rø O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
IIo rø ts ts ω ro ro rø rø rø rø rø rø rø ω rø w rø rø o o o o o o o o o o o o o o o o o o o I f cr
4-
-? -? -? -? -? -? Ω Ω ° Ω ffl ffl ffl ffl ffl ffl ro ro ;ω --u uω -r ω ~ rø H, rø H, ω HH HωH ω H, o — o — o — o — o — o — o — o — ΩI ΩJ JΩI 1*3 I i-n w rø o o o o o o o o w rø rø rø o o o o rø w rø rø o o o o ω rø rø rø o o o o rø rø ω |*3 I os ffl £ ro ro rø ^ ώ ro 2? ^ rø ro 2) ^ rø ro 21 ^ rø ro rø |' ώ ro w S rt rø ^ S l rø J -S ^ rø ro rø |*3
I LO
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O PI
rø rø o o o o rø ω ro ro o o o o ω ω rø rø o o o o ω rø rø w o o o o ω rø rø w o o o
or 21 o o o o o o o o o O O O O o o o o o o o o o o o o o o o o o o o o o o o o
33 53 53 53 S3 S3 33 F
IS rø rø rø rø rø rø rø ts rø w rø ts rø rø w rø rø rø rø rø rø rø W O O O o o o p I cr
0 0 0 0 0 0 0 — — rø rø rø W w ts o o o o o o o o o O O O ffl ro o O
TJ ro TJ Tj ffl Tj w ts ts t rø rø 1*3
LO to to to to to LO |-t I tn ω ts rø o o o o rø rø ro ro o o o o rø rø rø rø o o o o rø ro rø rø o o o o w ts rø w o o 1*3 I Ch ro ra ro rø ffl £ rø rø rø ro tn o m rø ø
3 3 3 -■ rø ro 2* £ f rø r β -ι 3 ro S rø ro tn r r |
3 3 ro 2- ω *3
3 o -i I to rø rø rø rø ts rø w ts rø rø rø rø rø ts rø rø w rø w rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø W rø W oro oro oro o o o 3 ^ ^ O O O O O O O O Q Q Q TJ TJ TJ TJ TJ TJ TJ TJ ffl O CO -? H? H? H? H? Ω Ω Ω Ω Ω ° Ω Ω ro ro τ] Q τ τj τl Q rø ω 1*3
o o o ω rø rø ω o o o o rø rø w rø o o o o rø rø rø rø o o o o w rø rø rø o o o o rø w |*3 I Ch
-.. -. -- -- ro ϋ rø £ ts ro -5 £ rø ro t mn £ ts ro 2? % § § § $ ® % § % ® % § i? ® % § t? & % V ffl ffl ffl CO CO CO ffl ffl CO CO ffl ffl ffl ffl -? Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 1 - cfeo-
Tj j j j j Tj j j Tj j j j j Tj ^ oi rh2 Qi ni roI Oτι Oro τOj Oro Offl fO O 1*3 ffl L fl ffl Offl roO Oro Oro Oτj Oτj Offl OTj Oτi Offl 1 cfer-
rø ts ts o o o o rø rø rø rø o o o o o o o o rø ω rø rø o o o o w ω rø rø o o o o rø rø |*3
1 Ch
ro tn o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fe fe fe fe fe fe fe fe fe 33 53 fe UZ fe fe fe fe fe fe fe fe fe fe fe l-O to fe fe fe fe fe fe fe fe fe fe fe fe P
ω ts rø o o o o o o o o o TJ o TJ o TJ o TJ o TJ o n o TJ o ro rø rø rø rø rø ro rø ω o o o o o o o o Ω 1*3 I rø ro rø rø rø rø rø o o o o w rø ω rø o o o o ω rø ω rø o o o o rø rø ω rø o o o o ω |*3 I CΛ
O O O O O O O fe fe fe fe fe fe fe rø rø ffl rø ro w ro w rø w rø ts rø ts rø cd rø ro rø ts rø rø rø ro rø ro rø rø w |*3 I • Pfe-
o o o rø rø ω rø o o o o o o o o o o o ro o TJ o o o ro o TJ ts. CO ffl CO CO CO ffl ffl O O O |*3
I tn o o O o o o o ts rø rø rø Ω Ω Ω Ω H? H? H? H? Ω Ω Ω Ω !-? ω ω ω o o o o rø rø rø rø o 1*3 I Ch ώ rø rø TI m £ ts ffl ffl £ o ro rø ro ? & ro r ro w
3 r o ro 2 S rø ro w S* t ω- ø ro ffl? £ 0 rø ro w £ rø |*3
3 3 ro 21 1 r I to
3 o o
53 S3 rø rø w rø w rø rø CO ro w ro rø rø ts rø ts rø ro rø rø ts rø ro rø w rø rø w rø w rø rø w PI o Q o o o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω rø rø ffl ffl rø ffl Tj Tj Tj o rø rø ts rø rø H roH Hrø, t Hs, rø H, o - o — o — o — o _ o — o _ o - JΩl JQJ ΩTI QTI ΩJ Q jΩJ o rø rø ro rø rø o n o o ffl co ffl ffl o n o o ffl co co ffl o n n o td ffl ffl co o o o o oo Pi
I Ch
CJ ffl eQ
υ _s o
ω ro 21 rø o ? rø rø f |*3
3 r 3 ro 21 ffl
3 rt ffl r ffl £ f 3 ro 2* ø l
3 ro 21 I to
3 o 33 o33 offi offi oHH oHH o--H oK offi o-- o-H oHH ofif o- oK oK o-H o--H oW o- oK oH oK o-]H o- oH o-C o-M PI *3 tn
o o o o rø w ω rø o o o o rø ω rø rø o o o o ω rø ω rø o o o o |*3
rø ro 2 ffl1 ro ro W ro J 2 m1 rø rø w T) ω ro ro 21 rø W Ht c rø r s tt-nnv ro ro i wϋ £ |*3
3 ~ r ts ffl
3 o 3 I LO
- - _ ,-, - _ ,_ _ - Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω
O O O O TJ TJ ro
o o o o rø ω rø rø o o o o o o o o rø ro rø w o o o o rø rø ω rø o o o o ω rø rø ts |*3 I Os
rø r ts ro 21 ro r 21 rø r ro w rø ro - ffliJ rø ? |*3
3 o 21 3 3 o 3 ro 21 rt ø o y m. r
3 3 3 r ø T. ffl ro ro 2
3 "« 3 I LO
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 33 S3 33 33 33 53 53 5H 53 33 33 33 33 53 33 33 S3 S3 S3
O O O O O O O O τj τj τj τj τj ro τj ffl Q Q τ τι Q τj τι Q ω HH ro -I w HI rø _ o o o o rø w w rø o o o o rø rø rø rø rø w rø rø o o o o rø rø rø rø o o o o rø w rø rø |*3
ώ ro rø ^ rø ro rø ^ ro j rø ^ rø τj rø S rø τj rø S rø j rø 2 rø 21 S
o n n n o n o o n n o o o n n o o o o o i^ *3 Ln
Ω Ω Q Ω Q Ω Q Ω Ω Ω Ω Ω Ω Q Ω Ω ffi ffi HH H^ Iro
Ito
H -H3 ---3 EHH H-H3 ffiHH —X - HH3 —-3 Oifl iOj Oi7i O>ιi Oiτ) Oiτi 'O7j ιOι « H H H ιro O
HH rø W rø rø j-. 53 ffl Ito o o o o rø rø rø rø o o o o rø ω ro ω rø rø rø rø o o o o ω rø rø rø o o o o rø rø rø w |*3
rø rø rø rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o rl 1* L3n
Tj Tj _J oTJ oTJ oTj oTJ oTj oj oTj oj t to t to to LO tO LO rø rø rø W W rø rø rø 33 33 33 33 33 33 3; 33 Ito
o o o o o o o o rø ω rø w o o o o rø rø ω rø o o o o ω rø rø rø o o o o ω rø ω rø l*!
δ g rø ώ rø ώ j rø ζ m ώ j w ώ j m ^ ό ώ rø 5? rø ro w w S ts J rø ^ ω ro w £
3 -i rt I 15? w
ro ro rø rø o o
— n —ro —ro —ro ,Q~, ,O--ι
ώ ro rø -? ώ 5 rø S ώ ζ S ' -? ffl H? S rø 3 ro -ι -? 2 ro ro ™ 2 ro 3 -i
*3 rø w ra ω ra ω rø ω rø ro rø rø ω ra w w ω rø ra rø o o o o o o o o o o o o o o o o pl tn
P
Ito ro -^ -J W Ω Ω Ω Ω Ω Ω Ω Ω ro ro ro n ro ro ro Tj Q Q Q Q Q Q Q Q H^ H-H Hfl Hfl H- HrH Hfl H^ I^ o 33
^ LO LO LO LO LO LO LO O I CJ* , Ito rø o o o o w ω rø rø o o o o w rø rø ω o o o o o o o o ω rø rø rø o o o o rø rø rø ω l*3
W TJ w £ ts o 2? rt ro I LO 3 -* 3 r 3 ro » rø
3 ro w rø ro ϋ tnJ rø 3 -* 3 ro 2? rø
3 ro 2? |*3
ts rø ω w o o o o rø w rø rø o o o o rø rø rø rø o o o o rø rø rø rø 1*3 I Os
** *—- •—. ts ffl ω ro tn1 rø ro ro tn rø ro 2 m ffl1 £ rø ro S
3 3 -i 3 -i 2 m1 ^ rø ro 2, ^ rø ro l ^ rt I PS to,
*3 rø w rø w rø M w w rø rø w w rø rø w w rø rø rø rø rø rø rø rø rø rø rø rø |^ tn
O
S3 r: ro rø rø rø rø rø rø rø O O O O O O O τj τj τj T 5. |Q to 1 ° |OJ
ώ '-d rø S ώώβ roζ H-H 2røΉ-l S.' tώ jr> ζ -y w <-••
*3 π π π Ω Q Q π π rø ro rø ω ω ffl rø ω ω ro rø ω rø rø rø w ro rø rø ω l5! tn
P
Ito Iffl
, Q-. ,n-. ,G-. ,ϋ-. , —-. , H---, ,-2, ,Q-, 0τj 0τj 0ro 0ro 0τj 0τj 0τj 0ro ιι ι— ' HH — — — HH rø rø rø W I*. o
33 . Ito ro o o o o ffl rø ω rø rø ω ω rø o o o o ω ω rø ω o o o o rø rø ω ω i*3
o o o o O O O O O O O O O O O O
33 t 3o3 t 3o3 L 3 HH HH t O3 LO tO l-O l-O LO LO l- tO l- l-O l-O l-
ro ts rø w -? Ω Ω Ω Ω Ω Ω Ω Ω ro ro τj rø o o o o ω ω rø ω o o o o rø rø ω ω o o o o rø w ω ω o o o o |*3
w rø 2 w $ l w 5 w rø ro -? $ l: ^
o o o o o o o o o o o o *3 tn tOS tOS l-SO tOS tSO LOS l-SO tSO l-SO tOS LSO tSO LSO I-SO l-SO LOS LSO LSO LSO LSO tSO tOS LSO β I B o
33
33 θ —O O — O — τj n ffl ffl ffl ffl ro ro —Q O O θ LOQ LOQ LOQ I-OQ LOQ LOQ LOQ LOQ -H - -- -H -H - -H -H ^rø ω ^ rø ^ | |?l ro
-— CJ* Ito
rø o o o o rø rø w rø o o o o o o o o rø w rø ω o o o o rø rø rø rø o o o o rø ω ω |*3
S t ζ rø £ t ζ 21 ^ rø τj rø 2 ro τ 2' £ rø τj rø S rø τj rø 2 rø τj rø ^ rø τ^
Ω Ω Ω Ω
S3 Ω Ω w o o o o rø rø rø rø o o o o rø w rø rø w w rø ω o o o o rø rø rø rø o o o o rø w rø |*3
S CD 3ro ^-? rø--*- Srt ro g- τ -?j S £ O ro -y τ-y w-H- Srt ^ro ro -? 2 ~? S rt ro 3 τ-? ^Η* 2rt ^ro τj ~| £ rt ώ g^ ro -? rø -* S CD cro τ -? -w• S CD ro ^ τ-?j 2"-1 |l'r?t,
ω o o o o rø ω rø rø o o o o rø rø ω rø rø w rø ω o o o o w rø ω rø o o o o ω ω w |*3
rø ro 2 tn? ffl ro 2? rø ts t ø
3 3 SI r wi ts tn
3 ω ro m ω TJ m £ rø
3 -* 3 -I 3 3 ro 21 r
3 ro 21 |*3 I to
ω rø rø w ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o P *3
II tn
O
— — — — — O O O O O O O O ι n ffl ffl ffl Tj Tj Tj '-rj Tj '-ri Tj Tj Tj rø rø W rø rø ro rø W τj i ; ' !n 3 3' f3 σ* Itofl
w o o o o o o o o ω w rø rø o o o o rø rø rø rø o o o o rø w rø w o o o o rø rø rø |*3
S rø ζ w £ ro rø ro τ rø ro rø ^ ώ ro rø ^ ώ ro w 2 ώ τ rø S ro τ rø S ώ τj
w o o o o o o o o ω rø rø rø o o o o ω ω ω rø o o o o rø ω ω rø o o o o ω rø rø |*3
2D t cs τ H?j rø -^ S to rø c τ -irj rø - 2t ώ £ τ H?j rø " 2t ro ^ τ-yj 2-H?- £a. rø ^ τ-?j rø-H- Srt ro g' τ-y. -H-| Srt ro c τ -? *? £ ni ώ ^ ro -? «rø £» ώ g* -y « ι w
ts rø rø ro ro w rø rø rø rø w rø rø ør rø rø ør ts w w rø
ro -? -? -? -? Ω Ω Ω Ω Ω Ω Ω ffl ffl ffl ro ffl ffl ffl ffl rø o o o o rø w rø rø o o o o rø rø ro rø o o o o o o o o rø rø rø w o o o o w HI roHI røHH lIffl O.
rø ffl rø ro 21 rø ro 2 ffl1 rø ro w £ ro T ww ffl ro ff ffl ffl ro 2 tn? |*3
3 -i I to
ro w rø rø w w w rø w ro rø rø ro rø rø ffl rø rø w ro rø w ro rø rø rø rø 1*3 *3
V, o w ro rø rø W rø rø ω o o o o o o 1 33 o o -rj Tj Tj * -3fe f *- [tfl σ o
ts rø rø ε? Ω o o rø rø ro rø o o o o rø rø ts rø o o o o rø w rø 1*3
I o,
'*3 rø rø rø rø rø w rø rø w rø rø rø rø rø rø rø rø rø w rø rø rø rø rø w rø rø *j?c. ι-n
P 53 Ito rø ro ro ffl ts ts ts ts o o o o o o o o Tj Tj Tj 1* *3 t *•
ro rø ts rø o o o o rø rø ω w o o o o ω rø ro ts o o o o ω rø rø |*3
ώ 3 ro -, rø ^ rt rø j- ro -*f/ <-*) ^ <π> ώ c ro HH 2^1 rt' rø c ro -H 2rt? rt' crø ro -y 2 •"■■? C.« rø JJ ro H* W o' ώ c ro 2l lJS-
1*3 o o o o o o o o w rø w rø rø rø rø rø rø rø rø w rø rø w rø w rø w II ι-n
P
Ito Iro o o o o o o o o Q rø rø rø o
LOQ LOQ LQO LOQ LQO LOQ LO LOQ f Il σ* 33 ffl Ito o o o o ro w ω ω ω rø rø ω o o o o ω rø ω rø o o o o ω rø ω |*3
ro w
O O o 33 to S3 to 33
O O o o o o ro ts rø w o o o o ω ω rø rø o o o o rø rø rø rø o o o o |*3
rø ro rø ts o o o o rø rø rø rø o o o o rø ω rø ω o o o o ω rø w rø o o o o rø ω rø rø 1*3
tS TJ g ffl> rt — ro ro -^ ™ ffl rø ro ffli £ ts ro ϋ ffl' rø ro S ffl
3 -i 3 *-* rø 3 ro ø -ι - ω7 r
3 -i s H - ? ? s pw
_ _ _ ^ Λ - _ ^ Λ _ Λ _ _ - - ^ o o o o o o o o o o o o o o o o o θ ιro *3
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω S3 53 S3 33 33 S3 33 33 33 33 33 S3 53 33 S3 33 53 33 33 3J H-*- tn
Ω Ω Ω Ω Ω Ω Ω Ω S3 ffi ffi 33 -i3 !-C --3 S3 ro ro ro Q n n Q τj tO tO tO LO LO LO LO to o -* o " o -* o "" p Ii σ- I "tfto
o o o o rø ω rø rø o o o o ω ω ω ω ω ω rø ω o o o o ω ω ω rø o o o o rø rø rø rø |*3
C ro ►τ?j 2 "1■ ^ « rø C ro rø -l § <^1) trø Cs - ffl^ - £^ CD ^ όM τ-?. --3*- ^rt rø g* τ -?j 2 w? ^ C £O rø ^ ro roH? ffl"-l ^rt £ rø c τ ►? rø - m* ^ £t rø C ro - wH-? £^ CO rø c rn τ ► S?j rø « w £ ct V I? to i*3 tn
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 33 33 33 33 33 33 53 S3 33 33 33 33 33 33 33 3; 3; 33 S; pl
P
I ,to rø o
Ω Ω Ω Ω Ω Ω Ω Ω ro τj τj ro ro ro τj τj 33 33 33 33 53 33 33 33 θ O O O ro 33
Ito o o o o rø rø w ω o o o o ω w rø rø rø rø rø ω o o o o rø rø rø rø o o o o ω ω rø rø |*3
ω ro fl o ffl IS ro 2? rø ro w 1*3 I to
3 ? ω
3 ro 2? ω r
3 ro 21 o r 2? ro miJ f r c o 3 ro - 3 ro -? 3 3 3 rø w rø w o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o ,*3 tn
O
33
- i-?' --?' -'-?' --?' ro ro ro ro Q — O — O H- O— j n ro ro rø -' rø-' -rø' rø-' -rø' ro-' -ro' ω-' Lon tQo tQo LQo LQo tQo LQo i-τo 33 53 3 33 | I^ o" Ito ro
o o o o o o o o o o o o w rø rø w o o o o ω rø rø rø o o o o rø w rø rø o o o o |*^
rø ro g ffl? £ rt ro t IS ffl rø r ω o ffl -i.J rø ffl r
3 3 ro ø m r ffl ro ffl -V £ ø
3 3 3 3 3 rt 3 ro « £ rt rø
3 ro 2? |*3 I to
3 3
o o o o o o o o rø rø rø rø o o o o rø ω w rø o o o o ω rø rø w o o o o rø rø rø rø |*3
rø ro rø |* r ro rø £ rø ro ffl £ w ro 21 -! rø ro rø ϊ ro - rø !' rø ro rø
3 -i 21 ø S rt £ 3 -I 3 -I rt I to
o o o o rø rø rø ω o o o o o o o o rø rø rø rø o o o o ω ω rø rø o o o o ω rø rø rø |*3
ro T. tn £ ro TJ t 2n? ts ro 21 ro ro 21 rø rø ro 21 ro TJ w |*3
I LO
ts rø ts ts rø ro rø rø rø rø w rø ts rø rø rø w rø rø rø rø rø rø rø rø ts rø rø
O O O O O O O O τj iτj ffl τj τj τj τj τj tS ffl rø rø
ω rø rø rø o o o o rø w rø rø o o o o rø rø w rø o o o o rø rø w rø 1*3
I Λ
rø ro 21 rø TJ 2 m m? ra rø -zr m ts rø ts rø rø ro 21 rø ro ffl M |*3
3 -i 3 ". 3 I-* I LO
ts ffl ts ts ts ro rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø w rø rø rø rø rø
rø rø ts rø ts ro ts rø O — O — O — O — O — O — O — O — τj Tj ffl τj | I:l σ*
ffl ro rø rø o o o o rø ω rø rø o o o o rø rø ω rø o o o o ω rø ω rø |*3
ro ?T HH^? ffl-*- rt ro ^ τ-pj rø--* Srt ro " τ -yj rø — S o ro ^ τ-? 2Η-| Srt rø "r -? rø-H- Srt ro ϊr τ-pj -| St ro ? τ H?j rø " ^ <»< l i';:',
ro rø rø rø rø rø ts rø ts
ro ts ω rø rø o o o o rø rø rø rø o o o o rø w w rø o o o o rø w rø rø l*3
HH H^ αo u u cj u u o u u u o c o O <-> HH -r* 5 u ππ Η 3 ω 3 I- 3 -H 3 W °- m tq °H ffl >g 2 ro CQ *-> — - 3 5 ω PH ffl w ffl m it Di S ω fV °?
~. *» a a -H. rø zr o _ r 21 5? ω ro S rø ro 2 tn1 rø rø rø TJ rø ro 2 ro? ts ro 2 tn1 ffl r ion ffl rø ro 2 tn ra ? rø ro 2 tn? 1*3 to
C S S 3 -i
o o o o o o o o o o o o o
o rø rø rø rø o o o o ro rø w rø o o o o w rø rø rø o o o o rø rø ro w o o o o rø rø ω
rø T) . ffl \ CO TJ 21 S rø ό TJ ffl £ rø 3 ro -ι S ffl £ ro ^ w £ ro - w £ ffl S rø 2 *s ^ rø ? t 3 I. S |':5-
*3
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 33 S3 53 S3 53 S3 33 S! 33 33 33 33 33 33 33 31 S3 53 l tn
P |33 t ro Ω Ω Ω Ω Ω Ω Ω Ω S3 33 33 33 33 33 S3 3-; ro ro ro ro Q τι Q Q p _. _. p-, i rro n |oHfi t I σ* iL
rø o o o o rø rø rø rø o o o o rø rø rø rø ω ω ω rø o o o o rø ω ω ω 'o o o o rø w rø |*3
§■ « 5 w §■ rø TJ ffl £ d rø τj rø -f' rø ro ? l' rø ro rø |' rø ro 2, l' rø ro s ^ S 3 - -S* s ^ -p -s E pS.
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω
O — O — O — O — O — — O — O — rø o o o o rø rø rø rø o o o o w rø ω ω rø rø rø rø o o o o rø rø w w o o o o rø ω rø |*3
ts ro 2- ω ro w rø ro 21 £t rø ΓH ro 21 £t W ro 2* ro ro flf rø n o
3 - T HHiJ 2 "* rt £ ro ro 21 ^ r ro ffl 1*3
3 -i 3 -! I to
rø rø rø rø rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o 1*3 i o
33 ro ro w CD rø CO rø CO H-j -- --j o o o o TJ Tj f te rø rø rø ts rø rø rø 0 0 0 0 0 0 0 0 - H- HH |*3 τj Tj τj τι τ] τj ffl τι S3 33 33 4-.
LO LO L LO LO LO LO LO | cj* , Ito rø
rø o o o o o o o o o o o o rø rø rø ω o o o o rø rø rø ffl o o o o rø rø rø rø Ω Ω Ω p
w o o o o o o o o w rø rø ω o o o o ω rø rø ω o o o o rø rø rø rø o o o o rø rø ω |*3
ro ro j 2 ra. £ rn W Tj. 2211 ?s, W ro 2' , 2s* ώro τroj rø2! 2s* ώro HroH ffl21 £ l " f c£t ro g H jH -ι 3 -< 3 -i ro or f ? ffl ~ £ r
3 a gt' oH-' '-' Srt ffl g* -r "l il':!w:',
rø ra rø rø ω w rø rø w w w ω ω
rø o o o o rø w rø rø o o o o o o o o w rø ω ω o o o o rø ω w rø o o o o ω ω rø |*3
rø ro 2 ffl? r &n t z ro - ffli.J ffl ffl - ffl5 -ς ffl TJ ffl ffl rø ro ffl? ffl ro 5 w* I? LO.
rø w rø rø w rø rø w rø rø rø rø rø rø w rø rø rø rø w rø rø rø w rø rø *3
-1 rø -I i * g tn
O O O O O O O O n ro ro ro ro ro ro ro ro W ro : Ito
ts ts rø rø o o o o rø rø rø rø o o o o rø ω ω ro O o o O rø ■-i ffl ffl |*3 1 Os
ts TJ w w ro w rø ^ΓJ n rø ro - tniJ ts ffl £ or l £ 3
3 3 3 3 t rø ff
3 ffl ffl 1*
3 1 t
w ro ro ffl o o o o ro ω rø w o o o o w rø ω rø o o o o ω rø ω |*3
rø G ro -H1 ^ ωG ro ™ ^^ røG ro 2? -^F w ro 2? ^ rø ro , ? rø ro l -f' ω ro w P9. ^ G ^ G '-I
*3 rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø Pϊ <-n o It fflo ro Q LQO LQO LQO LOQ tQo tQo w ^ ω ^ w -* -rø* ω rø ω o
LO LO ^ ω -• o p Il CJ* ffl
Ito rø rø ts rø o o o o rø rø rø rø o o o o rø rø rø rø o o o o ω rø ω |*3
£ ct ffl ro ffl £ rø TI ffl £ rø M £ ώ TJ ffl £ ro flf £ T) ffl rt 3 rt £t ro ffl £
3 3 rt 3 3 rt ffl
3 r 3 rt
O O O ro ro O O rø rø ffl rø rø rø ffl rø O O O O O O O O O O O O O O O TJ TJ TJ Tj Tj TJ TJ TJ J 1*3 o to to 1 tn
O o o o O o o O O o o o O o o o o o o O o O o O o o o O f 1l a rø rø ro rø ts rø ffl IS ro ro ffl ffl 1 σ*
o ffl rø TO ts o o O o rø ts rø ør o O O W rø ω rø o o o o ffl ffl ro ts |*3
o o o o O o o o O o o o O o o O o o o o o o o o o o o o o O O O O O O O O 1*3
33 53 S3 33 33 53 S3 S3 33 33 S3 S3 33 33 33 33 33 33 33 33 to to to to to •fe- ffl ro •-i ffl ffl ffl ro ffl ro ffl ffl ffl ω ro ro ω rø ffl •-i ro ffl ro ro ro ro rø ω •-i o o o o o o o o o o ro o O
Tj fl to ro o TJ f ro rø rø ω rø ω o o o o o o o Q Q ζj |*3 to to ro o to t ro o o to •-i ffl o 1 Ln
O o rø ro ffl rø o o o o ro ro ω ffl O o O O rø ts rø rø o o o o rø rø ro rø o o o o rø rø rø
o o ro ro w ro o o o o rø rø ro ffl o o O ro w ro ffl o o o o ro ro ro w o o o o ro w ffl 1 1* o3
ω rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o F+
TJ Tj O
o o o o o o ω rø ω rø o o o o rø rø rø ω o o o o ω rø rø ω o o o o rø ω m rø o o o V I O3s
-^ ffl £ ro -rt ffl £ ro τj -S ^ ro τj 2' 2 ro j rø S rø τ rø^ £! ώ τj 2? S rø ro I'?,
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O Q O O ITJ
toAJ? ,.? ι-7 ι-7 ij? 1 H, H, H, H, H, H, | *:
Q Q Q Q Q Q Q rø rø rø rø ω w rø rø Q Q θ o o o o Q Q Q Q Q Q Q Q ω rø rø w ω ω |*3
rø ro ro o o o o rø rø rø ω o o o o rø ω rø rø o o o o rø ω rø rø o o o o rø ω ω rø o o |*3
τj rø ^ ώ τj rø ^ rø τj ffl ^ rø ro W ^ ώ ro rø ^ ώ τj rø ^ rø ro rø S ώ % ffl rø rø rø w ω w ω ra rø rø ts w rø ts rø o o o o o o o o o o o o o o o o o o o o o o pl
O Tj OTj OTj OTj OTj On Qffl Offl Oro Oro Oro Oro Oor Oro rOo Q. ^Q oQ oQ Q oQ oQ rQ-, ^Q oQ oQ Q--. Q--, Q--. oQ ^Q, ^Tj _Tj Tjj Tjj _Tj, „Tj | r*j3., to - .
Ω Ω Ω Ω Ω Ω Ω ro ro Q Q Q Q Q Q Q θ o o o o o o Q Q Q Q Q Q ro ro -? » H? -? -? -? l^ ω ro rø o o o o rø rø ω rø o o o o rø ω rø rø o o o o rø w rø rø o o o o ω ω ω ω o o |*3
ro HH 2rt? lC? rø g* -roy 2 •"►5 l CD? rø _. ro -? 2"? l(,? rø c ro -? ~rø | rt? rø £* ' --yd 2 **♦? l CD" rø £ ^ " CD JJ <-, T ^ rt 3 -1 ** <t> g -r l w rø rø rø rø rø ts rø ro ro ro ro ro ro ro rø w w rø rø ts rø rø rø rø w rø rø rø rø w rø rø w w rø rø rø
O O — O — O — O — O — O — O — O — O — O — O — O — O — O fl ffl ro ro ro ro Tj ffl Tj Tj Tj ffl ffl Tj Tj Tj Tj Tj Tj Tj T] Iffl
— — n f | \σt_,
Ω Ω Ω Ω ° Ω Ω ffl Q n Q Q Q Q Q rø ω ω ω rø rø rø ω o o o o o o o o Q ro ro Q Q Q |^ ω ω rø o o o o ω ω ω ω o o o o ω ω ω rø o o o o ω ω rø rø o o o o rø rø rø ω o o |*3
|*3
I !-0 - - - - - - - - - - - - - O O O O O O O O O O O O O O O O O O O O O
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 S3 S3 53 33 33 S3 S3 31 33 33 33 S3 53 S1 S3 S3 53 53 S3 S3 pi
- ^? -^? -^? -^? -^? -^? -^? ° o o— o o o— o— o— o o~ LQO LOQ l-Q LOro l-roO LQO LOQ LQO LOQ LOQ LnO LQO LOQ LQO LQO LO LQO F I÷ σ*
Q Q Q Q Q Q Q rø rø rø rø rø rø rø ør Q o o o rø w ω rø rø w ω rø o o o o o o o o Q |*3
I tn
P Ω Ω -? H? H? H? H? H? H? H? Ω ^ o o o o o o Q Q Q Q Q Q Q Q ffl ω ffl ro w ro w ffl o |*3 I tn o o o ro ro rø rø o o o o rø rø rø w o o o o rø rø w rø o o o o w rø rø rø o o o o rø 1*3 I s
o o w rø rø rø rø rø rø rø rø rø rø rø rø w rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø ts Fl
o w rø rø rø rø o o o o w rø rø rø o o o o rø rø rø rø o o o o rø rø rø w o o o o rø 1*3 I Os
rø ro 2 W- £ ts ro W rø ro w r? ro ro ffl
S* rV ro i wi' ro ro iw-v ts TJ W |*3 t o o o o o o o o o o O O O
►--H UZ UZ HH ffi ffi ffl ffl ffl ffl fflo o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o o o o o
LO S3 L3O3 L 3O3 L 3o3 t33 LO 33 l- 3O3 LO S3 L3O3 I
TJ TJ TJ TJ TJ 53 53 33 33 53 53 S3 33 3! 33 3; 33 3; 33 33 3; 33 33 33 S3 33 33 5 —3 5HH3
o o o o o o o o o o o o o o o o o o o o o o o o o o o Ω Ω P
-? -? -? -? -? 53 53 33 33 33 S3 S3 S3 S3 33 33 33 S; 53 S3 S; 33 33 3; 33 33 rø O O O O O Ω Ω Ω ffl ro ffl ffl Q Q Q Q rø rø w w rø ro ts w o o Ω Ω 5. o rø ro rø ts o o o o rø rø w rø o o o o rø rø w rø o o o o rø rø ω ω 1*3
ffl ro ro 2? rø in ro ro ffl ϋJ ffl ro - tn ts J - fflV ro w ϋj ro ro m
3 ro Ml 3 3 3 3 ro rt ro ffl
3 ro t ro |*3 I to
3 3 -l MI £
3 ro 21
O O O O O O O O O O O O O O O O O O O O ff ff ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl o ffl o o o o l ffl ffl ffl ffl ffl ffl l ffl olff o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl t 3o3 L 3O3 LO 33 PI
O O O O O O O O O O O O O O O O O O TJ TJ TJ TJ TJ TJ TJ TI TI Tj ffl ffl ffl ffl
I pi CJ*
— — -. - - - - .-. - - O O O O O O O O ffl rø ro ro ro ro ro w o o o o o o o o Q Q ζj |*3 I tn
O O ffl ffl ffl ffl O O O O W W ffl ffl O O O O ffl rø rø S? Ω o o o rø ffl ffl ffl o o o o ts ts ro |*3 I Os ffl ffl ro M ffll £ ffl ro 2 W? £ ώ J W rø ro 2 W? ω rø M fflI ffl ffl ffl ffl ro ffl 2? i rø ro 2 ffl? W J ffl |*3 3 -i to ts w ts ts ts ts o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o pi rø ω rø rø ts ffl ts ro ts ts ts ts ts ts ro ro ω ts o o o o o o o o o o o o o o o o o o o F Il σ* t rø rø rø rø rø rø n o o o Q Q Q Q Q Q Q Q ω rø rø ω rø rø rø rø o o o Q Q n Q o Q Tj Q Tj Q Tj |*3 ) L*0 J I tn rø rø o o o o o o o o rø rø rø rø o o o o rø rø rø rø o o o o rø rø rø w o o o o rø rø rø |*3
I O rø £ ό w -? s rø £ ό rø ro rø 21 £ rø ro ør £ a ro ro - 23? 2 ώ J -3 ? d W ro ffl 2- £ o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o F Il ta o Tj o Tj o Tj o Tj oj o Tj rø rø rø rø rø rø rø 1*3 J ) C J L*J CoJ I cfer-
Q Q Q Q Q Q rø rø rø rø rø rø rø w o o o o o o o rø rø o o o o ω ω ro ro o o o o ro rø ω rø o o o o rø ω rø rø o o o o ω ω ω w o o o |*3 I Os
ro M tnl rø tn ffl lff £ ffl ffl r w c fl.
3? ro tn ø ro 2 m? ω w
3 3 o r - fJ -i 21 rø o r
3 -■ ffl 3 ro
3 -i o o o o o o o o o O O O O O O O O 33 33 ffl ffl ffl ffl ffl ffl ffl ffl Έo oS oHH oS oΈ Έo oΈ oΈ oS oΈ oS oHH oHH o
33 HH oHH HoH HoH oHH oHH oHH f 1t>
IS ffl ro ts rø rø w rø rø w rø rø IS rø rø ts rø rø rø rø ro is ffl ffl o o o o o o |*3
1 σ*
Ofl o ffl o TJ o TJ o ffl o TJ o ro ro W rø rø rø rø rø o o o O o o o o o O
TJ o ro o Tj to to ffl ffl o Tj o TJ o o f ffl o TJ ffl ro w ts w ffl |*3 ) to t to to 1 n ro ro ts o o o o ro ffl W ffl O O O O ffl ffl ro ro o o o o w ro ro ω o o o o ffl ffl ro ω o o |*3
1 Os rn £ ro ffl ω or m f ro M tnl ffl ffl IS ffl ffl ro M tnl ffl
3 3fl 3 3 ffl ro 2? ffl ro 2 tn? fe ro ffl ffl ffl ffl ffl ts ro ro ro ro ro ro rø rø ts ro ffl ro ro ro ts rø ts ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ro ro |*3
I 0 -fe)- o Tj o TJ o O O O O O Tj o Tj o o TJ TJ TJ TJ Tj Tj ro w to LO LO to t LO LO I cr
O O O O O O O O O O O
TJ TJ TJ TJ TJ TJ TJ TJ ts w ro ro ro ro rø ω o o o o o o o o Q Q Q Q Q Q Q Q W rø |*3 I tn o o o ω w ω rø o o o o w w rø ro o o o o w rø rø rø o o o o rø rø rø rø o o o o rø rø |*3 I ON
ro M ffll £ ffl ctl ffl ro l ^ ώ ro w S w ro rø S rø Tj ffl ^ ώ ro rø ^ ro
S - roi 2? r 30 -i 5 -? I - w S S i ff ro 1*3
3 -1 -1 rt »o e ι-ι <*"> e ι-ι ct C Ht I to rø ts rø rø rø rø rø rø rø rø rø w rø w rø o o o o o o o o o o o o o o o o o o o o o o pi j Tj Tj j j j j j Tj Tj j j j Tj Tj (j π o o o o o o ffl ts ffl o o o o ffl ro ro ro o o o o o o o o w ro ro ro o o o o ffl ffl ffl ffl o o o o ffl ffl 1*3
I ON
ffl rø ro 2? rø o t Mnl rø ro w <-? rø ro ffl ffl r 2? ro t & ffl ffl tn ffl Pi
3 3 r 3 3 -I 3 o
3 or 2 -n~? rt 3 ro Ml rt ro l
3 ro M tnl ff
3 t o o o o o o O o o o o o O O O O o o o o o o o o o n o o o o o o o o o
HH UZ UZ Z I--H uz 33 UZ UZ UZ HH UZ HH HH HH Z UZ UZ ffi Z Z UZ * z t t 3O3 L SO3 L SO3 L SO3 S3 33 33 33 LO 33 L 3O3 t 3o3 t 5o3 PI o o O O O O O |*3
Tj Toj Toj Toj Toj oj Tj Toj oj T n) Toj oJ Tn O j Tj Tj j Tj Tj Tj > ) ) U-> I cr
O ffl ffl ffl O O O O O O O O O O O O O j TJ TJ TJ TJ TJ o TJ o TJ ffl ffl ts ro ffl ro LO LO LO LO LO LO LO ts ω o o o o o o o o Q |*3 I tn ffl ts ts ts ts ts rø o o o o rø rø rø rø o o o o ro ffl ffl ro o o o o w w ro ro o o o o w |*3 I ON ro ro
3f 3 ffl
<-. ,-. O O O
P P p j ro rø rø rø rø ro ω ω rø rø rø rø rø M ro rø Q Q o TJ o TJ o Tj o Tj o ffl o Tj o Tj oJ oJ o Tj o Tj t τOι t roO L roO to p Ii cr to t o o o rø rø ro rø o o o o o o o o o O O ro T oJ T oj T oj o o rø rø rø rø rø rø rø rø o o o o o 1*3 to to I tn o o o o o o o ts ω rø ts o o o o ω ω rø ts o o o o ω w ro ro o o o o ω w ffl ffl o |*3 I ffl ffl IS r TJ rø m ø fl ro ro ffl £ 3 3 3 ro 2? o r o f wf - £ rø f f ro 2 j? δ ro « S ό ro o l
3 r 3 3 -i fl r ff1 £ & ώ w |*3 I t
O O HH — — ø ts to S3 l- S r rø rø rø rø rø rø rø O3 H? H? H? ffl ts ø rø ts ω rø rø rø W rø rø -d rø w rø ro rø ts rø rø r Fl o P o ro o o o Ω G Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω rø ffl ffl ffl rø rø rø ffl ffl o ro ro rø rø rø o o o o rø w rø rø o o o o rø rø rø ro o o o o ω ω rø rø o o o o rø 1*3 I ON
Table 30
F
F
F
F
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
CF3 CF3 2-OCF3 CF3 3-OCF3 CF3 4-OCF3
CF3 2-OCF2H CF3 3-OCF2H CF3 4-OCF2H
CF3 2-OCF2CF2H CF3 3-OCF2CF2H CF3 4-OCF2CF2H
CF3 2-OCH7CF3 CF3 3-OCH2CF3 CF3 4-OCH2CF3
CF3 2-SCF3 CF3 3-SCF3 CF3 4-SCF3
CF3 2-SOCF3 CF3 3-SOCF3 CF3 4-SOCF3
CF3 2-S02CF3 CF3 3-SO7CF3 CF3 4-S02CF3
CF3 2-SCF2H CF3 3-SCF2H CF3 4-SCF2H
CF3 2-SOCF2H CF3 3-SOCF2H CF3 4-SOCF2H
CF3 2-S02CF2H CF3 3-S02CF2H CF3 4-S02CF2H
OCF2H 2-CF3 OCF2H 3-CF3 OCF2H 4-CF3
OCF2H 2-OCF3 OCF2H 3-OCF3 OCF2H 4-OCF3
OCF2H 2-OCF2H OCF2H 3-OCF2H OCF2H 4-OCF2H
OCF2H 2-OCF2CF2H OCF2H 3-OCF2CF2H OCF2H 4-OCF2CF2H
OCF2H 2-OCH7CF3 OCF2H 3-OCH2CF3 OCF7H 4-OCH7CF3
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-SO7CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF7H 3-SOCF2H OCF2H 4-S0CF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 Cl 2-Me-4-CF3
Me 2-Me-4-OCF3 F 2-Me-4-OCF3 Cl 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H Cl 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 Cl 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 Cl 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 Cl 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 Cl 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H Cl 2-Me-4-SCF2H
Me 2_Me-4-SOCF2H F 2-Me-4-SOCF2H Cl 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H Cl 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-OCF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-OCF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3 o o o o o £ o rt £ rt £ rt rt rt Fl ro o Tj o Tj o o O Tj o Tj Tj o TJ o O
TJ TJ TJ rø w w J J J t J J to to
CΛ CΛ O O O O O — O — £ rt £ rt £ £ rt £ £ £ £ rt Fl £ £ £ £ £ £ £ £ ? rt c ClD S rt £ rt £ rt
O O O O O O O O O O O
Tj o O O O O O O O ro ro o ro o TJ ro o TJ o Tj oTj oj oTj oTj oTj o Tj o TJ oj o ffl oJ Tj Tj j Tj Tj Tj Tj to K> t tO to tJ ) J ) t J C-J 0- f J £ ffl lff ffl flf 53 rt
o O O
O o O O O O o o o O O O O
O r LOff T O O O o o
TJ Oro t toro o o TJ oJ O O toro TJ J or to IO to to to tro l O TJ O O O O o O o too to LOro LOffl J
L ιflf j Tj TJ -o LO LO LO LOro LOffl £
33 33 S3 33 33 S3 33 S3 33 33 33
£ 1*3 o rt Tj oj o O Tj o Tj oj o TJ o o ro ro rø rø rø rø ts ts ts rø £ £ £ £ £ £ ) ) i_ J ffl ffl ffl Tj
o O o l fl fl o ffl O o T o O O ff f O O o o o o l f j oj T oj T oj Tj o o O o o o ffl O O to ff £ £ £ £ £ πι £ £
53 53
O O
Z Z Z JZ JZ JZ JZ J 'Z o o O O O O O o o o o
O O O O O O O O O ro TJ Tj TJ ffl J j ff o J o ffl o ff o O o to to to to to t to to to ffl tol ffl ffl l t to to to to to ffl to ffl ffl 33 33 S3 33 ffl 53 33 S3
GO GO CΛ O O O o o o o o o O O O O O O
£ O O ,
£ £ £ £ £ £ Ω O O O O O O O O O o O O
O O O O O ffl ro o O ffl ffl o Tj ffl Tj rt £ £ £ £ £ £ to ffl ffl to t to t to t t to
33 33 33 ffl 53 53 33 33 33
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H | SMe 2-Me-4-S02CF2H
Table 33
o o o o O O O O O O O £ CD £CD £CD £CD £ £ £ £ £ £ £
o o o o o o o o o o o £ rt £rt £rt £rt £CD £CD £rt £rt £rt £rt £ rø ro w ro ro rø rt
O O O O O O O O O O O £ rt £rt £rt £rt £rt £rt £CD £rt £rt £rt £ ts ts ro ts ro ro rt
o o o O O O O O O O O j j Tj j Tj Tj Tj Tj j j o flf o Tj o o o o to to t flf to ffl ffl Tj o o o o o o o ffl ff ffl Tj ffl TJ o O toffl o O l O O l to t to to ffl t ffl to ffl to ffl to ff ffl ffl L fflO ffl
S3 S3 53 33 33 33 S3 S3 33 S3 S3
Br 2-Me-4-S02CF3 I 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H I 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H I 2-Me-4-SOCF2H OMe 2-Me-4-S0CF2H
Br 2-Me-4-S02CF2H I 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H
Formulation/Utility
Compounds of this invention will generally be used as a formulation or composition with an agriculturally suitable carrier comprising at least one of a liquid diluent, a solid diluent or a surfactant. The foπnulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts, powders, granules, pellets, tablets, films, and the like which can be water-dispersible ("wettable") or water-soluble. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or "overcoated"). Encapsulation can control or delay release of the active ingredient. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High-strength compositions are primarily used as intermediates for further formulation.
The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges that add up to 100 percent by weight. Weight Percent
Active
Ingredient Diluent Surfactant
Water-Dispersible and Water-soluble 5-90 0-94 1-15
Granules, Tablets and Powders.
Suspensions, Emulsions, Solutions 5-50 40-95 0-15
(including Emulsifiable
Concentrates)
Dusts 1-25 70-99 0-5
Granules and Pellets 0.01-99 5-99.99 0-15
High Strength Compositions 90-99 0-10 0-2
Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon 's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity.
Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, NN-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents include, for example, water, N,N-dimethylformamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, oils of olive, castor, linseed, tung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol.
Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. Dusts and powders can be prepared by blending and, usually, grinding as in a hammer mill or fluid-energy mill. Suspensions are usually prepared by wet-milling; see, for example, U.S. 3,060,084. Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-48, Penγ 's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and PCT Publication WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. 4,144,050, U.S. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. 5,180,587, U.S. 5,232,701 and U.S. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. 3,299,566.
For further information regarding the art of formulation, see T. S. Woods, "The Formulator's Toolbox - Product Forms for Modern Agriculture" in Pesticide Chemistiγ and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989. hi the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Tables A-D. Example A
Wettable Powder
Compound 7 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%.
Example B
Granule
Compound 7 10.0% attapulgite granules (low volatile matter,
0.71/0.30 mm; U.S.S. No. 25-50 sieves) 90.0%. Example C Extruded Pellet
Compound 7 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%.
Example D Emulsifiable Concentrate Compound 7 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%.
Example E Granule
Compound 7 0.5% cellulose 2.5% lactose 4.0% cornmeal 93.0%. Compounds of this invention are characterized by favorable metabolic and/or soil residual patterns and exhibit activity controlling a spectrum of agronomic and non- agronomic invertebrate pests. (In the context of this disclosure "invertebrate pest control" means inhibition of invertebrate pest development (including mortality) that causes significant reduction in feeding or other injury or damage caused by the pest; related expressions are defined analogously.) As referred to in this disclosure, the term
"invertebrate pest" includes arthropods, gastropods and nematodes of economic importance as pests. The term "arthropod" includes insects, mites, spiders, scorpions, centipedes, millipedes, pill bugs and symphylans. The term "gastropod" includes snails, slugs and other Stylommatophora. The tenn "nematode" includes all of the helminths, such as: roundworms, heartworms, and phytophagous nematodes (Nematoda), flukes (Tematoda), Acanthocephala, and tapeworms (Cestoda). Those skilled in the art will recognize that not all compounds are equally effective against all pests. Compounds of this invention display activity against economically important agronomic, forest, greenhouse, nursery, ornamentals, food and fiber, public and animal health, domestic and commercial structure, household, and stored product pests. These include larvae of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., fall armyworm (Spodoptera fugiperda J. E. Smith), beet armyworm (Spodoptera exigua Hiibner), black cutworm (Agrotis ipsilon Hufhagel), cabbage looper (Trichoplusia ni Hϋbner), tobacco budworm (Heliothis virescens Fabricius)); borers, casebearers, webworms, coneworms, cabbageworms and skeletonizers from the family Pyralidae (e.g., European corn borer (Ostrinia nubilalis Hϋbner), navel orangeworm (Amyelois transitella Walker), corn root webworm (Crambus caliginosellus Clemens), sod webwomi (Herpetogramma licarsisalis Walker)); leafrollers, budworms, seed worms, and fruit worms in the family Tortricidae (e.g., codling moth (Cydia pomonella Linnaeus), grape berry moth (Endopiza viteana Clemens), oriental fruit moth (Grapholita molesta Busck)); and many other economically important lepidoptera (e.g., diamondback moth (Plutella xylostella Linnaeus), pink bollworm (Pectinophora gossypiella Saunders), gypsy moth (Lymantria dispar Linnaeus)); nymphs and adults of the order Blattodea including cockroaches from the families Blattellidae and Blattidae (e.g., oriental cockroach (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), brownbanded cockroach (Supella longipalpa Fabricius), American cockroach (Periplaneta americana Linnaeus), brown cockroach (Periplaneta bninnea Burmeister),
Madeira cockroach (Leucophaea maderae Fabricius)); foliar feeding larvae and adults of the order Coleoptera including weevils from the families Anthribidae, Bruchidae, and Curculionidae (e.g., boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oiγzophilas Kuschel), granary weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oiγzae Linnaeus)); flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leafminers in the family Chrysomelidae (e.g., Colorado potato beetle (Leptinotarsa decemlineata Say), western corn rootworm (Diabrotica virgifera virgifera LeConte)); chafers and other beetles from the family Scaribaeidae (e.g., Japanese beetle (Popilliajaponica Newman) and European chafer (Rhizotrogus majalis Razoumowsky)); carpet beetles from the family Dermestidae; wireworms from the family Elateridae; bark beetles from the family Scolytidae and flour beetles from the family Tenebrionidae. In addition it includes: adults and larvae of the order Deπnaptera including earwigs from the family Forficulidae (e.g., European earwig (Forficula auricularia Linnaeus), black earwig (Chelisoches morio Fabricius)); adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leaflioppers (e.g. Empoasca spp.) from the family Cicadellidae, planthoppers from the families Fulgoroidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, whiteflies from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, mealybugs from the family Pseudococcidae, scales from the families Coccidae, Diaspididae and
Margarodidae, lace bugs from the family Tingidae, stink bugs from the family Pentatomidae, cinch bugs (e.g., Blissus spp.) and other seed bugs from the family Lygaeidae, spittlebugs from the family Cercopidae squash bugs from the family Coreidae, and red bugs and cotton stainers from the family Pyrrhocoridae. Also included are adults and larvae of the order Acari (mites) such as spider mites and red mites in the family Tetranychidae (e.g., European red mite (Panonychus ulmi Koch), two spotted spider mite (Tetranychus urticae Koch), McDaniel mite (Tetranγchus mcdanieli McGregor)), flat mites in the family Tenuipalpidae (e.g., citrus flat mite (Brevipalpus lewisi McGregor)), rust and bud mites in the family
Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e. dust mites in the family Epidermoptidae, follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae, ticks in the order Ixodidae (e.g., deer tick (Ixodes scapidaris Say), Australian paralysis tick (Ixodes holocyclus Neumann), American dog tick (Dermacentor variabilis Say), lone star tick (Amblyomma americanum Linnaeus) and scab and itch mites in the families Psoroptidae, Pyemotidae, and Sarcoptidae; adults and immatures of the order Orthoptera including grasshoppers, locusts and crickets (e.g., migratory grasshoppers (e.g., Melanoplus sanguinipes Fabricius, M. differentialis Thomas), American grasshoppers (e.g., Schistocerca americana Drury), desert locust (Schistocerca gregaria Forskal), migratory locust (Locitsta migratoria Linnaeus), house cricket (Acheta domesticus Linnaeus), mole crickets (G γllotalpa spp.)); adults and immatures of the order Diptera including leafminers, midges, fruit flies (Tephritidae), frit flies (e.g., Oscinella frit Linnaeus), soil maggots, house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia canicularis Linnaeus, F.femoralis Stein), stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chiγsomya spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bot flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g., Hypoderma spp.), deer flies (e.g., Clvγsops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimidium spp., Simulium spp.), biting midges, sand flies, sciarids, and other Nematocera; adults and immatures of the order Thysanoptera including onion thrips (Thrips tabaci Lindeman) and other foliar feeding thrips; insect pests of the order Hymenoptera including ants (e.g., red carpenter ant (Camponotus ferrugineus Fabricius), black carpenter ant (Camponotus pennsylvanicus De Geer), Pharaoh ant (Monomorium pharaonis Linnaeus), little fire ant (Wasmannia auropimctata Roger), fire ant (Solenopsis geminata Fabricius), red imported fire ant (Solenopsis invicta Buren), Argentine ant (Iridomyrmex humilis Mayr), crazy ant (Paratrechina longicornis Latreille), pavement ant (Tetramorium caespitum Linnaeus), cornfield ant (Lasius alienus Fόrster), odorous house ant (Tapinoma sessile Say)), bees (including carpenter bees), hornets, yellow jackets and wasps; insect pests of the order Isoptera including the eastern subterranean termite (Reticulitermes flavipes Kollar), western subterranean termite (Reticulitermes hesperus Banks), Formosan subterranean termite (Coptotermes formosanus Shiraki), West Indian drywood termite (Incisitermes immigrans Snyder) and other termites of economic importance; insect pests of the order Thysanura such as silverfish (Lepisma saccharina Linnaeus) and firebrat (Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse (Pediculus humanus capitis De Geer), body louse (Pediculus humanus humanus Linnaeus), chicken body louse (Menacanthus stramineus Nitszch), dog biting louse (Trichodectes canis De Geer), fluff louse (Goniocotes gallinae De Geer), sheep body louse (Bovicola ovis Schrank), short-nosed cattle louse (Haematopinus einγsternus Nitzsch), long-nosed cattle louse (Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea (Xenopsylla cheopis Rothschild), cat flea (Ctenocephalides felis Bouche), dog flea (Ctenocephalides canis Curtis), hen flea (Ceratophylhis gallinae Schrank), sticktight flea (Echidnophaga gallinacea Westwood), human flea (Pulex irritans Linnaeus) and other fleas afflicting mammals and birds. Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider (Loxosceles reclusa Gertsch & Mulaik) and the black widow spider (Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede (Scutigera coleoptrata Linnaeus). Activity also includes members of the Classes Nematoda, Cestoda, Trematoda, and Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne, lesion nematodes in the genus Pratylenchus, stubby root nematodes in the genus Trichodorus, etc.) and animal and human health pests (i.e. all economically important flukes, tapeworms, and roundworms, such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofύaria immitis Leidy in dogs, Anoplocephala perfoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.). Compounds of the invention show particularly high activity against pests in the order
Lepidoptera (e.g., Alabama argillacea Hϋbner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenee (rice leaf roller), Crambus caliginosellus Clemens (corn root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hϋbner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & Schiffermϋller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plntella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hϋbner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplnsia ni Hϋbner (cabbage looper) and Tula absoluta Meyrick (tomato leafrniner)). Compounds of the invention also have commercially significant activity on members from the order Homoptera including: Acyrthisiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis eiγsimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosipum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribis igri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (corn leaf aphid), Rhopalosiphum padi Linnaeus (bird cherry- oat aphid), Schi∑aphis graminum Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (citrus whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus Stal (rice leafhopper), Nilapamata lugens Stal (brown planthopper), Peregrinus maidis Ashmead (corn planthopper), Sogatella furcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Eiγthroneoura spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Iceiγa purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosas Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug complex); Cacopsylla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla). These compounds also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Coiγthuca gossγpii Fabricius (cotton lace bug), Cγrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herri ch-Schaffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf- footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper). Other insect orders controlled by compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande (western flower thrip), Scirthothrips citri Moulton (citrus thrip), Sericothrips variabilis Beach (soybean thrip), and Thrips tabaci Lindeman (onion thrip); and the order Coleoptera (e.g., Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).
Compounds of Formula I can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, growth regulators such as rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agricultural utility. Thus the present invention also relates to a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests. Likewise compositions of the present invention comprising a compound of Formula la can further comprise a biologically effective amount of at least one additional biologically active compound or agent. Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are: insecticides such as abamectin, acephate, acetamiprid, avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, fenoxycarb, fenpropathrin, fenproximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl. methoprene, methoxychlor, monocrotophos, methoxyfenozide, nithiazin, novaluron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, sulprofos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron; fungicides such as acibenzolar, azoxystrobin, benomyl, blasticidin-S, Bordeaux mixture (tribasic copper sulfate), bromuconazole, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, (S)-3,5-dichloro-N-(3- chloro- 1 -ethyl- l-methyl-2-oxopropyl)-4-methylbenzamide (RH 7281), diclocymet (S-2900), diclomezine, dicloran, difenoconazole, (S)-3,5-dihydro-5-methyl-2-(methylthio)-5-phenyl-3- (phenylamino)-4H-imidazol-4-one (RP 407213), dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid (SZX0722), fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, fluazinam, fludioxonil, flumetover (RPA 403397), fluquinconazole, flusilazole, flutolanil, flutriafol, folpet, fosetyl-aluminum, furalaxyl, furametapyr (S-82658), hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metconazole, metominostrobin/fenominostrobin (SSF-126), myclobutanil, neo-asozin (ferric methanearsonate), oxadixyl, penconazole, pencycuron, probenazole, prochloraz, propamocarb, propiconazole, pyrifenox, pyraclostrobin, pyrimethanil, pyroquilon, quinoxyfen, spiroxamine, sulfur, tebuconazole, tetraconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram, tiadinil, triadimefon, triadimenol, tricyclazole, trifloxystrobin, triticonazole, validamycin and vinclozolin; nematocides such as aldicarb, oxamyl and fenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; and biological agents such as Bacillus thiiringiensis including ssp. aizawai and kurstaki, Bacillus thiiringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, virus and fungi. A general reference for these agricultural protectants is EΛe Pesticide Manual, 12th Edition, C. D. S. Tomlin, Εd., British Crop Protection Council, Farnham, Surrey, U.K., 2000.
Preferred insecticides and acaricides for mixing with compounds of Fomiula I or la include pyrethroids such as cypermethrin, cyhalothrin, cyfluthrin, beta-cyfluthrin, esfenvalerate, fenvalerate and tralomethrin; carbamates such as fenothicarb, methomyl, oxamyl and thiodicarb; neonicotinoids such as clothianidin, iniidacloprid and thiacloprid; neuronal sodium channel blockers such as indoxacarb; insecticidal macrocyclic lactones such as spinosad, abamectin, avermectin and emamectin; γ-aminobutyric acid (GABA) antagonists such as endosulfan, ethiprole and fipronil; insecticidal ureas such as flufenoxuron and triflumuron; juvenile hormone mimics such as diofenolan and pyriproxyfen; pymetrozine; and amitraz. Preferred biological agents for mixing with compounds of Formula I or la include Bacillus thiiringiensis and Bacillus thiiringiensis delta endotoxin as well as naturally occurring and genetically modified viral insecticides including members of the family Baculoviridae as well as entomophagous fungi.
Most preferred mixtures include a mixture of a compound of Formula I or la with cyhalothrin; a mixture of a compound of Formula I or la with beta-cyfluthrin; a mixture of a compound of Fomiula I or la with esfenvalerate; a mixture of a compound of Formula I or la with methomyl; a mixture of a compound of Fomiula I or la with imidacloprid; a mixture of a compound of Fomiula I or la with thiacloprid; a mixture of a compound of Formula I or la with indoxacarb; a mixture of a compound of Fomiula I or la with abamectin; a mixture of a compound of Fomiula I or la with endosulfan; a mixture of a compound of Fomiula I or la with ethiprole; a mixture of a compound of Formula I or la with fϊpronil; a mixture of a compound of Formula I or la with flufenoxuron; a mixture of a compound of Fomiula I or la with pyriproxyfen; a mixture of a compound of Formula I or la with pymetrozine; a mixture of a compound of Formula I or la with amitraz; a mixture of a compound of Formula I or la with Bacillus thiiringiensis and a mixture of a compound of Formula I or la with Bacillus thiiringiensis delta endotoxin.
In certain instances, combinations with other invertebrate pest control compounds or agents having a similar spectrum of control but a different mode of action will be particularly advantageous for resistance management. Thus, compositions of the present invention comprising a compound of Formula la can further comprise a biologically effective amount of at least one additional invertebrate pest control compound or agent having a similar spectrum of control but a different mode of action, and the methods of the present invention can utilize compositions compromising a compound of Formula I and a biologically effective amount of at least one additional invertebrate pest control compound or agent having a similar spectrum of control but a different mode of action. Contacting a plant genetically modified to express a plant protection compound (e.g., protein) or the locus of the plant with a biologically effective amount of a compound of Formula I or la can also provide a broader spectrum of plant protection and be advantageous for resistance management.
Invertebrate pests are controlled and protection of agronomic, horticultural and specialty crops, animal and human health is achieved by applying one or more of the compounds of Formula I or la, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. Thus, the present invention comprises a method for the control of foliar- and soil-inhabiting invertebrates and protection of agronomic and/or nonagronomic crops, comprising contacting the invertebrates or their environment with a biologically effective amount of one or more of the compounds of Formula I, or with a composition comprising at least one such compound or a composition comprising at least one such compound and an effective amount of at least one additional biologically active compound or agent. A preferred method of contact is by spraying. Alternatively, a granular composition comprising a compound of Formula I or la can be applied to the plant foliage or the soil. Compounds of Formula I or la are effective in delivery through plant uptake by contacting the plant with a composition comprising a compound of Formula I or la applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery box treatment or a dip of transplants. Other methods of contact include application of a compound of Fomiula I or la or a composition comprising of Formula I or la of the invention by direct and residual sprays, aerial sprays, seed coats, microencapsulations, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, dusts and many others.
The compounds of Fomiula I or la can be incorporated into baits that are consumed by the invertebrates or within devices such as traps and the like. Granules or baits comprising between 0.01-5 % active ingredient, 0.05-10% moisture retaining agent(s) and 40-99% vegetable flour are effective in controlling soil insects at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact.
The compounds of Fomiula I or la can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy.
The rate of application required for effective control (i.e. "biologically effective amount") will depend on such factors as the species of invertebrate to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control. The following Tests in the Biological Examples of the Invention demonstrate the efficacy of methods of the invention for protecting plants from specific arthropod pests. "Control efficacy" represents inhibition of arthropod development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-D for compound descriptions. The following abbreviations are used in the Index Tables which follows: t is tertiary, n is normal, i is iso, s is secondary, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl and Bu is butyl; accordingly /-Pr is isopropyl, s-Bu is secondary butyl, etc. The abbreviation "Ex." stands for "Example" and is followed by a number indicating in which example the compound is prepared.
Index Table A
Compound RJ R4 R 5a R 5b mp °C
1 ;-Pr 2-Me H 4-OCF3 oil
2 /-Pr 2-Me H 4-CF3 oil
3 (Ex. 1) -Pr 2-Me 2-Me 4-CF3 100-103 Index Table B
Compound R3 R4 X mp °C
/-Pr Cl NPh N CH CCF3 155-159
Index Table C
Compound R3 R4 W X Y R5 m.p. °C
5 /-Pr Me C-Me N CH CH CF3 132-135
6 /-Pr Me C-Et N CH CH Cl 127-131 Index Table D
Compound R3 R4a R4b R6 R7 V mp cC
7 (Ex. 3) Me Cl H Cl CF3 N 155-159
8 /-Pr Me H H CF3 CH
9 CH2CHC1CH3 Me H Cl CF3 CH 178-180
10 (Ex. 2) Me Me Cl Cl CF3 N solid
11 /-Pr Me Cl Cl Br N 190-193
Index Table E
Compound R3 R 4a R6 R7 V mp °C
12 CH2C≡CH Me Cl Br CH
BIOLOGICAL EXAMPLES OF THE INVENTION
TEST For evaluating control of diamondback moth (Plutella xylostella) the test unit consisted of a small open container with a 12-14-day-old radish plant inside. This was pre-infested with 10-15 neonate larvae on a piece of insect diet by use of a core sampler to remove a plug from a sheet of hardened insect diet having many larvae growing on it and transfer the plug containing larvae and diet to the test unit. The larvae moved onto the test plant as the diet plug dried out. Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm X-77® Spreader Lo-Foam Formula non-ionic surfactant containing alkylarylpolyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.), unless otherwise indicated. The formulated compounds were applied in 1 mL of liquid through a SUJ2 atomizer nozzle with 1/8 JJ custom body (Spraying Systems Co.) positioned 1.27 cm (0.5 inches) above the top of each test unit. All experimental compounds in this screen were sprayed at 250 ppm and replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 hour and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 25 °C and 70% relative humidity. Plant feeding damage was then visually assessed. Of the compounds tested, the following provided very good levels of plant protection
(20% or less feeding damage): 3, 4, 5, 6, 8 and 10.

Claims

CLAIMSWhat is claimed is:
1. A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Fomiula I, its N-oxide or an agriculturally suitable salt of the compound
wherein
B is O or S;
J is a phenyl ring substituted with 1 to 4 R5, or a naphthyl ring system, a 5- or
6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5; K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
R3 is G; CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CΝ, ΝO2, hydroxy, C--C alkoxy, Cj-C4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylcarbonyl, C3-C6 trialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from R6; hydroxy; Cj-C4 alkoxy; C--C4 alkylamino; C2-C8 dialkylamino; C3-C6 cycloalkylamino; C -C6 alkoxycarbonyl or C2-Cg alkylcarbonyl; G is a phenyl ring or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12; each R4 is independently H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, Cj-Cg haloalkyl, C2-Cg haloalkenyl, C -Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C--C4 alkoxy, Cj-C4 haloalkoxy, C--C alkylthio, C--C4 alkylsulfinyl, C--C4 alkylsulfonyl, C--C4 haloalkylthio, C C4 haloalkylsulfinyl, C*-C4 haloalkylsulfonyl, CrC4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C--C4 alkoxyalkyl, Cj-C4 hydroxyalkyl,
C(O)R10, CO2R10, C(O)N lθRll, NR^Rl l, N(RH)COR10, N(RH)CO2R10 or C3-C6 trialkylsilyl; or each R4 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C7-C6 alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C2-Cg haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, Cj-C4 haloalkoxy, C C4 alkylthio, C--C alkylsulfinyl, Cj-C4 alkylsulfonyl, C!-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, CrC4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C7-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl, C3-Cg trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6; or (R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O-, or -OCF2CF2O-; each R6 is independently CrC4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, C C4 alkylthio, -C4 alkylsulfinyl, CrC4 alkylsulfonyl, C]-C alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl;
R10 is H or C C4 alkyl or C C4 haloalkyl; R" is H or Cι-C4 alkyl; each R12 is independently CJ-CT alkyl, halogen, CN, NO and C*-C2 alkoxy; and n is 1 to 4.
2. The method of Claim 1 wherein B is O and R3 is Cj-Cg alkyl, -Cg alkenyl, C2-Cg alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C--C2 alkoxy, C--C alkylthio, Cj-C2 alkylsulfinyl and C--C alkylsulfonyl.
3. The method of Claim 2 wherein J is a phenyl group substituted with 1 to 4 R5.
4. The method of Claim 3 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is
CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, Cj-C alkylthio, C- -C4 alkylsulfinyl, C--C4 alkylsulfonyl, C--C4 haloalkylthio, C--C haloalkylsulfinyl or Cj-C4 haloalkylsulfonyl; and each R5 is independently H, halogen, C--C4 alkyl, C--C2 alkoxy, C--C4 haloalkyl, CN, NO2, C - -C4 haloalkoxy, C - -C4 alkylthio, C - -C4 alkylsulfinyl, C j -C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, Cj-C4 haloalkylsulfonyl or C7-C4 alkoxycarbonyl; or each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6; or ( 5)2 when attached to adjacent carbon atoms can be taken together as -OCF7O-,
-CF2CF2O- or -OCF2CF2O-.
5. The method of Claim 4 wherein
R3 is Cj-C alkyl optionally substituted with halogen, CN, OCH3 or
S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(O)pCF3,
S(O)pCHF2, OCH7CF3, OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with -C4 alkyl, C1-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2.
6. The method of Claim 5 wherein R3 is /-propyl or t-butyl.
7. The method of Claim 2 wherein J is a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R5.
8. The method of Claim 7 wherein
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R5
J-l J-2 J-3 J-4 J.
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N.
9. The method of Claim 8 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, C--C4 alkylthio, C--C4 alkylsulfinyl, Cj-C4 alkylsulfonyl, C--C4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C]-C4 haloalkylsulfonyl; and each R5 is independently H, C C4 alkyl, C--C haloalkyl, halogen, CN, NO , C--C4 haloalkoxy, Cj-C4 alkylthio, C C4 alkylsulfinyl, C C4 alkylsulfonyl, C1-C4 haloalkylthio, C--C4 haloalkylsulfinyl, Cγ-C4 haloalkylsulfonyl or C -C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6.
10. The method of Claim 9 wherein J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
R5 IS
V is N, CH, CF, CC1, CBr or CI; each R7 is independently H, Cj-C6 alkyl, Cj-Cg haloalkyl, halogen, CN, C C4 alkoxy,
C--C4 haloalkoxy or C C4 haloalkylthio; R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; and n is 0, 1 or 2.
11. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-6;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
12. The method of Claim 11 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
13. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-7;
R3 is C C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
14. The method of Claim 13 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3 ;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2) CC1F2, CH2CF3, or CF2CHF2.
15. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-8; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
16. The method of Claim 15 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R7 is halogen or CF3.
17. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-9; R is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
18. The method of Claim 17 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R7 is CF3.
19. The method of Claim 10 wherein
J substituted with 1 to 3 R5 is J-10;
R3 is C1-C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C1-C4 alkyl, CrC4 haloalkyl, halogen or CN;
R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
20. The method of Claim 19 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3. CHF2, CBrF2, CC1F2, CH7CF3, or CF2CHF2.
21. The method of Claim 10 wherein
J substituted with 1 to 3 R5 is J-l 1 ;
R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3 ;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN;
R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
22. The method of Claim 21 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R7 is halogen or CF3.
23. The method of Claim 10 wherein
J substituted with 1 to 3 R5 is J-l 2;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
24. The method of Claim 23 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2; CC1F2, CH2CF3, or CF2CHF2.
25. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-l 3; R3 is C - -C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3 ; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2) S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, C--C4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
26. The method of Claim 25 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH7CF3, or CF2CHF2.
27. The method of Claim 1 wherein the compound of Formula I is selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-8-methyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-
(l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3,8-dimethyl-
4(3H)-quinazoline, 6-chloro-2-[3-chloro-l-(3-chloiO-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-8-methyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3- (l,l-dimethylethyl)-S-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3,8- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl-
8-methyl-4(3H)-quinazoline, 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3-(l-methylethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-
(l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-(l-methylethyl)- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazo line, 2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethyl ethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-p">τazol-5-yl]-3- ethyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-methyl-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-
(l-methylethyl)-4(3H)-quinazoline, 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-methyl- 4(3H)-quinazoline,
6,S-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-
(l-methylethyl)-4(3H)-quinazoline.
28. The method of Claim 1 wherein the compound of Formula I is comprised in a composition, said composition optionally further comprising an effective amount of at least one additional biologically active compound or agent.
29. The method of Claim 28 wherein at least one additional biologically active compound or agent is selected from arthropodicides of the group consisting of pyrethroids, carbamates, neonicotinoids, neuronal sodium channel blockers, insecticidal macrocyclic lactones, γ-aminobutyric acid (GABA) antagonists, insecticidal ureas and juvenile hormone mimics.
30. The method of Claim 28 wherein at least one additional biologically active compound or agent is selected from insecticide, nematocide, acaricide or biological agents in the group consisting of abamectin, acephate, acetamiprid, avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, cliromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, fenoxycarb, fenpropathrin, fenproximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, monocrotophos, methoxyfenozide, nithiazin, novaluron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, sulprofos, tebufenozide, teflubenzuron, teflutl rin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, tliiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron, aldicarb, oxamyl, fenamiphos, amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben, tebufenpyrad, Bacillus thiiringiensis, Bacillus thiiringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, vims and fungi.
31. The method of Claim 30 wherein at least one additional biologically active compound or agent is selected from insecticide, nematocide, acaricide or biological agents in the group consisting of cypermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, esfenvalerate, fenvalerate, tralomethrin, fenothicarb, methomyl, oxamyl, thiodicarb, clothianidin, imidacloprid, thiacloprid, indoxacarb, spinosad, abamectin, aveπnectin, emamectin, endosulfan, ethiprole, fipronil, flufenoxuron, triflumuron, diofenolan, pyriproxyfen, pymetrozine, amitraz, Bacillus thiiringiensis, Bacillus thiiringiensis delta endotoxin and entomophagous fungi.
32. The method of Claim 1 wherein at least one insect pest controlled is selected from the group consisting oi Alabama argillacea Hϋbner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenee (rice leaf roller), Crambus caliginosellus Clemens (co root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hϋbner (American bollworm), Helicoverpa zea Boddie (com earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & Schiffermϋller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plutella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hϋbner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplusia ni Hϋbner (cabbage looper) and Tuta absoluta Meyrick (tomato leafminer), Acyrthisiphon pisum Harris (pea ■ aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aiilacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis e ysimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosipum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribisnigri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (com leaf aphid), Rhopalosiphum padi Limiaeus (bird cherry-oat aphid), Schizaphis gramimtm Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citms aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (cit s whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus Stal (rice leafhopper), Nilapa -vata lugens Stal (brown planthopper), Peregrinus maidis Ashmead (com planthopper), Sogatella furcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Eiγthroneoura spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Iceiγa purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosas Comstock (San Jose scale); Planococcus citri Risso (citms mealybug); Pseitdococcus spp. (other mealybug complex); Cacopsγlla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla), Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Coiγthuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schaffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf- footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper), Frankliniella occidentalis Pergande (western flower thrip), Scirthothrips citri Moulton (citms thrip), Sericothrips variabilis Beach (soybean thrip), and Thrips tabaci Lindeman (onion thrip), Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).
33. A compound of Formula la, its N-oxide or an agriculturally suitable salt of the compound
la
wherein
K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
R3 is Cj-Cg alkyl, C2-C6 alkenyl, C2-Cg alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, CrC2 alkoxy, CrC2 alkylthio, CrC2 alkylsulfinyl and CrC2 alkylsulfonyl; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is CrC alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, -C4 alkylthio, -C4 alkylsulfinyl, -C4 alkylsulfonyl, C-A4 haloalkylthio, -C4 haloalkylsulfinyl, or CJ-C4 haloalkylsulfonyl; and an optional second R4 is H, CrC6 alkyl, C2-C6 alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C--C6 haloalkyl, C2-Cg haloalkenyl, C7-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C--C4 haloalkylthio, Cj-C4 haloalkylsulfinyl, C C4 haloalkylsulfonyl, CrC4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, Ct-C4 alkoxyalkyl, C--C hydroxyalkyl, C(O)R10, CO2R10, C^NR^ 1 NR10RJ *, N(R* ^COR-O, N(R* ^CO^10 or C3-C6 trialkylsilyl; R5 is
V is N, CH, CF, CC1, CBr or CI; each R6 is independently Cj-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C]-C4 haloalkyl, C7-C4 haloalkenyl, C7-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, CrC4 alkylamino, C2-Cg dialkylamino, C3- Cg cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3- C6 trialkylsilyl; each R7 is independently H, Cj-Cg alkyl, C Cg haloalkyl, halogen, CN, C--C4 alkoxy, C1-C4 haloalkoxy or C1-C4 haloalkylthio;
R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; R10 is H or C--C4 alkyl or C*-C4 haloalkyl;
R11 is H or C!-C4 alkyl; and n is 0, 1 or 2.
34. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-6; R3 is C-J-C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
35. The compound of Claim 34 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
36. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-7;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C - -C4 alkyl, C - -C4 haloalkyl, halogen or CN;
R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
37. The compound of Claim 36 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
38. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-8;
R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen;
R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
39. The compound of Claim 38 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
40. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-9;
R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN;
R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
41. The compound of Claim 40 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R7 is CF3.
42. The compound of Claim 33 wherein
J substituted with 1 to 3 R5 is J-10;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN;
R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
43. The compound of Claim 42 wherein
R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH7CF3, or CF2CHF2.
44. The compound of Claim 33 wherein
J substituted with 1 to 3 R5 is J-l 1;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN;
R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
45. The compound of Claim 44 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
46. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-l 2; R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
47. The compound of Claim 46 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3 ;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
48. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-l 3; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
49. The compound of Claim 48 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
50. The compound of Claim 33 selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl- 4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-8-methyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2 -pyridinyl)- lH-pyrazol-5-yl]-6-chloro-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-
(l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2 -pyridinyl)- lH-pyrazol-5-yl]-3,8-dimethyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-8-methyl- 4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethyl ethyl)-8-methyl-4(3H)-quinazoline, 6-chloro-2-[ 1 -(3 -chloro-2-pyridinyl)-3 -(trifluoromethyl)- 1 H-pyrazol-5-yl] -3 , 8- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl-
S-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3-(l -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloiO-2-pyridinyl)-3-(trifluoroniethyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-S-methyl-3-(l-methylethyl)-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- ethyl-4(3H)-quinazoline, 6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,S-dichloiO-3-methyl-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3- ( 1 -methyl ethyl)-4(3H)-quinazoline, 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-methyl-
4(3H)-quinazoline,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and
6, 8-dichloro-2- [3-chloro- 1 -(3 -chloro-2-pyridinyl)- 1 H-pyrazol-5 -yl] -3- (1 -methylethyl)-4(3H)-quinazoline.
51. A composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Fomiula la of Claim 33 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
52. A composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Fomiula la of Claim 33 and an effective amount of at least one additional biologically active compound or agent.
EP01996125A 2000-12-11 2001-12-03 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests Withdrawn EP1341772A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25461400P 2000-12-11 2000-12-11
US254614P 2000-12-11
PCT/US2001/046629 WO2002048115A2 (en) 2000-12-11 2001-12-03 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests

Publications (1)

Publication Number Publication Date
EP1341772A2 true EP1341772A2 (en) 2003-09-10

Family

ID=22964948

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01996125A Withdrawn EP1341772A2 (en) 2000-12-11 2001-12-03 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests

Country Status (4)

Country Link
EP (1) EP1341772A2 (en)
JP (1) JP2004515543A (en)
AU (1) AU2002227243A1 (en)
WO (1) WO2002048115A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110747A1 (en) 2001-03-07 2002-09-12 Bayer Ag Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use
KR100849815B1 (en) * 2001-05-21 2008-07-31 이 아이 듀폰 디 네모아 앤드 캄파니 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
AR036872A1 (en) 2001-08-13 2004-10-13 Du Pont ANTRANILAMIDE COMPOSITE, COMPOSITION THAT INCLUDES IT AND METHOD FOR CONTROLLING AN INVERTEBRATE PEST
EP1944304B1 (en) * 2001-08-13 2012-11-28 E.I. Du Pont De Nemours And Company Substituted 1h-dihydropyrazoles, their preparation and use
TWI312274B (en) 2001-08-13 2009-07-21 Du Pont Method for controlling particular insect pests by applying anthranilamide compounds
AU2002319814A1 (en) 2001-08-13 2003-03-03 E.I. Du Pont De Nemours And Company Substituted 1h-dihydropyrazoles, their preparation and use
AU2002331706B2 (en) 2001-08-15 2009-01-22 E.I. Du Pont De Nemours And Company Ortho-substituted aryl amides for controlling invertebrate pests
TWI283164B (en) 2001-09-21 2007-07-01 Du Pont Anthranilamide arthropodicide treatment
TWI326283B (en) * 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
US7863428B2 (en) * 2002-12-27 2011-01-04 Tibotec Bvba Fluorogenic enzyme substrates and methods of preparation
CL2004000234A1 (en) * 2003-02-12 2005-04-15 Biogen Idec Inc DERIVATIVE COMPOUNDS 3- (PIRIDIN-2-IL) -4-HETEROARIL-PIRAZOL SUBSTITUTED, ANTAGONISTS OF AIK5 AND / OR AIK4; PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND IN THE TREATMENT OF FIBROTIC DISORDERS AS SCLERODERMIA, LUPUS NEFRITICO, CICATRIZACION DE HERID
DE102004006075A1 (en) 2003-11-14 2005-06-16 Bayer Cropscience Ag Composition for controlling animal pests comprises a synergistic combination of a nicotinergic acetylcholine receptor agonist or antagonist and an anthranilamide derivative
NZ551004A (en) 2004-04-02 2010-07-30 Prana Biotechnology Ltd Neurologically-active compounds
DE102004042607A1 (en) 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituted phenylaminothiazoles and their use
TWI363756B (en) * 2004-12-07 2012-05-11 Du Pont Method for preparing n-phenylpyrazole-1-carboxamides
UY30090A1 (en) 2006-01-16 2007-08-31 Syngenta Participations Ag NEW INSECTICIDES
DE102006042143A1 (en) 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Novel substituted bipyridine derivatives and their use
DE102006056739A1 (en) 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituted 4-amino-3,5-dicyano-2-thiopyridines and their use
DE102006056740A1 (en) 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclic substituted 3,5-dicyano-2-thiopyridines and their use
DE102007035367A1 (en) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituted aryloxazoles and their use
DE102007036076A1 (en) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid Produgs and their use
DE102007061764A1 (en) 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellated cyanopyridines and their use
DE102007061763A1 (en) 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituted azabicyclic compounds and their use
DE102008013587A1 (en) 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituted dicyanopyridines and their use
CN101531638B (en) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 Compound used as a regulator of estrogen-related receptor and applications thereof
ES2428818T3 (en) 2008-05-29 2013-11-11 Bayer Intellectual Property Gmbh Dicianopyridines substituted with 2-alkoxy and their use
CN101380020B (en) * 2008-07-17 2012-11-07 张少武 Acaricide composition containing fenpyroximate with synergistic action
CN101628913B (en) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 Compound as estrogen-related receptor modulator and application thereof
DE102008062567A1 (en) 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid prodrugs and their use
DE102009006602A1 (en) 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
CN102285971B (en) * 2010-06-21 2013-12-18 中国中化股份有限公司 Pyrazolyl quinazolinone compound and application thereof
DE102010030688A1 (en) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituted dicyanopyridines and their use
US9150588B2 (en) 2010-08-10 2015-10-06 Takeda Pharmaceutical Company Limited Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
US20120058983A1 (en) 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
CN104542691A (en) * 2011-05-04 2015-04-29 陕西韦尔奇作物保护有限公司 Pesticide composition containing etoxazole
CN102260245A (en) * 2011-06-02 2011-11-30 南开大学 2,3-dihydro-quinazolinone derivative, and preparation method and application thereof
CN103355340B (en) * 2012-03-31 2016-02-17 陕西韦尔奇作物保护有限公司 A kind of Pesticidal combination containing pyridalyl
CN104395298A (en) * 2012-06-22 2015-03-04 住友化学株式会社 Fused heterocyclic compound
CN105418590B (en) * 2014-09-18 2018-06-29 沈阳中化农药化工研发有限公司 6- substituted pyrazolecarboxylic base quianzolinones and application thereof
CN105532711B (en) * 2016-01-15 2018-07-13 陕西上格之路生物科学有限公司 A kind of Pesticidal combination and application thereof containing clothianidin and cyromazine
US11957759B1 (en) 2022-09-07 2024-04-16 Arvinas Operations, Inc. Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0687835A (en) * 1992-07-17 1994-03-29 Rohm & Haas Co Herbicidal 2-aryl-5,6-condensed-ring pyrimidine
ATE144500T1 (en) * 1992-07-17 1996-11-15 Rohm & Haas 2-SUBSTITUTED PYRIMIDINES AND THEIR USE AS HERBICIDES
MY115814A (en) * 1995-06-16 2003-09-30 Bayer Ip Gmbh Crop protection compositions
GB9613637D0 (en) * 1996-06-28 1996-08-28 Agrevo Uk Ltd Fungicidal compositions
GB9719411D0 (en) * 1997-09-12 1997-11-12 Ciba Geigy Ag New Pesticides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0248115A3 *

Also Published As

Publication number Publication date
AU2002227243A1 (en) 2002-06-24
WO2002048115A2 (en) 2002-06-20
JP2004515543A (en) 2004-05-27
WO2002048115A3 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
AU2003212811B2 (en) Quinazoline(di) ones for invertebrate pest control
AU2002331706B2 (en) Ortho-substituted aryl amides for controlling invertebrate pests
AU2002254107B2 (en) Heterocyclic diamide invertebrate pest control agents
WO2002048115A2 (en) Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
AU2003295491B2 (en) Novel anthranilamide insecticides
US20040242645A1 (en) Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
AU2002343512B2 (en) Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
US20040110777A1 (en) Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
AU2003212811A1 (en) Quinazoline(di) ones for invertebrate pest control
AU2002331706A1 (en) Ortho-substituted aryl amides for controlling invertebrate pests
WO2004033468A1 (en) Anthranilamide insecticides
AU2005277228A1 (en) Novel anthranilamides useful for controlling invertebrate pests
US7157475B2 (en) Diamide invertebrate pest control agents
AU2002343512A1 (en) Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
US20040235959A1 (en) Insecticidal diamides
EP1511385A1 (en) Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
WO2002032856A2 (en) Insecticidal 1,8-naphthalenedicarboxamides
AU2003202966A1 (en) Diamide invertebrate pest control agents
AU2002334581A1 (en) Insecticidal diamides
AU2002331708A1 (en) Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030512

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

R17D Deferred search report published (corrected)

Effective date: 20020906

17Q First examination report despatched

Effective date: 20040121

RBV Designated contracting states (corrected)

Designated state(s): AT BE CH CY DE ES FR IT LI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070703